Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type

Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

154634333 185321 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 185321 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
326869 112874 None 2 Human Functional pEC50 = 9.0 9.0 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 112874 None 2 Human Functional pEC50 = 9.0 9.0 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
164610101 184981 None 0 Human Functional pEC50 = 7 7.0 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 184981 None 0 Human Functional pEC50 = 7 7.0 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
135399235 4134 None 41 Mouse Functional pEC50 = 6 6.0 -31 3
Agonist activity at mouse GPR35 by beta-arrestin recruitment assayAgonist activity at mouse GPR35 by beta-arrestin recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmc.2023.117511
2919 4134 None 41 Mouse Functional pEC50 = 6 6.0 -31 3
Agonist activity at mouse GPR35 by beta-arrestin recruitment assayAgonist activity at mouse GPR35 by beta-arrestin recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmc.2023.117511
5722 4134 None 41 Mouse Functional pEC50 = 6 6.0 -31 3
Agonist activity at mouse GPR35 by beta-arrestin recruitment assayAgonist activity at mouse GPR35 by beta-arrestin recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmc.2023.117511
CHEMBL28079 4134 None 41 Mouse Functional pEC50 = 6 6.0 -31 3
Agonist activity at mouse GPR35 by beta-arrestin recruitment assayAgonist activity at mouse GPR35 by beta-arrestin recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmc.2023.117511
12138435 68079 None 26 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
CHEMBL1914576 68079 None 26 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
70696510 75329 None 0 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 296 1 1 3 4.1 O=C(O)c1sc2c(Br)csc2c1Cl 10.1016/j.bmcl.2012.04.057
CHEMBL2037458 75329 None 0 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 296 1 1 3 4.1 O=C(O)c1sc2c(Br)csc2c1Cl 10.1016/j.bmcl.2012.04.057
70682869 77410 None 0 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 275 2 4 4 3.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccsc1 10.1021/ml300076u
CHEMBL2086422 77410 None 0 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 275 2 4 4 3.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccsc1 10.1021/ml300076u
5281605 208190 None 72 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
CHEMBL8260 208190 None 72 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
172462775 196680 None 0 Human Functional pEC50 = 6.0 6.0 -8 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 490 4 2 6 4.2 O=C(Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC2CCCC2)c1Cl)C(=O)OC1CCCC1 10.1016/j.bmc.2023.117511
CHEMBL5429740 196680 None 0 Human Functional pEC50 = 6.0 6.0 -8 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 490 4 2 6 4.2 O=C(Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC2CCCC2)c1Cl)C(=O)OC1CCCC1 10.1016/j.bmc.2023.117511
145950576 162974 None 0 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 333 3 2 5 2.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccco1 10.1021/acsmedchemlett.7b00510
CHEMBL4173352 162974 None 0 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 333 3 2 5 2.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccco1 10.1021/acsmedchemlett.7b00510
70687103 77731 None 0 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 337 2 4 3 4.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(Cl)cc(Cl)c1 10.1021/ml300076u
CHEMBL2089222 77731 None 0 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 337 2 4 3 4.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(Cl)cc(Cl)c1 10.1021/ml300076u
70687102 77730 None 0 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1ccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)cc1 10.1021/ml300076u
CHEMBL2089221 77730 None 0 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1ccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)cc1 10.1021/ml300076u
5281855 205301 None 65 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
CHEMBL6246 205301 None 65 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
53257379 68083 None 0 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 363 1 0 4 5.0 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1Cl 10.1021/jm200999f
CHEMBL1914580 68083 None 0 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 363 1 0 4 5.0 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1Cl 10.1021/jm200999f
135403802 26539 None 39 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
CHEMBL1360563 26539 None 39 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
411 2593 None 63 Human Functional pEC50 = 5.0 5.0 -144 2
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
5281670 2593 None 63 Human Functional pEC50 = 5.0 5.0 -144 2
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
CHEMBL28626 2593 None 63 Human Functional pEC50 = 5.0 5.0 -144 2
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
4488 205479 None 66 Human Functional pEC50 = 5.9 5.9 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
CHEMBL63323 205479 None 66 Human Functional pEC50 = 5.9 5.9 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
70692387 75336 None 2 Human Functional pEC50 = 4.9 4.9 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 259 1 2 2 3.0 Cc1c(C(=O)O)[nH]c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037465 75336 None 2 Human Functional pEC50 = 4.9 4.9 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 259 1 2 2 3.0 Cc1c(C(=O)O)[nH]c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
66561718 75333 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 275 2 1 4 4.0 Cc1c(C(=O)O)sc2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037462 75333 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 275 2 1 4 4.0 Cc1c(C(=O)O)sc2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
172457931 196452 None 0 Mouse Functional pEC50 = 6.9 6.9 -1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 434 4 2 6 2.6 O=C(Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC2CC2)c1Cl)C(=O)OC1CC1 10.1016/j.bmc.2023.117511
CHEMBL5424229 196452 None 0 Mouse Functional pEC50 = 6.9 6.9 -1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 434 4 2 6 2.6 O=C(Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC2CC2)c1Cl)C(=O)OC1CC1 10.1016/j.bmc.2023.117511
71733843 90890 None 7 Human Functional pEC50 = 7.9 7.9 87 3
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1016/j.bmc.2023.117511
CHEMBL2392174 90890 None 7 Human Functional pEC50 = 7.9 7.9 87 3
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1016/j.bmc.2023.117511
CHEMBL2425818 90890 None 7 Human Functional pEC50 = 7.9 7.9 87 3
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1016/j.bmc.2023.117511
172452315 196082 None 0 Mouse Functional pEC50 = 7.9 7.9 11 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 320 2 4 4 0.8 O=C(O)C(=O)Nc1cc(NC(=O)C(=O)O)cc(C(F)(F)F)c1 10.1016/j.bmc.2023.117511
CHEMBL5416593 196082 None 0 Mouse Functional pEC50 = 7.9 7.9 11 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 320 2 4 4 0.8 O=C(O)C(=O)Nc1cc(NC(=O)C(=O)O)cc(C(F)(F)F)c1 10.1016/j.bmc.2023.117511
154634327 184845 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 184845 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
153273978 198382 None 6 Human Functional pEC50 = 4.9 4.9 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
5098885 198382 None 6 Human Functional pEC50 = 4.9 4.9 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
CHEMBL559337 198382 None 6 Human Functional pEC50 = 4.9 4.9 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
12897316 196999 None 0 Human Functional pEC50 = 6.9 6.9 41 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 330 3 5 5 0.1 O=C(O)C(=O)Nc1cc(C(=O)O)cc(NC(=O)C(=O)O)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL5436420 196999 None 0 Human Functional pEC50 = 6.9 6.9 41 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 330 3 5 5 0.1 O=C(O)C(=O)Nc1cc(C(=O)O)cc(NC(=O)C(=O)O)c1Cl 10.1016/j.bmc.2023.117511
172462775 196680 None 0 Mouse Functional pEC50 = 6.9 6.9 8 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 490 4 2 6 4.2 O=C(Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC2CCCC2)c1Cl)C(=O)OC1CCCC1 10.1016/j.bmc.2023.117511
CHEMBL5429740 196680 None 0 Mouse Functional pEC50 = 6.9 6.9 8 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 490 4 2 6 4.2 O=C(Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC2CCCC2)c1Cl)C(=O)OC1CCCC1 10.1016/j.bmc.2023.117511
70681838 75325 None 0 Human Functional pEC50 = 5.9 5.9 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 290 1 1 3 4.0 Cc1sc2c(C)c(C(=O)O)sc2c1Br 10.1016/j.bmcl.2012.04.057
CHEMBL2037453 75325 None 0 Human Functional pEC50 = 5.9 5.9 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 290 1 1 3 4.0 Cc1sc2c(C)c(C(=O)O)sc2c1Br 10.1016/j.bmcl.2012.04.057
70689185 77734 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 337 2 4 3 4.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccc(C(F)(F)F)cc1 10.1021/ml300076u
CHEMBL2089225 77734 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 337 2 4 3 4.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccc(C(F)(F)F)cc1 10.1021/ml300076u
72103 43422 None 23 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 356 5 4 4 2.1 CCCCc1cc2c(=O)cc(C(=O)O)[nH]c2c2c(=O)cc(C(=O)O)[nH]c12 10.1016/j.bmc.2023.117511
CHEMBL150764 43422 None 23 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 356 5 4 4 2.1 CCCCc1cc2c(=O)cc(C(=O)O)[nH]c2c2c(=O)cc(C(=O)O)[nH]c12 10.1016/j.bmc.2023.117511
72103 43422 None 23 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 356 5 4 4 2.1 CCCCc1cc2c(=O)cc(C(=O)O)[nH]c2c2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL150764 43422 None 23 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 356 5 4 4 2.1 CCCCc1cc2c(=O)cc(C(=O)O)[nH]c2c2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
154634331 184654 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4848109 184654 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145951566 162860 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4171782 162860 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
145951566 162860 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4171782 162860 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
145959592 162444 None 0 Human Functional pEC50 = 5.9 5.9 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4164993 162444 None 0 Human Functional pEC50 = 5.9 5.9 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
411 2593 None 63 Human Functional pEC50 = 5.9 5.9 -144 2
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
5281670 2593 None 63 Human Functional pEC50 = 5.9 5.9 -144 2
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
CHEMBL28626 2593 None 63 Human Functional pEC50 = 5.9 5.9 -144 2
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
135399235 4134 None 41 Human Functional pEC50 = 6.9 6.9 -18 3
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
2919 4134 None 41 Human Functional pEC50 = 6.9 6.9 -18 3
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
5722 4134 None 41 Human Functional pEC50 = 6.9 6.9 -18 3
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
CHEMBL28079 4134 None 41 Human Functional pEC50 = 6.9 6.9 -18 3
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
12533774 185624 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4862654 185624 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
172455183 196373 None 0 Human Functional pEC50 = 6.9 6.9 -2 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 518 4 2 6 5.0 O=C(Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC2CCCCC2)c1Cl)C(=O)OC1CCCCC1 10.1016/j.bmc.2023.117511
CHEMBL5422437 196373 None 0 Human Functional pEC50 = 6.9 6.9 -2 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 518 4 2 6 5.0 O=C(Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC2CCCCC2)c1Cl)C(=O)OC1CCCCC1 10.1016/j.bmc.2023.117511
172452315 196082 None 0 Human Functional pEC50 = 6.8 6.8 -11 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 320 2 4 4 0.8 O=C(O)C(=O)Nc1cc(NC(=O)C(=O)O)cc(C(F)(F)F)c1 10.1016/j.bmc.2023.117511
CHEMBL5416593 196082 None 0 Human Functional pEC50 = 6.8 6.8 -11 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 320 2 4 4 0.8 O=C(O)C(=O)Nc1cc(NC(=O)C(=O)O)cc(C(F)(F)F)c1 10.1016/j.bmc.2023.117511
53258793 68092 None 0 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 374 8 1 3 6.3 CCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914589 68092 None 0 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 374 8 1 3 6.3 CCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
5281672 56570 None 72 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL164 56570 None 72 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
70694439 75331 None 0 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 222 1 1 3 3.0 C#Cc1csc2c(C)c(C(=O)O)sc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037460 75331 None 0 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 222 1 1 3 3.0 C#Cc1csc2c(C)c(C(=O)O)sc12 10.1016/j.bmcl.2012.04.057
154634337 185439 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4859764 185439 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
135468531 90858 None 19 Human Functional pEC50 = 7.8 7.8 524 3
GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.6019/CHEMBL5442687
CHEMBL2392141 90858 None 19 Human Functional pEC50 = 7.8 7.8 524 3
GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.6019/CHEMBL5442687
16103462 68091 None 17 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914588 68091 None 17 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
12138434 68084 None 1 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 317 4 0 4 4.4 CCCCc1ccc(C2(C)OC(=C(C#N)C#N)C(C#N)=C2C)cc1 10.1021/jm200999f
CHEMBL1914581 68084 None 1 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 317 4 0 4 4.4 CCCCc1ccc(C2(C)OC(=C(C#N)C#N)C(C#N)=C2C)cc1 10.1021/jm200999f
66561717 75327 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 356 1 2 4 3.9 O=C(O)c1sc2c(Br)c(Br)sc2c1O 10.1016/j.bmcl.2012.04.057
CHEMBL2037456 75327 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 356 1 2 4 3.9 O=C(O)c1sc2c(Br)c(Br)sc2c1O 10.1016/j.bmcl.2012.04.057
135399235 4134 None 41 Human Functional pEC50 = 6.8 6.8 -18 3
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
2919 4134 None 41 Human Functional pEC50 = 6.8 6.8 -18 3
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
5722 4134 None 41 Human Functional pEC50 = 6.8 6.8 -18 3
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
CHEMBL28079 4134 None 41 Human Functional pEC50 = 6.8 6.8 -18 3
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
135399235 4134 None 41 Human Functional pEC50 = 6.8 6.8 -18 3
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
2919 4134 None 41 Human Functional pEC50 = 6.8 6.8 -18 3
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
5722 4134 None 41 Human Functional pEC50 = 6.8 6.8 -18 3
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
CHEMBL28079 4134 None 41 Human Functional pEC50 = 6.8 6.8 -18 3
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
70691268 77738 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 364 1 2 3 4.1 Cc1c(C(=O)O)sc2cc(Br)c(O)c(Br)c12 10.1021/ml300076u
CHEMBL2089229 77738 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 364 1 2 3 4.1 Cc1c(C(=O)O)sc2cc(Br)c(O)c(Br)c12 10.1021/ml300076u
135399235 4134 None 41 Human Functional pEC50 = 6.8 6.8 -18 3
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
2919 4134 None 41 Human Functional pEC50 = 6.8 6.8 -18 3
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
5722 4134 None 41 Human Functional pEC50 = 6.8 6.8 -18 3
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
CHEMBL28079 4134 None 41 Human Functional pEC50 = 6.8 6.8 -18 3
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
151577785 186659 None 0 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4878047 186659 None 0 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
45093111 77735 None 7 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 208 1 3 4 1.9 Cc1c(C(=O)O)oc2cc(O)c(O)cc12 10.1021/ml300076u
CHEMBL2089226 77735 None 7 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 208 1 3 4 1.9 Cc1c(C(=O)O)oc2cc(O)c(O)cc12 10.1021/ml300076u
154634333 185321 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 185321 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
154634330 186058 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4869539 186058 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634321 186103 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 186103 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
135468531 90858 None 19 Mouse Functional pEC50 = 4.8 4.8 -1122 3
Agonist activity at mouse GPR35 by beta-arrestin recruitment assayAgonist activity at mouse GPR35 by beta-arrestin recruitment assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1016/j.bmc.2023.117511
CHEMBL2392141 90858 None 19 Mouse Functional pEC50 = 4.8 4.8 -1122 3
Agonist activity at mouse GPR35 by beta-arrestin recruitment assayAgonist activity at mouse GPR35 by beta-arrestin recruitment assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1016/j.bmc.2023.117511
9990345 68087 None 32 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 199 0 0 4 1.9 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)C 10.1021/jm200999f
CHEMBL1914584 68087 None 32 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 199 0 0 4 1.9 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)C 10.1021/jm200999f
70697499 77721 None 0 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 297 3 3 4 3.1 Cc1ccc(Cn2c(C(=O)O)cc3cc(O)c(O)cc32)cc1 10.1021/ml300076u
CHEMBL2089195 77721 None 0 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 297 3 3 4 3.1 Cc1ccc(Cn2c(C(=O)O)cc3cc(O)c(O)cc32)cc1 10.1021/ml300076u
12897302 110480 None 0 Human Functional pEC50 = 6.8 6.8 20 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 286 2 4 4 0.4 O=C(O)C(=O)Nc1cccc(NC(=O)C(=O)O)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL3245042 110480 None 0 Human Functional pEC50 = 6.8 6.8 20 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 286 2 4 4 0.4 O=C(O)C(=O)Nc1cccc(NC(=O)C(=O)O)c1Cl 10.1016/j.bmc.2023.117511
110720191 162552 None 1 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccc(-c3nnn[nH]3)cc2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4166802 162552 None 1 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccc(-c3nnn[nH]3)cc2)cc1 10.1021/acsmedchemlett.7b00510
70692386 75334 None 0 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 280 2 1 4 4.7 Cc1c(C(=O)O)sc2c(-c3ccsc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037463 75334 None 0 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 280 2 1 4 4.7 Cc1c(C(=O)O)sc2c(-c3ccsc3)csc12 10.1016/j.bmcl.2012.04.057
16103462 68091 None 17 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
CHEMBL1914588 68091 None 17 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
73157 197815 None 27 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
CHEMBL551842 197815 None 27 Human Functional pEC50 = 4.8 4.8 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
154634326 185198 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 185198 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
149708825 186497 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875771 186497 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
53258795 68093 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914590 68093 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
145959306 162409 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4164556 162409 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
145949189 162832 None 0 Human Functional pEC50 = 6.7 6.7 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4171326 162832 None 0 Human Functional pEC50 = 6.7 6.7 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
2920 2997 None 64 Human Functional pEC50 = 8.7 8.7 2398 2
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
54742459 2997 None 64 Human Functional pEC50 = 8.7 8.7 2398 2
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
8546 2997 None 64 Human Functional pEC50 = 8.7 8.7 2398 2
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
CHEMBL177880 2997 None 64 Human Functional pEC50 = 8.7 8.7 2398 2
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
154634332 185233 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 185233 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
172458982 196417 None 0 Mouse Functional pEC50 = 7.7 7.7 1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 442 7 2 8 2.2 CCOC(=O)C(=O)Nc1cc(C(=O)OCC(C)C)cc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL5423540 196417 None 0 Mouse Functional pEC50 = 7.7 7.7 1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 442 7 2 8 2.2 CCOC(=O)C(=O)Nc1cc(C(=O)OCC(C)C)cc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
145949189 162832 None 0 Human Functional pEC50 = 6.7 6.7 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4171326 162832 None 0 Human Functional pEC50 = 6.7 6.7 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
135399235 4134 None 41 Human Functional pEC50 = 5.7 5.7 -18 3
Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitmentAgonist activity at human GPR35 assessed as induction of beta-arrestin recruitment
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.7b00510
2919 4134 None 41 Human Functional pEC50 = 5.7 5.7 -18 3
Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitmentAgonist activity at human GPR35 assessed as induction of beta-arrestin recruitment
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.7b00510
5722 4134 None 41 Human Functional pEC50 = 5.7 5.7 -18 3
Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitmentAgonist activity at human GPR35 assessed as induction of beta-arrestin recruitment
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.7b00510
CHEMBL28079 4134 None 41 Human Functional pEC50 = 5.7 5.7 -18 3
Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitmentAgonist activity at human GPR35 assessed as induction of beta-arrestin recruitment
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.7b00510
135399235 4134 None 41 Human Functional pEC50 = 5.7 5.7 -18 3
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmc.2023.117511
2919 4134 None 41 Human Functional pEC50 = 5.7 5.7 -18 3
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmc.2023.117511
5722 4134 None 41 Human Functional pEC50 = 5.7 5.7 -18 3
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmc.2023.117511
CHEMBL28079 4134 None 41 Human Functional pEC50 = 5.7 5.7 -18 3
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmc.2023.117511
70693381 77726 None 0 Human Functional pEC50 = 4.7 4.7 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 269 2 4 3 2.9 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccccc1 10.1021/ml300076u
CHEMBL2089217 77726 None 0 Human Functional pEC50 = 4.7 4.7 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 269 2 4 3 2.9 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccccc1 10.1021/ml300076u
145958445 162225 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4161574 162225 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
152243845 185005 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4853043 185005 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
145955278 162654 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(Cl)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4168406 162654 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(Cl)c1 10.1021/acsmedchemlett.7b00510
152550147 185434 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4859675 185434 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
154634334 185531 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4861414 185531 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
70681838 75325 None 0 Human Functional pEC50 = 4.7 4.7 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 290 1 1 3 4.0 Cc1sc2c(C)c(C(=O)O)sc2c1Br 10.1016/j.bmcl.2012.04.057
CHEMBL2037453 75325 None 0 Human Functional pEC50 = 4.7 4.7 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 290 1 1 3 4.0 Cc1sc2c(C)c(C(=O)O)sc2c1Br 10.1016/j.bmcl.2012.04.057
70687102 77730 None 0 Human Functional pEC50 = 4.7 4.7 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1ccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)cc1 10.1021/ml300076u
CHEMBL2089221 77730 None 0 Human Functional pEC50 = 4.7 4.7 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1ccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)cc1 10.1021/ml300076u
53258795 68093 None 0 Human Functional pEC50 = 4.6 4.6 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914590 68093 None 0 Human Functional pEC50 = 4.6 4.6 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
5281605 208190 None 72 Human Functional pEC50 = 4.6 4.6 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
CHEMBL8260 208190 None 72 Human Functional pEC50 = 4.6 4.6 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
53258796 68094 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 444 13 1 3 8.3 CCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914591 68094 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 444 13 1 3 8.3 CCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
3715518 29766 None 5 Human Functional pEC50 = 4.6 4.6 -13 4
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 379 9 1 3 5.2 COc1ccc(CNCCC(c2ccc(F)cc2)c2ccc(OC)cc2)cc1 nan
CHEMBL1386881 29766 None 5 Human Functional pEC50 = 4.6 4.6 -13 4
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 379 9 1 3 5.2 COc1ccc(CNCCC(c2ccc(F)cc2)c2ccc(OC)cc2)cc1 nan
119405 97197 None 48 Human Functional pEC50 = 4.6 4.6 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 193 1 4 3 1.3 O=C(O)c1cc2cc(O)c(O)cc2[nH]1 10.1021/ml300076u
CHEMBL267855 97197 None 48 Human Functional pEC50 = 4.6 4.6 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 193 1 4 3 1.3 O=C(O)c1cc2cc(O)c(O)cc2[nH]1 10.1021/ml300076u
150386356 185252 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856916 185252 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
119405 97197 None 48 Human Functional pEC50 = 4.6 4.6 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 193 1 4 3 1.3 O=C(O)c1cc2cc(O)c(O)cc2[nH]1 10.1021/ml300076u
CHEMBL267855 97197 None 48 Human Functional pEC50 = 4.6 4.6 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 193 1 4 3 1.3 O=C(O)c1cc2cc(O)c(O)cc2[nH]1 10.1021/ml300076u
CHEMBL4784835 216536 None 44 Human Functional pEC50 = 6.6 6.6 - 1
GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35
ChEMBL None None None O=C([O-])c1cc2ccccc2c(Cc2c(O)c(C(=O)[O-])cc3ccccc23)c1O.[Na+].[Na+] 10.6019/CHEMBL5442687
73157 197815 None 27 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
CHEMBL551842 197815 None 27 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
152684818 185098 None 0 Human Functional pEC50 = 4.6 4.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
CHEMBL4854346 185098 None 0 Human Functional pEC50 = 4.6 4.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
66561718 75333 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 275 2 1 4 4.0 Cc1c(C(=O)O)sc2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037462 75333 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 275 2 1 4 4.0 Cc1c(C(=O)O)sc2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
70687103 77731 None 0 Human Functional pEC50 = 4.6 4.6 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 337 2 4 3 4.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(Cl)cc(Cl)c1 10.1021/ml300076u
CHEMBL2089222 77731 None 0 Human Functional pEC50 = 4.6 4.6 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 337 2 4 3 4.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(Cl)cc(Cl)c1 10.1021/ml300076u
66561717 75327 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 356 1 2 4 3.9 O=C(O)c1sc2c(Br)c(Br)sc2c1O 10.1016/j.bmcl.2012.04.057
CHEMBL2037456 75327 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 356 1 2 4 3.9 O=C(O)c1sc2c(Br)c(Br)sc2c1O 10.1016/j.bmcl.2012.04.057
70695483 77727 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccc(Cl)c1 10.1021/ml300076u
CHEMBL2089218 77727 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccc(Cl)c1 10.1021/ml300076u
70689184 77729 None 0 Human Functional pEC50 = 4.6 4.6 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1cccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)c1 10.1021/ml300076u
CHEMBL2089220 77729 None 0 Human Functional pEC50 = 4.6 4.6 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1cccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)c1 10.1021/ml300076u
154634327 184845 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 184845 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
135468531 90858 None 19 Human Functional pEC50 = 7.6 7.6 524 3
GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.6019/CHEMBL5442687
CHEMBL2392141 90858 None 19 Human Functional pEC50 = 7.6 7.6 524 3
GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.6019/CHEMBL5442687
172458982 196417 None 0 Human Functional pEC50 = 7.6 7.6 -1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 442 7 2 8 2.2 CCOC(=O)C(=O)Nc1cc(C(=O)OCC(C)C)cc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL5423540 196417 None 0 Human Functional pEC50 = 7.6 7.6 -1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 442 7 2 8 2.2 CCOC(=O)C(=O)Nc1cc(C(=O)OCC(C)C)cc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
172465526 196714 None 0 Human Functional pEC50 = 7.6 7.6 1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 364 2 4 4 1.1 O=C(O)C(=O)Nc1cc(Br)cc(NC(=O)C(=O)O)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL5430512 196714 None 0 Human Functional pEC50 = 7.6 7.6 1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 364 2 4 4 1.1 O=C(O)C(=O)Nc1cc(Br)cc(NC(=O)C(=O)O)c1Cl 10.1016/j.bmc.2023.117511
154634326 185198 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 185198 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
70691267 77733 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccc(Cl)cc1 10.1021/ml300076u
CHEMBL2089224 77733 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccc(Cl)cc1 10.1021/ml300076u
944642 59137 None 8 Human Functional pEC50 = 4.6 4.6 -30 4
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 324 5 2 4 4.2 CCOc1ccc(-c2n[nH]c(C)c2-c2ccc(OC)cc2)c(O)c1 nan
CHEMBL1698243 59137 None 8 Human Functional pEC50 = 4.6 4.6 -30 4
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 324 5 2 4 4.2 CCOc1ccc(-c2n[nH]c(C)c2-c2ccc(OC)cc2)c(O)c1 nan
135468531 90858 None 19 Human Functional pEC50 = 7.6 7.6 524 3
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1016/j.bmc.2023.117511
CHEMBL2392141 90858 None 19 Human Functional pEC50 = 7.6 7.6 524 3
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1016/j.bmc.2023.117511
70692386 75334 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 280 2 1 4 4.7 Cc1c(C(=O)O)sc2c(-c3ccsc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037463 75334 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 280 2 1 4 4.7 Cc1c(C(=O)O)sc2c(-c3ccsc3)csc12 10.1016/j.bmcl.2012.04.057
40915 78306 None 17 Mouse Functional pEC50 = 6.6 6.6 -9 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 367 4 2 7 1.2 CCOC(=O)C(=O)Nc1cc(C#N)cc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL2107161 78306 None 17 Mouse Functional pEC50 = 6.6 6.6 -9 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 367 4 2 7 1.2 CCOC(=O)C(=O)Nc1cc(C#N)cc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
70690212 75330 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 302 2 1 3 4.3 O=C(O)c1sc2c(Br)csc2c1C1CC1 10.1016/j.bmcl.2012.04.057
CHEMBL2037459 75330 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 302 2 1 3 4.3 O=C(O)c1sc2c(Br)csc2c1C1CC1 10.1016/j.bmcl.2012.04.057
66561793 75337 None 0 Human Functional pEC50 = 4.6 4.6 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 258 2 2 3 3.3 Cc1c(C(=O)O)[nH]c2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037466 75337 None 0 Human Functional pEC50 = 4.6 4.6 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 258 2 2 3 3.3 Cc1c(C(=O)O)[nH]c2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
172469929 197028 None 0 Mouse Functional pEC50 = 7.6 7.6 1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 382 2 2 6 1.6 COC(=O)C(=O)Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL5437161 197028 None 0 Mouse Functional pEC50 = 7.6 7.6 1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 382 2 2 6 1.6 COC(=O)C(=O)Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC)c1Cl 10.1016/j.bmc.2023.117511
150149078 186450 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875041 186450 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
172465526 196714 None 0 Mouse Functional pEC50 = 7.6 7.6 -1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 364 2 4 4 1.1 O=C(O)C(=O)Nc1cc(Br)cc(NC(=O)C(=O)O)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL5430512 196714 None 0 Mouse Functional pEC50 = 7.6 7.6 -1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 364 2 4 4 1.1 O=C(O)C(=O)Nc1cc(Br)cc(NC(=O)C(=O)O)c1Cl 10.1016/j.bmc.2023.117511
172448625 196009 None 0 Human Functional pEC50 = 7.5 7.5 1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 420 4 2 6 2.1 CCOC(=O)C(=O)Nc1cc(Br)cc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL5415083 196009 None 0 Human Functional pEC50 = 7.5 7.5 1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 420 4 2 6 2.1 CCOC(=O)C(=O)Nc1cc(Br)cc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
3884 44512 None 53 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
CHEMBL15193 44512 None 53 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
152727536 184593 None 0 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4847144 184593 None 0 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
40915 78306 None 17 Human Functional pEC50 = 7.5 7.5 9 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 367 4 2 7 1.2 CCOC(=O)C(=O)Nc1cc(C#N)cc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL2107161 78306 None 17 Human Functional pEC50 = 7.5 7.5 9 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 367 4 2 7 1.2 CCOC(=O)C(=O)Nc1cc(C#N)cc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
154634322 185486 None 0 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4860550 185486 None 0 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
5281855 205301 None 65 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
CHEMBL6246 205301 None 65 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
57134579 162727 None 21 Human Functional pEC50 = 4.5 4.5 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 239 1 2 4 1.2 Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4169520 162727 None 21 Human Functional pEC50 = 4.5 4.5 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 239 1 2 4 1.2 Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
2920 2997 None 64 Human Functional pEC50 = 7.5 7.5 2398 2
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1016/j.bmc.2023.117511
54742459 2997 None 64 Human Functional pEC50 = 7.5 7.5 2398 2
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1016/j.bmc.2023.117511
8546 2997 None 64 Human Functional pEC50 = 7.5 7.5 2398 2
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1016/j.bmc.2023.117511
CHEMBL177880 2997 None 64 Human Functional pEC50 = 7.5 7.5 2398 2
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1016/j.bmc.2023.117511
145957901 162169 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4160729 162169 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
145957901 162169 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4160729 162169 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
5281672 56570 None 72 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL164 56570 None 72 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
172469929 197028 None 0 Human Functional pEC50 = 7.5 7.5 -1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 382 2 2 6 1.6 COC(=O)C(=O)Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL5437161 197028 None 0 Human Functional pEC50 = 7.5 7.5 -1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 382 2 2 6 1.6 COC(=O)C(=O)Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC)c1Cl 10.1016/j.bmc.2023.117511
145951357 162859 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4171772 162859 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
154634320 186716 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4879017 186716 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
172454119 195785 None 0 Mouse Functional pEC50 = 5.5 5.5 -33 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 307 3 4 6 -0.4 COc1c(NC(=O)C(=O)O)cc(C#N)cc1NC(=O)C(=O)O 10.1016/j.bmc.2023.117511
CHEMBL5410743 195785 None 0 Mouse Functional pEC50 = 5.5 5.5 -33 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 307 3 4 6 -0.4 COc1c(NC(=O)C(=O)O)cc(C#N)cc1NC(=O)C(=O)O 10.1016/j.bmc.2023.117511
70683937 75067 None 0 Human Functional pEC50 = 4.5 4.5 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 408 1 1 3 5.2 O=C(O)c1sc2c(Br)c(Br)sc2c1C(F)(F)F 10.1016/j.bmcl.2012.04.057
CHEMBL2035007 75067 None 0 Human Functional pEC50 = 4.5 4.5 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 408 1 1 3 5.2 O=C(O)c1sc2c(Br)c(Br)sc2c1C(F)(F)F 10.1016/j.bmcl.2012.04.057
145951357 162859 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4171772 162859 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
12138435 68079 None 26 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
CHEMBL1914576 68079 None 26 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
5215 2386 None 74 Human Functional pEC50 = 5.5 5.5 -1 4
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
5280445 2386 None 74 Human Functional pEC50 = 5.5 5.5 -1 4
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
CHEMBL151 2386 None 74 Human Functional pEC50 = 5.5 5.5 -1 4
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
12897301 110477 None 0 Mouse Functional pEC50 = 5.5 5.5 -40 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 342 4 2 6 1.3 CCOC(=O)C(=O)Nc1cccc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL3245010 110477 None 0 Mouse Functional pEC50 = 5.5 5.5 -40 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 342 4 2 6 1.3 CCOC(=O)C(=O)Nc1cccc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
154634315 184984 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccc(F)cc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852718 184984 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccc(F)cc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
56646802 68080 None 0 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 351 1 0 4 3.8 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1c(F)c(F)c(F)c(F)c1F 10.1021/jm200999f
CHEMBL1914577 68080 None 0 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 351 1 0 4 3.8 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1c(F)c(F)c(F)c(F)c1F 10.1021/jm200999f
135399235 4134 None 41 Human Functional pEC50 = 6.5 6.5 -18 3
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
2919 4134 None 41 Human Functional pEC50 = 6.5 6.5 -18 3
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
5722 4134 None 41 Human Functional pEC50 = 6.5 6.5 -18 3
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
CHEMBL28079 4134 None 41 Human Functional pEC50 = 6.5 6.5 -18 3
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
16103482 68088 None 0 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1c(C(=O)O)sc2ccsc12 10.1021/jm200999f
CHEMBL1914585 68088 None 0 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1c(C(=O)O)sc2ccsc12 10.1021/jm200999f
70695483 77727 None 0 Human Functional pEC50 = 4.5 4.5 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccc(Cl)c1 10.1021/ml300076u
CHEMBL2089218 77727 None 0 Human Functional pEC50 = 4.5 4.5 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccc(Cl)c1 10.1021/ml300076u
145971743 163199 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4177096 163199 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
145971743 163199 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4177096 163199 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
11674067 68081 None 27 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 315 1 0 4 3.6 CC1=C(C#N)C(=C(C#N)C#N)OC1(c1ccccc1)C(F)(F)F 10.1021/jm200999f
CHEMBL1914578 68081 None 27 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 315 1 0 4 3.6 CC1=C(C#N)C(=C(C#N)C#N)OC1(c1ccccc1)C(F)(F)F 10.1021/jm200999f
12897302 110480 None 0 Mouse Functional pEC50 = 5.4 5.4 -20 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 286 2 4 4 0.4 O=C(O)C(=O)Nc1cccc(NC(=O)C(=O)O)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL3245042 110480 None 0 Mouse Functional pEC50 = 5.4 5.4 -20 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 286 2 4 4 0.4 O=C(O)C(=O)Nc1cccc(NC(=O)C(=O)O)c1Cl 10.1016/j.bmc.2023.117511
145953959 162772 None 0 Human Functional pEC50 = 5.4 5.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(C(F)(F)F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4170205 162772 None 0 Human Functional pEC50 = 5.4 5.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(C(F)(F)F)cc1 10.1021/acsmedchemlett.7b00510
70686064 75326 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 354 1 1 3 4.5 Cc1c(C(=O)O)sc2c(Br)c(Br)sc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037454 75326 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 354 1 1 3 4.5 Cc1c(C(=O)O)sc2c(Br)c(Br)sc12 10.1016/j.bmcl.2012.04.057
154634324 185817 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4865638 185817 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
70686065 75335 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 264 2 2 4 3.4 Cc1c(C(=O)O)sc2c(-c3cn[nH]c3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037464 75335 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 264 2 2 4 3.4 Cc1c(C(=O)O)sc2c(-c3cn[nH]c3)csc12 10.1016/j.bmcl.2012.04.057
12897304 110481 None 2 Mouse Functional pEC50 = 6.4 6.4 11 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 277 2 4 5 -0.4 N#Cc1cc(NC(=O)C(=O)O)cc(NC(=O)C(=O)O)c1 10.1016/j.bmc.2023.117511
CHEMBL3245047 110481 None 2 Mouse Functional pEC50 = 6.4 6.4 11 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 277 2 4 5 -0.4 N#Cc1cc(NC(=O)C(=O)O)cc(NC(=O)C(=O)O)c1 10.1016/j.bmc.2023.117511
145971240 163182 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4176719 163182 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145971240 163182 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4176719 163182 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
5491415 75318 None 18 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
CHEMBL2037378 75318 None 18 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
154634318 186105 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4870255 186105 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
70696510 75329 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 296 1 1 3 4.1 O=C(O)c1sc2c(Br)csc2c1Cl 10.1016/j.bmcl.2012.04.057
CHEMBL2037458 75329 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 296 1 1 3 4.1 O=C(O)c1sc2c(Br)csc2c1Cl 10.1016/j.bmcl.2012.04.057
2918 2204 None 75 Human Functional pEC50 = 4.4 4.4 -2630 4
Agonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assayAgonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
3845 2204 None 75 Human Functional pEC50 = 4.4 4.4 -2630 4
Agonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assayAgonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
CHEMBL299155 2204 None 75 Human Functional pEC50 = 4.4 4.4 -2630 4
Agonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assayAgonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
DB11937 2204 None 75 Human Functional pEC50 = 4.4 4.4 -2630 4
Agonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assayAgonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
70691265 77723 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 325 4 3 5 2.9 Cc1ccc(C(=O)Cn2c(C(=O)O)cc3cc(O)c(O)cc32)cc1 10.1021/ml300076u
CHEMBL2089197 77723 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 325 4 3 5 2.9 Cc1ccc(C(=O)Cn2c(C(=O)O)cc3cc(O)c(O)cc32)cc1 10.1021/ml300076u
4488 205479 None 66 Human Functional pEC50 = 4.4 4.4 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
CHEMBL63323 205479 None 66 Human Functional pEC50 = 4.4 4.4 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
145956623 162107 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4159575 162107 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
3325 2338 None 44 Human Functional pEC50 = 7.4 7.4 12 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1016/j.bmc.2023.117511
44564 2338 None 44 Human Functional pEC50 = 7.4 7.4 12 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1016/j.bmc.2023.117511
9743 2338 None 44 Human Functional pEC50 = 7.4 7.4 12 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1016/j.bmc.2023.117511
CHEMBL1201266 2338 None 44 Human Functional pEC50 = 7.4 7.4 12 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1016/j.bmc.2023.117511
DB06794 2338 None 44 Human Functional pEC50 = 7.4 7.4 12 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1016/j.bmc.2023.117511
145956623 162107 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4159575 162107 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
12897322 110482 None 0 Human Functional pEC50 = 7.4 7.4 1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 300 2 4 4 0.7 Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1 10.1016/j.bmc.2023.117511
CHEMBL3245049 110482 None 0 Human Functional pEC50 = 7.4 7.4 1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 300 2 4 4 0.7 Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1 10.1016/j.bmc.2023.117511
70682865 77724 None 0 Human Functional pEC50 = 5.4 5.4 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 1 4 3 2.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1Br 10.1021/ml300076u
CHEMBL2089199 77724 None 0 Human Functional pEC50 = 5.4 5.4 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 1 4 3 2.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1Br 10.1021/ml300076u
172448625 196009 None 0 Mouse Functional pEC50 = 7.4 7.4 -1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 420 4 2 6 2.1 CCOC(=O)C(=O)Nc1cc(Br)cc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL5415083 196009 None 0 Mouse Functional pEC50 = 7.4 7.4 -1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 420 4 2 6 2.1 CCOC(=O)C(=O)Nc1cc(Br)cc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
135399235 4134 None 41 Human Functional pEC50 = 5.4 5.4 -18 3
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
2919 4134 None 41 Human Functional pEC50 = 5.4 5.4 -18 3
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
5722 4134 None 41 Human Functional pEC50 = 5.4 5.4 -18 3
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
CHEMBL28079 4134 None 41 Human Functional pEC50 = 5.4 5.4 -18 3
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
3325 2338 None 44 Mouse Functional pEC50 = 6.4 6.4 -12 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1016/j.bmc.2023.117511
44564 2338 None 44 Mouse Functional pEC50 = 6.4 6.4 -12 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1016/j.bmc.2023.117511
9743 2338 None 44 Mouse Functional pEC50 = 6.4 6.4 -12 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1016/j.bmc.2023.117511
CHEMBL1201266 2338 None 44 Mouse Functional pEC50 = 6.4 6.4 -12 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1016/j.bmc.2023.117511
DB06794 2338 None 44 Mouse Functional pEC50 = 6.4 6.4 -12 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1016/j.bmc.2023.117511
660319 11007 None 59 Human Functional pEC50 = 4.4 4.4 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 184 1 1 3 2.7 O=C(O)c1cc2sccc2s1 10.1021/jm200999f
CHEMBL1173787 11007 None 59 Human Functional pEC50 = 4.4 4.4 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 184 1 1 3 2.7 O=C(O)c1cc2sccc2s1 10.1021/jm200999f
12126688 110479 None 0 Human Functional pEC50 = 5.4 5.4 1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 252 2 4 4 -0.3 O=C(O)C(=O)Nc1cccc(NC(=O)C(=O)O)c1 10.1016/j.bmc.2023.117511
CHEMBL3245041 110479 None 0 Human Functional pEC50 = 5.4 5.4 1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 252 2 4 4 -0.3 O=C(O)C(=O)Nc1cccc(NC(=O)C(=O)O)c1 10.1016/j.bmc.2023.117511
68324914 185837 None 34 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
CHEMBL4865971 185837 None 34 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
13950957 157420 None 8 Human Functional pEC50 = 5.4 5.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4077503 157420 None 8 Human Functional pEC50 = 5.4 5.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
15774808 77720 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 283 3 3 4 2.8 O=C(O)c1cc2cc(O)c(O)cc2n1Cc1ccccc1 10.1021/ml300076u
CHEMBL2089194 77720 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 283 3 3 4 2.8 O=C(O)c1cc2cc(O)c(O)cc2n1Cc1ccccc1 10.1021/ml300076u
145958495 162292 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
CHEMBL4162653 162292 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
70687104 77732 None 0 Human Functional pEC50 = 5.4 5.4 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 305 2 4 3 3.2 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(F)cc(F)c1 10.1021/ml300076u
CHEMBL2089223 77732 None 0 Human Functional pEC50 = 5.4 5.4 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 305 2 4 3 3.2 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(F)cc(F)c1 10.1021/ml300076u
70689180 77722 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 311 4 3 5 2.6 O=C(Cn1c(C(=O)O)cc2cc(O)c(O)cc21)c1ccccc1 10.1021/ml300076u
CHEMBL2089196 77722 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 311 4 3 5 2.6 O=C(Cn1c(C(=O)O)cc2cc(O)c(O)cc21)c1ccccc1 10.1021/ml300076u
145958495 162292 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
CHEMBL4162653 162292 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
10868388 162227 None 37 Human Functional pEC50 = 4.4 4.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 239 1 2 4 1.2 Nc1ccc(Br)cc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4161599 162227 None 37 Human Functional pEC50 = 4.4 4.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 239 1 2 4 1.2 Nc1ccc(Br)cc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
1599 2341 None 28 Human Functional pEC50 = 6.4 6.4 -239 32
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.6019/CHEMBL5442687
3955 2341 None 28 Human Functional pEC50 = 6.4 6.4 -239 32
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.6019/CHEMBL5442687
3955.0 2341 None 28 Human Functional pEC50 = 6.4 6.4 -239 32
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.6019/CHEMBL5442687
7215 2341 None 28 Human Functional pEC50 = 6.4 6.4 -239 32
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.6019/CHEMBL5442687
CHEMBL841 2341 None 28 Human Functional pEC50 = 6.4 6.4 -239 32
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.6019/CHEMBL5442687
DB00836 2341 None 28 Human Functional pEC50 = 6.4 6.4 -239 32
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.6019/CHEMBL5442687
145954149 162694 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4169062 162694 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
12897304 110481 None 2 Human Functional pEC50 = 5.4 5.4 -11 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 277 2 4 5 -0.4 N#Cc1cc(NC(=O)C(=O)O)cc(NC(=O)C(=O)O)c1 10.1016/j.bmc.2023.117511
CHEMBL3245047 110481 None 2 Human Functional pEC50 = 5.4 5.4 -11 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 277 2 4 5 -0.4 N#Cc1cc(NC(=O)C(=O)O)cc(NC(=O)C(=O)O)c1 10.1016/j.bmc.2023.117511
154634323 184710 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4848949 184710 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145954149 162694 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4169062 162694 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
15774807 77718 None 24 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 207 1 3 4 1.3 Cn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
CHEMBL2089192 77718 None 24 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 207 1 3 4 1.3 Cn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
53258898 68095 None 0 Human Functional pEC50 = 5.3 5.3 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 472 15 1 3 9.1 CCCCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914592 68095 None 0 Human Functional pEC50 = 5.3 5.3 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 472 15 1 3 9.1 CCCCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
70697498 77719 None 0 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 221 2 3 4 1.8 CCn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
CHEMBL2089193 77719 None 0 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 221 2 3 4 1.8 CCn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
21337669 68085 None 0 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 239 0 0 4 2.9 CC1=C(C#N)C(=C(C#N)C#N)OC12CCCCC2 10.1021/jm200999f
CHEMBL1914582 68085 None 0 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 239 0 0 4 2.9 CC1=C(C#N)C(=C(C#N)C#N)OC12CCCCC2 10.1021/jm200999f
145952561 163054 None 0 Human Functional pEC50 = 5.3 5.3 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(C(F)(F)F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4174783 163054 None 0 Human Functional pEC50 = 5.3 5.3 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(C(F)(F)F)c1 10.1021/acsmedchemlett.7b00510
70691268 77738 None 0 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 364 1 2 3 4.1 Cc1c(C(=O)O)sc2cc(Br)c(O)c(Br)c12 10.1021/ml300076u
CHEMBL2089229 77738 None 0 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 364 1 2 3 4.1 Cc1c(C(=O)O)sc2cc(Br)c(O)c(Br)c12 10.1021/ml300076u
135403802 26539 None 39 Human Functional pEC50 = 5.3 5.3 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
CHEMBL1360563 26539 None 39 Human Functional pEC50 = 5.3 5.3 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
3884 44512 None 53 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
CHEMBL15193 44512 None 53 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
154634328 185207 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856069 185207 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
164627011 186512 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 186512 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
2920 2997 None 64 Human Functional pEC50 = 6.3 6.3 2398 2
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
54742459 2997 None 64 Human Functional pEC50 = 6.3 6.3 2398 2
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
8546 2997 None 64 Human Functional pEC50 = 6.3 6.3 2398 2
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
CHEMBL177880 2997 None 64 Human Functional pEC50 = 6.3 6.3 2398 2
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
6619478 25945 None 1 Human Functional pEC50 = 6.3 6.3 -9 2
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 501 4 2 8 4.5 COc1ccc(NC(=O)c2cnn3c(O)cc(C4CCN(C(=O)OC(C)(C)C)CC4)nc23)cc1Cl nan
CHEMBL1354041 25945 None 1 Human Functional pEC50 = 6.3 6.3 -9 2
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 501 4 2 8 4.5 COc1ccc(NC(=O)c2cnn3c(O)cc(C4CCN(C(=O)OC(C)(C)C)CC4)nc23)cc1Cl nan
70683937 75067 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 408 1 1 3 5.2 O=C(O)c1sc2c(Br)c(Br)sc2c1C(F)(F)F 10.1016/j.bmcl.2012.04.057
CHEMBL2035007 75067 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 408 1 1 3 5.2 O=C(O)c1sc2c(Br)c(Br)sc2c1C(F)(F)F 10.1016/j.bmcl.2012.04.057
145955027 162635 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
CHEMBL4168042 162635 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
145955027 162635 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
CHEMBL4168042 162635 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
5491415 75318 None 18 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
CHEMBL2037378 75318 None 18 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
44351698 120912 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 464 8 3 7 3.2 O=C(O)c1cc(=O)c2c(CCC(O)CCc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1 10.1021/acs.jmedchem.0c01624
CHEMBL3558475 120912 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 464 8 3 7 3.2 O=C(O)c1cc(=O)c2c(CCC(O)CCc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1 10.1021/acs.jmedchem.0c01624
145958540 162364 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4163894 162364 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
6622007 39053 None 4 Human Functional pEC50 = 5.3 5.3 -9 4
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 489 3 2 7 4.6 CC(C)(C)OC(=O)N1CCC(c2cc(O)n3ncc(C(=O)Nc4ccc(F)c(Cl)c4)c3n2)CC1 nan
CHEMBL1468612 39053 None 4 Human Functional pEC50 = 5.3 5.3 -9 4
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 489 3 2 7 4.6 CC(C)(C)OC(=O)N1CCC(c2cc(O)n3ncc(C(=O)Nc4ccc(F)c(Cl)c4)c3n2)CC1 nan
145958540 162364 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4163894 162364 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
70683939 75332 None 0 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 238 2 1 3 3.8 Cc1c(C(=O)O)sc2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037461 75332 None 0 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 238 2 1 3 3.8 Cc1c(C(=O)O)sc2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
70686065 75335 None 0 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 264 2 2 4 3.4 Cc1c(C(=O)O)sc2c(-c3cn[nH]c3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037464 75335 None 0 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 264 2 2 4 3.4 Cc1c(C(=O)O)sc2c(-c3cn[nH]c3)csc12 10.1016/j.bmcl.2012.04.057
70690213 75339 None 0 Human Functional pEC50 = 5.3 5.3 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 273 1 1 3 3.0 Cc1c(C(=O)O)n(C)c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037468 75339 None 0 Human Functional pEC50 = 5.3 5.3 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 273 1 1 3 3.0 Cc1c(C(=O)O)n(C)c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
135399235 4134 None 41 Human Functional pEC50 = 5.3 5.3 -18 3
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
2919 4134 None 41 Human Functional pEC50 = 5.3 5.3 -18 3
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
5722 4134 None 41 Human Functional pEC50 = 5.3 5.3 -18 3
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
CHEMBL28079 4134 None 41 Human Functional pEC50 = 5.3 5.3 -18 3
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
12897316 196999 None 0 Mouse Functional pEC50 = 5.3 5.3 -41 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 330 3 5 5 0.1 O=C(O)C(=O)Nc1cc(C(=O)O)cc(NC(=O)C(=O)O)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL5436420 196999 None 0 Mouse Functional pEC50 = 5.3 5.3 -41 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 330 3 5 5 0.1 O=C(O)C(=O)Nc1cc(C(=O)O)cc(NC(=O)C(=O)O)c1Cl 10.1016/j.bmc.2023.117511
21337671 68086 None 0 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 297 1 0 4 3.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(F)cc1F 10.1021/jm200999f
CHEMBL1914583 68086 None 0 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 297 1 0 4 3.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(F)cc1F 10.1021/jm200999f
153273978 198382 None 6 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
5098885 198382 None 6 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
CHEMBL559337 198382 None 6 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
164627011 186512 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 186512 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
70694439 75331 None 0 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 222 1 1 3 3.0 C#Cc1csc2c(C)c(C(=O)O)sc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037460 75331 None 0 Human Functional pEC50 = 4.3 4.3 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 222 1 1 3 3.0 C#Cc1csc2c(C)c(C(=O)O)sc12 10.1016/j.bmcl.2012.04.057
12897310 110484 None 1 Mouse Functional pEC50 = 7.3 7.3 1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 354 2 4 4 1.4 O=C(O)C(=O)Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)O)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL3245052 110484 None 1 Mouse Functional pEC50 = 7.3 7.3 1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 354 2 4 4 1.4 O=C(O)C(=O)Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)O)c1Cl 10.1016/j.bmc.2023.117511
145971442 163122 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4175848 163122 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
2882 1208 None 41 Mouse Functional pEC50 = 4.2 4.2 -15 5
Agonist activity at mouse GPR35 by beta-arrestin recruitment assayAgonist activity at mouse GPR35 by beta-arrestin recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1016/j.bmc.2023.117511
741 1208 None 41 Mouse Functional pEC50 = 4.2 4.2 -15 5
Agonist activity at mouse GPR35 by beta-arrestin recruitment assayAgonist activity at mouse GPR35 by beta-arrestin recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1016/j.bmc.2023.117511
7608 1208 None 41 Mouse Functional pEC50 = 4.2 4.2 -15 5
Agonist activity at mouse GPR35 by beta-arrestin recruitment assayAgonist activity at mouse GPR35 by beta-arrestin recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1016/j.bmc.2023.117511
CHEMBL428880 1208 None 41 Mouse Functional pEC50 = 4.2 4.2 -15 5
Agonist activity at mouse GPR35 by beta-arrestin recruitment assayAgonist activity at mouse GPR35 by beta-arrestin recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1016/j.bmc.2023.117511
DB01003 1208 None 41 Mouse Functional pEC50 = 4.2 4.2 -15 5
Agonist activity at mouse GPR35 by beta-arrestin recruitment assayAgonist activity at mouse GPR35 by beta-arrestin recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1016/j.bmc.2023.117511
145971442 163122 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4175848 163122 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
2920 2997 None 64 Human Functional pEC50 = 6.2 6.2 2398 2
GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.6019/CHEMBL5442687
54742459 2997 None 64 Human Functional pEC50 = 6.2 6.2 2398 2
GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.6019/CHEMBL5442687
8546 2997 None 64 Human Functional pEC50 = 6.2 6.2 2398 2
GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.6019/CHEMBL5442687
CHEMBL177880 2997 None 64 Human Functional pEC50 = 6.2 6.2 2398 2
GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35GPCR PRESTO-Tango dose-response in agonist mode with target: GPR35
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.6019/CHEMBL5442687
5280343 188382 None 69 Human Functional pEC50 = 5.2 5.2 -8 12
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL1520590 188382 None 69 Human Functional pEC50 = 5.2 5.2 -8 12
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL50 188382 None 69 Human Functional pEC50 = 5.2 5.2 -8 12
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
154634332 185233 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 185233 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
16103465 68090 None 0 Human Functional pEC50 = 5.2 5.2 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 254 1 1 4 4.2 Cc1csc2c1sc1cc(C(=O)O)sc12 10.1021/jm200999f
CHEMBL1914587 68090 None 0 Human Functional pEC50 = 5.2 5.2 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 254 1 1 4 4.2 Cc1csc2c1sc1cc(C(=O)O)sc12 10.1021/jm200999f
16103462 68091 None 17 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL1914588 68091 None 17 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1016/j.bmcl.2012.04.057
172455183 196373 None 0 Mouse Functional pEC50 = 7.2 7.2 2 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 518 4 2 6 5.0 O=C(Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC2CCCCC2)c1Cl)C(=O)OC1CCCCC1 10.1016/j.bmc.2023.117511
CHEMBL5422437 196373 None 0 Mouse Functional pEC50 = 7.2 7.2 2 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 518 4 2 6 5.0 O=C(Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC2CCCCC2)c1Cl)C(=O)OC1CCCCC1 10.1016/j.bmc.2023.117511
145952912 162539 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4166473 162539 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
135399235 4134 None 41 Human Functional pEC50 = 5.2 5.2 -18 3
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
2919 4134 None 41 Human Functional pEC50 = 5.2 5.2 -18 3
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
5722 4134 None 41 Human Functional pEC50 = 5.2 5.2 -18 3
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
CHEMBL28079 4134 None 41 Human Functional pEC50 = 5.2 5.2 -18 3
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
70682869 77410 None 0 Human Functional pEC50 = 4.2 4.2 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 275 2 4 4 3.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccsc1 10.1021/ml300076u
CHEMBL2086422 77410 None 0 Human Functional pEC50 = 4.2 4.2 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 275 2 4 4 3.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccsc1 10.1021/ml300076u
145954727 162516 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4166100 162516 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145952912 162539 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4166473 162539 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
70684936 77737 None 0 Human Functional pEC50 = 5.2 5.2 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 224 1 3 4 2.3 Cc1c(C(=O)O)sc2cc(O)c(O)cc12 10.1021/ml300076u
CHEMBL2089228 77737 None 0 Human Functional pEC50 = 5.2 5.2 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 224 1 3 4 2.3 Cc1c(C(=O)O)sc2cc(O)c(O)cc12 10.1021/ml300076u
135399235 4134 None 41 Human Functional pEC50 = 7.2 7.2 -18 3
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
2919 4134 None 41 Human Functional pEC50 = 7.2 7.2 -18 3
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
5722 4134 None 41 Human Functional pEC50 = 7.2 7.2 -18 3
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
CHEMBL28079 4134 None 41 Human Functional pEC50 = 7.2 7.2 -18 3
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
154634321 186103 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 186103 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145954727 162516 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4166100 162516 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
135399235 4134 None 41 Human Functional pEC50 = 5.2 5.2 -18 3
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
2919 4134 None 41 Human Functional pEC50 = 5.2 5.2 -18 3
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
5722 4134 None 41 Human Functional pEC50 = 5.2 5.2 -18 3
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
CHEMBL28079 4134 None 41 Human Functional pEC50 = 5.2 5.2 -18 3
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
12897310 110484 None 1 Human Functional pEC50 = 7.2 7.2 -1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 354 2 4 4 1.4 O=C(O)C(=O)Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)O)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL3245052 110484 None 1 Human Functional pEC50 = 7.2 7.2 -1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 354 2 4 4 1.4 O=C(O)C(=O)Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)O)c1Cl 10.1016/j.bmc.2023.117511
12897309 110478 None 1 Mouse Functional pEC50 = 7.2 7.2 1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 410 4 2 6 2.4 CCOC(=O)C(=O)Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL3245030 110478 None 1 Mouse Functional pEC50 = 7.2 7.2 1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 410 4 2 6 2.4 CCOC(=O)C(=O)Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
66561793 75337 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 258 2 2 3 3.3 Cc1c(C(=O)O)[nH]c2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037466 75337 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 258 2 2 3 3.3 Cc1c(C(=O)O)[nH]c2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
16103462 68091 None 17 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914588 68091 None 17 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
16103462 68091 None 17 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
CHEMBL1914588 68091 None 17 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
172459163 196166 None 0 Human Functional pEC50 = 7.2 7.2 141 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 320 3 4 6 -0.3 CN(C)c1c(NC(=O)C(=O)O)cc(C#N)cc1NC(=O)C(=O)O 10.1016/j.bmc.2023.117511
CHEMBL5418035 196166 None 0 Human Functional pEC50 = 7.2 7.2 141 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 320 3 4 6 -0.3 CN(C)c1c(NC(=O)C(=O)O)cc(C#N)cc1NC(=O)C(=O)O 10.1016/j.bmc.2023.117511
15774807 77718 None 24 Human Functional pEC50 = 4.2 4.2 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 207 1 3 4 1.3 Cn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
CHEMBL2089192 77718 None 24 Human Functional pEC50 = 4.2 4.2 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 207 1 3 4 1.3 Cn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
45489602 59293 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL1704189 59293 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
154634336 186174 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4871203 186174 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
45489602 59293 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL1704189 59293 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
21337670 68082 None 0 Human Functional pEC50 = 5.2 5.2 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 321 0 0 4 4.1 CC1=C(C#N)C(=C(C#N)C#N)OC12c1ccccc1-c1ccccc12 10.1021/jm200999f
CHEMBL1914579 68082 None 0 Human Functional pEC50 = 5.2 5.2 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 321 0 0 4 4.1 CC1=C(C#N)C(=C(C#N)C#N)OC12c1ccccc1-c1ccccc12 10.1021/jm200999f
12897322 110482 None 0 Mouse Functional pEC50 = 7.2 7.2 -1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 300 2 4 4 0.7 Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1 10.1016/j.bmc.2023.117511
CHEMBL3245049 110482 None 0 Mouse Functional pEC50 = 7.2 7.2 -1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 300 2 4 4 0.7 Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1 10.1016/j.bmc.2023.117511
70686064 75326 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 354 1 1 3 4.5 Cc1c(C(=O)O)sc2c(Br)c(Br)sc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037454 75326 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 354 1 1 3 4.5 Cc1c(C(=O)O)sc2c(Br)c(Br)sc12 10.1016/j.bmcl.2012.04.057
44351698 120912 None 0 Human Functional pEC50 = 5.2 5.2 - 1
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 464 8 3 7 3.2 O=C(O)c1cc(=O)c2c(CCC(O)CCc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1 10.1021/acs.jmedchem.0c01624
CHEMBL3558475 120912 None 0 Human Functional pEC50 = 5.2 5.2 - 1
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 464 8 3 7 3.2 O=C(O)c1cc(=O)c2c(CCC(O)CCc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1 10.1021/acs.jmedchem.0c01624
5328791 207442 None 48 Human Functional pEC50 = 4.2 4.2 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
CHEMBL76602 207442 None 48 Human Functional pEC50 = 4.2 4.2 - 1
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
1024 16495 None 63 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
CHEMBL1235421 16495 None 63 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
5215 2386 None 74 Human Functional pEC50 = 5.1 5.1 -1 4
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
5280445 2386 None 74 Human Functional pEC50 = 5.1 5.1 -1 4
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
CHEMBL151 2386 None 74 Human Functional pEC50 = 5.1 5.1 -1 4
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
20259231 77736 None 21 Human Functional pEC50 = 5.1 5.1 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 210 1 3 4 2.0 O=C(O)c1cc2cc(O)c(O)cc2s1 10.1021/ml300076u
CHEMBL2089227 77736 None 21 Human Functional pEC50 = 5.1 5.1 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 210 1 3 4 2.0 O=C(O)c1cc2cc(O)c(O)cc2s1 10.1021/ml300076u
172457931 196452 None 0 Human Functional pEC50 = 7.1 7.1 1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 434 4 2 6 2.6 O=C(Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC2CC2)c1Cl)C(=O)OC1CC1 10.1016/j.bmc.2023.117511
CHEMBL5424229 196452 None 0 Human Functional pEC50 = 7.1 7.1 1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 434 4 2 6 2.6 O=C(Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC2CC2)c1Cl)C(=O)OC1CC1 10.1016/j.bmc.2023.117511
70689184 77729 None 0 Human Functional pEC50 = 4.1 4.1 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1cccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)c1 10.1021/ml300076u
CHEMBL2089220 77729 None 0 Human Functional pEC50 = 4.1 4.1 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1cccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)c1 10.1021/ml300076u
12897309 110478 None 1 Human Functional pEC50 = 7.1 7.1 -1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 410 4 2 6 2.4 CCOC(=O)C(=O)Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL3245030 110478 None 1 Human Functional pEC50 = 7.1 7.1 -1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 410 4 2 6 2.4 CCOC(=O)C(=O)Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
70697498 77719 None 0 Human Functional pEC50 = 4.1 4.1 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 221 2 3 4 1.8 CCn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
CHEMBL2089193 77719 None 0 Human Functional pEC50 = 4.1 4.1 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 221 2 3 4 1.8 CCn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
12897314 194968 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 310 3 5 5 -0.3 Cc1c(NC(=O)C(=O)O)cc(C(=O)O)cc1NC(=O)C(=O)O 10.1016/j.bmc.2023.117511
CHEMBL5394255 194968 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 310 3 5 5 -0.3 Cc1c(NC(=O)C(=O)O)cc(C(=O)O)cc1NC(=O)C(=O)O 10.1016/j.bmc.2023.117511
12897301 110477 None 0 Human Functional pEC50 = 7.1 7.1 40 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 342 4 2 6 1.3 CCOC(=O)C(=O)Nc1cccc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
CHEMBL3245010 110477 None 0 Human Functional pEC50 = 7.1 7.1 40 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 342 4 2 6 1.3 CCOC(=O)C(=O)Nc1cccc(NC(=O)C(=O)OCC)c1Cl 10.1016/j.bmc.2023.117511
326869 112874 None 2 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 112874 None 2 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
164610101 184981 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 184981 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
2882 1208 None 41 Human Functional pEC50 = 5.1 5.1 -11 5
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1016/j.bmc.2023.117511
741 1208 None 41 Human Functional pEC50 = 5.1 5.1 -11 5
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1016/j.bmc.2023.117511
7608 1208 None 41 Human Functional pEC50 = 5.1 5.1 -11 5
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1016/j.bmc.2023.117511
CHEMBL428880 1208 None 41 Human Functional pEC50 = 5.1 5.1 -11 5
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1016/j.bmc.2023.117511
DB01003 1208 None 41 Human Functional pEC50 = 5.1 5.1 -11 5
Agonist activity at human GPR35 by beta-arrestin recruitment assayAgonist activity at human GPR35 by beta-arrestin recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1016/j.bmc.2023.117511
5280343 188382 None 69 Human Functional pEC50 = 5.1 5.1 -8 12
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL1520590 188382 None 69 Human Functional pEC50 = 5.1 5.1 -8 12
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL50 188382 None 69 Human Functional pEC50 = 5.1 5.1 -8 12
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
12126688 110479 None 0 Mouse Functional pEC50 = 5.1 5.1 -1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 252 2 4 4 -0.3 O=C(O)C(=O)Nc1cccc(NC(=O)C(=O)O)c1 10.1016/j.bmc.2023.117511
CHEMBL3245041 110479 None 0 Mouse Functional pEC50 = 5.1 5.1 -1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 252 2 4 4 -0.3 O=C(O)C(=O)Nc1cccc(NC(=O)C(=O)O)c1 10.1016/j.bmc.2023.117511
154634314 186715 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4878979 186715 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145953203 162633 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
CHEMBL4167991 162633 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
16103462 68091 None 17 Human Functional pEC50 = 5.1 5.1 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL1914588 68091 None 17 Human Functional pEC50 = 5.1 5.1 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1016/j.bmcl.2012.04.057
145953203 162633 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
CHEMBL4167991 162633 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
70681839 75338 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 221 2 2 2 3.1 Cc1c(C(=O)O)[nH]c2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037467 75338 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 221 2 2 2 3.1 Cc1c(C(=O)O)[nH]c2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
70689183 77728 None 0 Human Functional pEC50 = 4.1 4.1 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 270 2 4 4 2.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccnc1 10.1021/ml300076u
CHEMBL2089219 77728 None 0 Human Functional pEC50 = 4.1 4.1 - 1
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 270 2 4 4 2.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccnc1 10.1021/ml300076u
145952039 162903 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4172440 162903 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145952039 162903 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4172440 162903 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145974046 163107 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4175617 163107 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
151271218 186261 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4872368 186261 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
145959908 162156 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4160515 162156 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
145952453 162883 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
CHEMBL4172188 162883 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
145959908 162156 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4160515 162156 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
145952453 162883 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
CHEMBL4172188 162883 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
145974046 163107 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4175617 163107 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
70690213 75339 None 0 Human Functional pEC50 = 4.1 4.1 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 273 1 1 3 3.0 Cc1c(C(=O)O)n(C)c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037468 75339 None 0 Human Functional pEC50 = 4.1 4.1 - 1
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 273 1 1 3 3.0 Cc1c(C(=O)O)n(C)c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
70684936 77737 None 0 Human Functional pEC50 = 4.0 4.0 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 224 1 3 4 2.3 Cc1c(C(=O)O)sc2cc(O)c(O)cc12 10.1021/ml300076u
CHEMBL2089228 77737 None 0 Human Functional pEC50 = 4.0 4.0 - 1
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 224 1 3 4 2.3 Cc1c(C(=O)O)sc2cc(O)c(O)cc12 10.1021/ml300076u
172459163 196166 None 0 Mouse Functional pEC50 = 5.0 5.0 -141 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 320 3 4 6 -0.3 CN(C)c1c(NC(=O)C(=O)O)cc(C#N)cc1NC(=O)C(=O)O 10.1016/j.bmc.2023.117511
CHEMBL5418035 196166 None 0 Mouse Functional pEC50 = 5.0 5.0 -141 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 320 3 4 6 -0.3 CN(C)c1c(NC(=O)C(=O)O)cc(C#N)cc1NC(=O)C(=O)O 10.1016/j.bmc.2023.117511
154634335 184589 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4847100 184589 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
154634316 186448 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4875009 186448 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
172454119 195785 None 0 Human Functional pEC50 = 7.0 7.0 33 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 307 3 4 6 -0.4 COc1c(NC(=O)C(=O)O)cc(C#N)cc1NC(=O)C(=O)O 10.1016/j.bmc.2023.117511
CHEMBL5410743 195785 None 0 Human Functional pEC50 = 7.0 7.0 33 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 307 3 4 6 -0.4 COc1c(NC(=O)C(=O)O)cc(C#N)cc1NC(=O)C(=O)O 10.1016/j.bmc.2023.117511
172444421 195231 None 0 Mouse Functional pEC50 = 7.0 7.0 1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 462 4 2 6 3.4 O=C(Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC2CCC2)c1Cl)C(=O)OC1CCC1 10.1016/j.bmc.2023.117511
CHEMBL5399225 195231 None 0 Mouse Functional pEC50 = 7.0 7.0 1 2
Agonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at mouse GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 462 4 2 6 3.4 O=C(Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC2CCC2)c1Cl)C(=O)OC1CCC1 10.1016/j.bmc.2023.117511
53258899 68089 None 0 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1csc2cc(C(=O)O)sc12 10.1021/jm200999f
CHEMBL1914586 68089 None 0 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1csc2cc(C(=O)O)sc12 10.1021/jm200999f
57697 14472 None 29 Rat Functional pEC50 = 7.0 7.0 - 1
Agonist activity at recombinant rat N-terminal FLAG/eYFP-fused GPR35 expressed in HEK293 cells assessed as induction of beta-arrestin recruitment by BRET assayAgonist activity at recombinant rat N-terminal FLAG/eYFP-fused GPR35 expressed in HEK293 cells assessed as induction of beta-arrestin recruitment by BRET assay
ChEMBL 228 1 1 6 0.2 Cc1cccn2c(=O)c(-c3nnn[nH]3)cnc12 10.1021/acsmedchemlett.7b00510
CHEMBL1201198 14472 None 29 Rat Functional pEC50 = 7.0 7.0 - 1
Agonist activity at recombinant rat N-terminal FLAG/eYFP-fused GPR35 expressed in HEK293 cells assessed as induction of beta-arrestin recruitment by BRET assayAgonist activity at recombinant rat N-terminal FLAG/eYFP-fused GPR35 expressed in HEK293 cells assessed as induction of beta-arrestin recruitment by BRET assay
ChEMBL 228 1 1 6 0.2 Cc1cccn2c(=O)c(-c3nnn[nH]3)cnc12 10.1021/acsmedchemlett.7b00510
70683939 75332 None 0 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 238 2 1 3 3.8 Cc1c(C(=O)O)sc2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037461 75332 None 0 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 238 2 1 3 3.8 Cc1c(C(=O)O)sc2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
70683938 75328 None 1 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 200 1 2 4 2.4 O=C(O)c1sc2ccsc2c1O 10.1016/j.bmcl.2012.04.057
CHEMBL2037457 75328 None 1 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 200 1 2 4 2.4 O=C(O)c1sc2ccsc2c1O 10.1016/j.bmcl.2012.04.057
172444421 195231 None 0 Human Functional pEC50 = 7.0 7.0 -1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 462 4 2 6 3.4 O=C(Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC2CCC2)c1Cl)C(=O)OC1CCC1 10.1016/j.bmc.2023.117511
CHEMBL5399225 195231 None 0 Human Functional pEC50 = 7.0 7.0 -1 2
Agonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assayAgonist activity at human GPR35 expressed in HEK293 cells co-expressing Galpha16 assessed as increase in calcium mobilization by Fluo-4 AM dye based fluorescence assay
ChEMBL 462 4 2 6 3.4 O=C(Nc1cc(C(F)(F)F)cc(NC(=O)C(=O)OC2CCC2)c1Cl)C(=O)OC1CCC1 10.1016/j.bmc.2023.117511
5328791 207442 None 48 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
CHEMBL76602 207442 None 48 Human Functional pEC50 = 5.0 5.0 - 1
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
154634333 185321 None 0 Human Functional pIC50 = 9.3 9.3 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 185321 None 0 Human Functional pIC50 = 9.3 9.3 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
326869 112874 None 2 Human Functional pIC50 = 9.1 9.1 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 112874 None 2 Human Functional pIC50 = 9.1 9.1 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
154634333 185321 None 0 Human Functional pIC50 = 8 8.0 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 185321 None 0 Human Functional pIC50 = 8 8.0 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
3110120 41932 None 6 Human Functional pIC50 = 6 6.0 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 474 10 3 5 5.2 CCCCCOC(=O)c1ccc(NC(=O)c2cccc(NC(=O)c3ccccc3C(=O)O)c2)cc1 nan
CHEMBL1494365 41932 None 6 Human Functional pIC50 = 6 6.0 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 474 10 3 5 5.2 CCCCCOC(=O)c1ccc(NC(=O)c2cccc(NC(=O)c3ccccc3C(=O)O)c2)cc1 nan
644413 33539 None 5 Human Functional pIC50 = 6 6.0 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 315 1 1 5 2.0 CN1C=CC2=C(C#N)C(N)C(C#N)(C#N)C(c3ccccc3)C2C1 nan
CHEMBL1420573 33539 None 5 Human Functional pIC50 = 6 6.0 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 315 1 1 5 2.0 CN1C=CC2=C(C#N)C(N)C(C#N)(C#N)C(c3ccccc3)C2C1 nan
9581006 59406 None 1 Human Functional pIC50 = 6 6.0 12 3
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 379 5 2 6 3.0 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)Nc1ccccc1 nan
CHEMBL1709028 59406 None 1 Human Functional pIC50 = 6 6.0 12 3
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 379 5 2 6 3.0 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)Nc1ccccc1 nan
18296 69884 None 1 Human Functional pIC50 = 6 6.0 6 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
5351211 69884 None 1 Human Functional pIC50 = 6 6.0 6 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
5474842 69884 None 1 Human Functional pIC50 = 6 6.0 6 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
6326610 69884 None 1 Human Functional pIC50 = 6 6.0 6 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
CHEMBL193872 69884 None 1 Human Functional pIC50 = 6 6.0 6 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
CHEMBL466853 69884 None 1 Human Functional pIC50 = 6 6.0 6 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
152550147 185434 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4859675 185434 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
154634315 184984 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccc(F)cc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852718 184984 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccc(F)cc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
53257379 68083 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 363 1 0 4 5.0 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1Cl 10.1021/jm200999f
CHEMBL1914580 68083 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 363 1 0 4 5.0 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1Cl 10.1021/jm200999f
53258793 68092 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 374 8 1 3 6.3 CCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914589 68092 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 374 8 1 3 6.3 CCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
135399235 4134 None 41 Human Functional pIC50 = 5.0 5.0 -18 3
Antagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assayAntagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
2919 4134 None 41 Human Functional pIC50 = 5.0 5.0 -18 3
Antagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assayAntagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
5722 4134 None 41 Human Functional pIC50 = 5.0 5.0 -18 3
Antagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assayAntagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
CHEMBL28079 4134 None 41 Human Functional pIC50 = 5.0 5.0 -18 3
Antagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assayAntagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
151271218 186261 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4872368 186261 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
4811966 43703 None 4 Human Functional pIC50 = 6.0 6.0 2 5
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 383 4 1 4 3.3 CC(NC(=O)Cn1ncc(Cl)c(Cl)c1=O)C12CC3CC(CC(C3)C1)C2 nan
CHEMBL1510156 43703 None 4 Human Functional pIC50 = 6.0 6.0 2 5
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 383 4 1 4 3.3 CC(NC(=O)Cn1ncc(Cl)c(Cl)c1=O)C12CC3CC(CC(C3)C1)C2 nan
512282 758 None 42 Human Functional pIC50 = 6.0 6.0 -158 5
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 434 6 2 4 3.1 NC(=O)Nc1cc(Cl)ccc1OCC(=O)N1CCN(C[C@H]1C)Cc1ccc(cc1)F 10.6019/CHEMBL5442687
767 758 None 42 Human Functional pIC50 = 6.0 6.0 -158 5
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 434 6 2 4 3.1 NC(=O)Nc1cc(Cl)ccc1OCC(=O)N1CCN(C[C@H]1C)Cc1ccc(cc1)F 10.6019/CHEMBL5442687
CHEMBL232656 758 None 42 Human Functional pIC50 = 6.0 6.0 -158 5
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 434 6 2 4 3.1 NC(=O)Nc1cc(Cl)ccc1OCC(=O)N1CCN(C[C@H]1C)Cc1ccc(cc1)F 10.6019/CHEMBL5442687
16103462 68091 None 17 Human Functional pIC50 = 7.0 7.0 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914588 68091 None 17 Human Functional pIC50 = 7.0 7.0 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
145957901 162169 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4160729 162169 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
145951357 162859 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4171772 162859 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
5602180 55522 None 3 Human Functional pIC50 = 5.0 5.0 1 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 334 1 1 2 4.1 CC1(C)Cc2c(ccc3ccccc23)/C(=C/C(=O)N2CCCCC2)N1 nan
CHEMBL1416442 55522 None 3 Human Functional pIC50 = 5.0 5.0 1 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 334 1 1 2 4.1 CC1(C)Cc2c(ccc3ccccc23)/C(=C/C(=O)N2CCCCC2)N1 nan
CHEMBL1620242 55522 None 3 Human Functional pIC50 = 5.0 5.0 1 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 334 1 1 2 4.1 CC1(C)Cc2c(ccc3ccccc23)/C(=C/C(=O)N2CCCCC2)N1 nan
16195500 41745 None 8 Human Functional pIC50 = 6.0 6.0 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 4 2 5 4.9 N=C1/C(=C/c2ccc(-c3cccc(C(=O)O)c3)o2)C(=O)N=C2SC=C(c3ccccc3)N12 nan
CHEMBL1492565 41745 None 8 Human Functional pIC50 = 6.0 6.0 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 4 2 5 4.9 N=C1/C(=C/c2ccc(-c3cccc(C(=O)O)c3)o2)C(=O)N=C2SC=C(c3ccccc3)N12 nan
9581008 59565 None 3 Human Functional pIC50 = 6.0 6.0 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
CHEMBL1716874 59565 None 3 Human Functional pIC50 = 6.0 6.0 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
150386356 185252 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856916 185252 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
2963825 47716 None 7 Human Functional pIC50 = 6.0 6.0 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 382 4 1 6 4.4 O=C(Nc1nc2ccccc2s1)c1ccc(N2CCCCC2)c([N+](=O)[O-])c1 nan
CHEMBL1547464 47716 None 7 Human Functional pIC50 = 6.0 6.0 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 382 4 1 6 4.4 O=C(Nc1nc2ccccc2s1)c1ccc(N2CCCCC2)c([N+](=O)[O-])c1 nan
2259994 41419 None 4 Human Functional pIC50 = 6.0 6.0 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 262 2 0 4 1.9 CN1C(=O)/C(=C\c2ccc(N(C)C)cc2)OC1=S nan
CHEMBL1490312 41419 None 4 Human Functional pIC50 = 6.0 6.0 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 262 2 0 4 1.9 CN1C(=O)/C(=C\c2ccc(N(C)C)cc2)OC1=S nan
135549592 108498 None 3 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 369 7 4 6 1.4 COc1ccc(/C=C\C(=O)NCC(=O)N/N=C/c2ccc(O)cc2O)cc1 nan
CHEMBL3198952 108498 None 3 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 369 7 4 6 1.4 COc1ccc(/C=C\C(=O)NCC(=O)N/N=C/c2ccc(O)cc2O)cc1 nan
1416931 23426 None 2 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1333032 23426 None 2 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccc(C(=O)O)cc1 nan
1348328 31794 None 4 Human Functional pIC50 = 5.9 5.9 16 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C/C=C/c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1406190 31794 None 4 Human Functional pIC50 = 5.9 5.9 16 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C/C=C/c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
5334489 45978 None 4 Human Functional pIC50 = 5.9 5.9 10 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 374 7 1 4 5.3 CCN(CC)c1ccc(/C=C(/C#N)c2nc3ccccc3[nH]2)c(OC(C)C)c1 nan
CHEMBL1532412 45978 None 4 Human Functional pIC50 = 5.9 5.9 10 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 374 7 1 4 5.3 CCN(CC)c1ccc(/C=C(/C#N)c2nc3ccccc3[nH]2)c(OC(C)C)c1 nan
4137407 29820 None 2 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 438 3 1 7 4.6 Cc1nc(N2CCC(C)CC2)c2c(C)c(C(=O)Nc3ccc4c(c3)OCCO4)sc2n1 nan
CHEMBL1387336 29820 None 2 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 438 3 1 7 4.6 Cc1nc(N2CCC(C)CC2)c2c(C)c(C(=O)Nc3ccc4c(c3)OCCO4)sc2n1 nan
152684818 185098 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
CHEMBL4854346 185098 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
5733585 40983 None 6 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 486 9 2 7 4.0 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1OC nan
CHEMBL1487024 40983 None 6 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 486 9 2 7 4.0 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1OC nan
655684 41102 None 4 Human Functional pIC50 = 4.9 4.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 383 1 1 5 3.3 CN1CC=C2C(C#N)=C(N)C(C#N)(C#N)C(c3cccc(Cl)c3Cl)C2C1 nan
CHEMBL1487918 41102 None 4 Human Functional pIC50 = 4.9 4.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 383 1 1 5 3.3 CN1CC=C2C(C#N)=C(N)C(C#N)(C#N)C(c3cccc(Cl)c3Cl)C2C1 nan
9990345 68087 None 32 Human Functional pIC50 = 4.9 4.9 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 199 0 0 4 1.9 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)C 10.1021/jm200999f
CHEMBL1914584 68087 None 32 Human Functional pIC50 = 4.9 4.9 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 199 0 0 4 1.9 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)C 10.1021/jm200999f
135399235 4134 None 41 Human Functional pIC50 = 5.9 5.9 -18 3
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
2919 4134 None 41 Human Functional pIC50 = 5.9 5.9 -18 3
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
5722 4134 None 41 Human Functional pIC50 = 5.9 5.9 -18 3
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
CHEMBL28079 4134 None 41 Human Functional pIC50 = 5.9 5.9 -18 3
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
6484583 37247 None 1 Human Functional pIC50 = 4.9 4.9 -89 3
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]
ChEMBL 410 5 1 5 2.6 COc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1ccc(Cl)cc1 nan
CHEMBL1453578 37247 None 1 Human Functional pIC50 = 4.9 4.9 -89 3
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]
ChEMBL 410 5 1 5 2.6 COc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1ccc(Cl)cc1 nan
9581013 59730 None 3 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 351 4 2 6 1.7 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(Cl)cc1 nan
CHEMBL1723578 59730 None 3 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 351 4 2 6 1.7 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(Cl)cc1 nan
1348329 26256 None 8 Human Functional pIC50 = 5.9 5.9 3 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C\C=C\c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1357976 26256 None 8 Human Functional pIC50 = 5.9 5.9 3 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C\C=C\c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
145952561 163054 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(C(F)(F)F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4174783 163054 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(C(F)(F)F)c1 10.1021/acsmedchemlett.7b00510
13950957 157420 None 8 Human Functional pIC50 = 6.9 6.9 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4077503 157420 None 8 Human Functional pIC50 = 6.9 6.9 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
2961024 44945 None 4 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 452 8 2 4 5.7 CCOc1ccc(NC(=O)C(C)Oc2ccccc2C(=O)Nc2ccc(C)c(Cl)c2)cc1 nan
CHEMBL1523126 44945 None 4 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 452 8 2 4 5.7 CCOc1ccc(NC(=O)C(C)Oc2ccccc2C(=O)Nc2ccc(C)c(Cl)c2)cc1 nan
149708825 186497 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875771 186497 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
24792210 55207 None 0 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 391 5 1 4 5.0 CN(C)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
CHEMBL1351967 55207 None 0 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 391 5 1 4 5.0 CN(C)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
CHEMBL1617564 55207 None 0 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 391 5 1 4 5.0 CN(C)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
145953959 162772 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(C(F)(F)F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4170205 162772 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(C(F)(F)F)cc1 10.1021/acsmedchemlett.7b00510
72652 34857 None 44 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 309 0 0 3 3.5 O=c1cc(C(F)(F)F)c2cc3c4c(c2o1)CCCN4CCC3 nan
CHEMBL1431610 34857 None 44 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 309 0 0 3 3.5 O=c1cc(C(F)(F)F)c2cc3c4c(c2o1)CCCN4CCC3 nan
151577785 186659 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4878047 186659 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
135475176 108080 None 8 Human Functional pIC50 = 4.9 4.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 2 1 4 5.1 CC12CCC(C/C1=N\NC1=NC(=O)/C(=C\c3ccc(Cl)cc3)S1)C2(C)C nan
135517099 108080 None 8 Human Functional pIC50 = 4.9 4.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 2 1 4 5.1 CC12CCC(C/C1=N\NC1=NC(=O)/C(=C\c3ccc(Cl)cc3)S1)C2(C)C nan
CHEMBL3194571 108080 None 8 Human Functional pIC50 = 4.9 4.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 2 1 4 5.1 CC12CCC(C/C1=N\NC1=NC(=O)/C(=C\c3ccc(Cl)cc3)S1)C2(C)C nan
2745687 933 None 27 Human Functional pIC50 = 5.9 5.9 10 3
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
9741 933 None 27 Human Functional pIC50 = 5.9 5.9 10 3
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
CHEMBL1708510 933 None 27 Human Functional pIC50 = 5.9 5.9 10 3
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
1346721 29827 None 9 Human Functional pIC50 = 5.9 5.9 1 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 440 7 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1 nan
CHEMBL1387413 29827 None 9 Human Functional pIC50 = 5.9 5.9 1 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 440 7 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1 nan
145956623 162107 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4159575 162107 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
3153499 32584 None 13 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 344 3 0 5 2.5 CS(=O)(=O)N1N=C(c2ccccc2)CC1c1ccc2c(c1)OCO2 nan
CHEMBL1412529 32584 None 13 Human Functional pIC50 = 5.9 5.9 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 344 3 0 5 2.5 CS(=O)(=O)N1N=C(c2ccccc2)CC1c1ccc2c(c1)OCO2 nan
16196320 55075 None 0 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
3394229 55075 None 0 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
5813410 55075 None 0 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
CHEMBL1308547 55075 None 0 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
CHEMBL1616589 55075 None 0 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
1382708 29872 None 8 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.6 O=C(CCCN1C(=O)S/C(=C/c2ccccc2)C1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1387749 29872 None 8 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.6 O=C(CCCN1C(=O)S/C(=C/c2ccccc2)C1=S)Nc1ccc(C(=O)O)cc1 nan
4362054 26099 None 5 Human Functional pIC50 = 4.8 4.8 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 495 9 2 8 4.3 CCOc1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
CHEMBL1355774 26099 None 5 Human Functional pIC50 = 4.8 4.8 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 495 9 2 8 4.3 CCOc1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
152727536 184593 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4847144 184593 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
24761764 52829 None 0 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 5 1 3 4.3 CC(NS(=O)(=O)OCC(Cl)(Cl)Cl)c1ccc(C(C)(C)C)cc1 nan
CHEMBL1595152 52829 None 0 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 5 1 3 4.3 CC(NS(=O)(=O)OCC(Cl)(Cl)Cl)c1ccc(C(C)(C)C)cc1 nan
16103482 68088 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1c(C(=O)O)sc2ccsc12 10.1021/jm200999f
CHEMBL1914585 68088 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1c(C(=O)O)sc2ccsc12 10.1021/jm200999f
6518655 108863 None 4 Human Functional pIC50 = 5.8 5.8 2 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 528 7 1 7 5.5 COc1ccc(/N=C2\S/C(=C\c3ccc(N4CCOCC4)o3)C(=O)N2CCc2c[nH]c3ccccc23)cc1 nan
CHEMBL3209511 108863 None 4 Human Functional pIC50 = 5.8 5.8 2 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 528 7 1 7 5.5 COc1ccc(/N=C2\S/C(=C\c3ccc(N4CCOCC4)o3)C(=O)N2CCc2c[nH]c3ccccc23)cc1 nan
154634327 184845 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 184845 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
154634324 185817 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4865638 185817 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
164627011 186512 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 186512 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
154634326 185198 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 185198 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
150386356 185252 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856916 185252 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
1382708 29872 None 8 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.6 O=C(CCCN1C(=O)S/C(=C/c2ccccc2)C1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1387749 29872 None 8 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.6 O=C(CCCN1C(=O)S/C(=C/c2ccccc2)C1=S)Nc1ccc(C(=O)O)cc1 nan
2885134 44453 None 7 Human Functional pIC50 = 4.8 4.8 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 373 6 2 5 5.0 CCOc1ccc2nc3cc(NCc4ccc(OC)cc4)ccc3c(N)c2c1 nan
CHEMBL1518827 44453 None 7 Human Functional pIC50 = 4.8 4.8 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 373 6 2 5 5.0 CCOc1ccc2nc3cc(NCc4ccc(OC)cc4)ccc3c(N)c2c1 nan
45917986 59373 None 4 Human Functional pIC50 = 4.8 4.8 -6 2
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 314 2 0 4 4.4 Cc1ccc(-c2nnc(C)c3nn(-c4ccc(C)cc4)cc23)cc1 nan
CHEMBL1707517 59373 None 4 Human Functional pIC50 = 4.8 4.8 -6 2
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 314 2 0 4 4.4 Cc1ccc(-c2nnc(C)c3nn(-c4ccc(C)cc4)cc23)cc1 nan
2286888 41093 None 6 Human Functional pIC50 = 5.8 5.8 11 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 466 8 2 5 5.0 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)cc2)C1=O)=C\c1ccccc1 nan
CHEMBL1487870 41093 None 6 Human Functional pIC50 = 5.8 5.8 11 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 466 8 2 5 5.0 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)cc2)C1=O)=C\c1ccccc1 nan
2247463 27601 None 6 Human Functional pIC50 = 5.8 5.8 15 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 515 8 3 7 4.6 CCc1nnc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)/C=C/c3ccc(C(C)C)cc3)cc2)s1 nan
CHEMBL1369492 27601 None 6 Human Functional pIC50 = 5.8 5.8 15 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 515 8 3 7 4.6 CCc1nnc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)/C=C/c3ccc(C(C)C)cc3)cc2)s1 nan
154634328 185207 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856069 185207 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
152727536 184593 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4847144 184593 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
145954149 162694 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4169062 162694 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
2745687 933 None 27 Human Functional pIC50 = 6.8 6.8 10 3
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
9741 933 None 27 Human Functional pIC50 = 6.8 6.8 10 3
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
CHEMBL1708510 933 None 27 Human Functional pIC50 = 6.8 6.8 10 3
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
8072340 55858 None 4 Human Functional pIC50 = 5.8 5.8 -1 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 263 2 1 0 3.8 Cc1ccc2[nH]c(C)c(/C=C/c3cc[n+](C)cc3)c2c1 nan
CHEMBL1517609 55858 None 4 Human Functional pIC50 = 5.8 5.8 -1 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 263 2 1 0 3.8 Cc1ccc2[nH]c(C)c(/C=C/c3cc[n+](C)cc3)c2c1 nan
CHEMBL1623159 55858 None 4 Human Functional pIC50 = 5.8 5.8 -1 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 263 2 1 0 3.8 Cc1ccc2[nH]c(C)c(/C=C/c3cc[n+](C)cc3)c2c1 nan
1205881 36175 None 2 Human Functional pIC50 = 5.8 5.8 23 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1cccc(C(=O)O)c1 nan
CHEMBL1444708 36175 None 2 Human Functional pIC50 = 5.8 5.8 23 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1cccc(C(=O)O)c1 nan
21337669 68085 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 239 0 0 4 2.9 CC1=C(C#N)C(=C(C#N)C#N)OC12CCCCC2 10.1021/jm200999f
CHEMBL1914582 68085 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 239 0 0 4 2.9 CC1=C(C#N)C(=C(C#N)C#N)OC12CCCCC2 10.1021/jm200999f
1231538 27526 None 29 Human Functional pIC50 = 4.8 4.8 -1 3
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
CHEMBL1368962 27526 None 29 Human Functional pIC50 = 4.8 4.8 -1 3
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
3596034 42343 None 4 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 308 2 0 4 3.0 CCN1CCN(C2=CC3=CC(=C(C#N)C#N)CCC3CC2)CC1 nan
CHEMBL1498210 42343 None 4 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 308 2 0 4 3.0 CCN1CCN(C2=CC3=CC(=C(C#N)C#N)CCC3CC2)CC1 nan
9581010 59198 None 3 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 449 5 2 6 3.9 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
CHEMBL1700467 59198 None 3 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 449 5 2 6 3.9 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
154634337 185439 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4859764 185439 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
145971743 163199 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4177096 163199 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
9581010 59198 None 3 Human Functional pIC50 = 6.8 6.8 - 1
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 449 5 2 6 3.9 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
CHEMBL1700467 59198 None 3 Human Functional pIC50 = 6.8 6.8 - 1
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 449 5 2 6 3.9 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
152684818 185098 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
CHEMBL4854346 185098 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
21157241 71905 None 3 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 381 5 1 5 2.3 COc1ccc(/C=c2\s/c(=C/C(=O)c3ccc(C)cc3)[nH]c2=O)c(OC)c1 nan
CHEMBL1970711 71905 None 3 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 381 5 1 5 2.3 COc1ccc(/C=c2\s/c(=C/C(=O)c3ccc(C)cc3)[nH]c2=O)c(OC)c1 nan
1502520 34510 None 16 Human Functional pIC50 = 4.8 4.8 -9 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 398 4 0 6 3.8 Cc1ccc(Cn2ncc3c(N4CCN(c5ccccc5C)CC4)ncnc32)cc1 nan
CHEMBL1428840 34510 None 16 Human Functional pIC50 = 4.8 4.8 -9 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 398 4 0 6 3.8 Cc1ccc(Cn2ncc3c(N4CCN(c5ccccc5C)CC4)ncnc32)cc1 nan
15945506 48035 None 5 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 5 1 4 5.8 CC(=O)c1ccc(NC(=O)C(C)n2nc(-c3ccccc3)c3cc(Cl)ccc32)cc1 nan
CHEMBL1550295 48035 None 5 Human Functional pIC50 = 5.8 5.8 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 5 1 4 5.8 CC(=O)c1ccc(NC(=O)C(C)n2nc(-c3ccccc3)c3cc(Cl)ccc32)cc1 nan
154634326 185198 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 185198 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634321 186103 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 186103 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
152243845 185005 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4853043 185005 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
2770749 56045 None 1 Human Functional pIC50 = 5.7 5.7 1 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
5708223 56045 None 1 Human Functional pIC50 = 5.7 5.7 1 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
5830170 56045 None 1 Human Functional pIC50 = 5.7 5.7 1 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
CHEMBL1572785 56045 None 1 Human Functional pIC50 = 5.7 5.7 1 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
CHEMBL1624721 56045 None 1 Human Functional pIC50 = 5.7 5.7 1 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
53258796 68094 None 0 Human Functional pIC50 = 5.7 5.7 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 444 13 1 3 8.3 CCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914591 68094 None 0 Human Functional pIC50 = 5.7 5.7 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 444 13 1 3 8.3 CCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
2277094 49030 None 6 Human Functional pIC50 = 5.7 5.7 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1cccc(C(=O)O)c1 nan
CHEMBL1560901 49030 None 6 Human Functional pIC50 = 5.7 5.7 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1cccc(C(=O)O)c1 nan
11674067 68081 None 27 Human Functional pIC50 = 5.7 5.7 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 315 1 0 4 3.6 CC1=C(C#N)C(=C(C#N)C#N)OC1(c1ccccc1)C(F)(F)F 10.1021/jm200999f
CHEMBL1914578 68081 None 27 Human Functional pIC50 = 5.7 5.7 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 315 1 0 4 3.6 CC1=C(C#N)C(=C(C#N)C#N)OC1(c1ccccc1)C(F)(F)F 10.1021/jm200999f
2526579 54783 None 1 Human Functional pIC50 = 5.7 5.7 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 423 12 1 7 5.0 CCN(CC)CCCNc1ccc(-c2nnc(-c3ccc(OCC(C)C)cc3)o2)cn1 nan
CHEMBL1612267 54783 None 1 Human Functional pIC50 = 5.7 5.7 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 423 12 1 7 5.0 CCN(CC)CCCNc1ccc(-c2nnc(-c3ccc(OCC(C)C)cc3)o2)cn1 nan
6489901 56179 None 1 Human Functional pIC50 = 5.7 5.7 1 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 289 4 0 1 4.1 C=CCn1c(C)c(/C=C/c2cc[n+](C)cc2)c2ccccc21 nan
CHEMBL1576905 56179 None 1 Human Functional pIC50 = 5.7 5.7 1 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 289 4 0 1 4.1 C=CCn1c(C)c(/C=C/c2cc[n+](C)cc2)c2ccccc21 nan
CHEMBL1626041 56179 None 1 Human Functional pIC50 = 5.7 5.7 1 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 289 4 0 1 4.1 C=CCn1c(C)c(/C=C/c2cc[n+](C)cc2)c2ccccc21 nan
326869 112874 None 2 Human Functional pIC50 = 8.7 8.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 112874 None 2 Human Functional pIC50 = 8.7 8.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
154634321 186103 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 186103 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
154634332 185233 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 185233 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
68324914 185837 None 34 Human Functional pIC50 = 7.7 7.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
CHEMBL4865971 185837 None 34 Human Functional pIC50 = 7.7 7.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
154634328 185207 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856069 185207 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145958495 162292 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
CHEMBL4162653 162292 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
150149078 186450 None 0 Human Functional pIC50 = 5.7 5.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875041 186450 None 0 Human Functional pIC50 = 5.7 5.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
5144920 21355 None 2 Human Functional pIC50 = 4.7 4.7 1 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 424 3 1 7 4.3 Cc1c(C(=O)Nc2ccc3c(c2)OCCO3)sc2ncnc(N3CCC(C)CC3)c12 nan
CHEMBL1314099 21355 None 2 Human Functional pIC50 = 4.7 4.7 1 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 424 3 1 7 4.3 Cc1c(C(=O)Nc2ccc3c(c2)OCCO3)sc2ncnc(N3CCC(C)CC3)c12 nan
4557537 38109 None 2 Human Functional pIC50 = 5.7 5.7 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 424 3 1 7 4.3 Cc1nc(N2CCCCC2)c2c(C)c(C(=O)Nc3ccc4c(c3)OCCO4)sc2n1 nan
CHEMBL1460894 38109 None 2 Human Functional pIC50 = 5.7 5.7 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 424 3 1 7 4.3 Cc1nc(N2CCCCC2)c2c(C)c(C(=O)Nc3ccc4c(c3)OCCO4)sc2n1 nan
91754 85284 None 43 Human Functional pIC50 = 6.7 6.7 -31 3
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 364 3 0 4 5.2 CC(C)(C)c1ccc(CSc2cnn(C(C)(C)C)c(=O)c2Cl)cc1 10.6019/CHEMBL5442687
CHEMBL225963 85284 None 43 Human Functional pIC50 = 6.7 6.7 -31 3
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 364 3 0 4 5.2 CC(C)(C)c1ccc(CSc2cnn(C(C)(C)C)c(=O)c2Cl)cc1 10.6019/CHEMBL5442687
6203183 52368 None 5 Human Functional pIC50 = 5.7 5.7 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 486 7 3 8 3.4 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)c(O)c1 nan
CHEMBL1589711 52368 None 5 Human Functional pIC50 = 5.7 5.7 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 486 7 3 8 3.4 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)c(O)c1 nan
6876400 73014 None 5 Human Functional pIC50 = 5.7 5.7 3 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 448 8 2 6 5.0 CCOc1ccc(/C=N/NC(=O)Cc2csc(Nc3cccc(C(F)(F)F)c3)n2)cc1 nan
CHEMBL2007593 73014 None 5 Human Functional pIC50 = 5.7 5.7 3 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 448 8 2 6 5.0 CCOc1ccc(/C=N/NC(=O)Cc2csc(Nc3cccc(C(F)(F)F)c3)n2)cc1 nan
154634324 185817 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4865638 185817 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145958540 162364 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4163894 162364 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
145952912 162539 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4166473 162539 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
9581015 59417 None 3 Human Functional pIC50 = 6.7 6.7 - 1
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(=S)Nc1ccccc1 nan
CHEMBL1709632 59417 None 3 Human Functional pIC50 = 6.7 6.7 - 1
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(=S)Nc1ccccc1 nan
3243122 46418 None 4 Human Functional pIC50 = 5.7 5.7 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 421 3 0 5 4.6 COc1ccc2nc3oc(C(=O)N4CCN(c5cccc(Cl)c5)CC4)cc3cc2c1 nan
CHEMBL1536710 46418 None 4 Human Functional pIC50 = 5.7 5.7 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 421 3 0 5 4.6 COc1ccc2nc3oc(C(=O)N4CCN(c5cccc(Cl)c5)CC4)cc3cc2c1 nan
5731274 52366 None 6 Human Functional pIC50 = 4.7 4.7 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 468 8 1 6 4.8 CCOC(=O)c1ccc(NC(=O)CCCN2C(=O)/C(=C/c3ccc(C)cc3)SC2=S)cc1 nan
CHEMBL1589694 52366 None 6 Human Functional pIC50 = 4.7 4.7 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 468 8 1 6 4.8 CCOC(=O)c1ccc(NC(=O)CCCN2C(=O)/C(=C/c3ccc(C)cc3)SC2=S)cc1 nan
21337670 68082 None 0 Human Functional pIC50 = 4.7 4.7 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 321 0 0 4 4.1 CC1=C(C#N)C(=C(C#N)C#N)OC12c1ccccc1-c1ccccc12 10.1021/jm200999f
CHEMBL1914579 68082 None 0 Human Functional pIC50 = 4.7 4.7 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 321 0 0 4 4.1 CC1=C(C#N)C(=C(C#N)C#N)OC12c1ccccc1-c1ccccc12 10.1021/jm200999f
8108341 37640 None 3 Human Functional pIC50 = 5.7 5.7 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 364 7 1 3 5.1 O=C(O)COc1ccc(/C=C/C(=O)c2ccc(C3CCCCC3)cc2)cc1 nan
CHEMBL1457048 37640 None 3 Human Functional pIC50 = 5.7 5.7 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 364 7 1 3 5.1 O=C(O)COc1ccc(/C=C/C(=O)c2ccc(C3CCCCC3)cc2)cc1 nan
720233 50205 None 37 Human Functional pIC50 = 5.7 5.7 2 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 288 2 0 3 3.3 O=c1c(Cl)c(Cl)cnn1Cc1ccccc1Cl nan
CHEMBL1570760 50205 None 37 Human Functional pIC50 = 5.7 5.7 2 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 288 2 0 3 3.3 O=c1c(Cl)c(Cl)cnn1Cc1ccccc1Cl nan
9581015 59417 None 3 Human Functional pIC50 = 4.7 4.7 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(=S)Nc1ccccc1 nan
CHEMBL1709632 59417 None 3 Human Functional pIC50 = 4.7 4.7 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(=S)Nc1ccccc1 nan
154634314 186715 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4878979 186715 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
3420390 178715 None 3 Human Functional pIC50 = 5.7 5.7 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 474 8 2 5 1.6 NS(=O)(=O)c1ccc(CCNC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1 nan
CHEMBL467373 178715 None 3 Human Functional pIC50 = 5.7 5.7 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 474 8 2 5 1.6 NS(=O)(=O)c1ccc(CCNC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1 nan
151577785 186659 None 0 Human Functional pIC50 = 5.7 5.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4878047 186659 None 0 Human Functional pIC50 = 5.7 5.7 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
5513575 42741 None 5 Human Functional pIC50 = 5.6 5.6 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 4 2 5 4.9 N=C1/C(=C\c2ccc(-c3cccc(C(=O)O)c3)o2)C(=O)N=C2SC=C(c3ccccc3)N12 nan
CHEMBL1501743 42741 None 5 Human Functional pIC50 = 5.6 5.6 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 4 2 5 4.9 N=C1/C(=C\c2ccc(-c3cccc(C(=O)O)c3)o2)C(=O)N=C2SC=C(c3ccccc3)N12 nan
9581008 59565 None 3 Human Functional pIC50 = 5.6 5.6 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
CHEMBL1716874 59565 None 3 Human Functional pIC50 = 5.6 5.6 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
4623233 60067 None 4 Human Functional pIC50 = 4.6 4.6 -12 3
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 320 2 0 4 4.4 Cc1nnc(-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12 nan
CHEMBL1736438 60067 None 4 Human Functional pIC50 = 4.6 4.6 -12 3
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 320 2 0 4 4.4 Cc1nnc(-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12 nan
16193843 46093 None 4 Human Functional pIC50 = 4.6 4.6 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 412 3 1 7 3.8 CC(C)CSC1=NSC2=NC(=O)/C(=C\c3coc4ccccc4c3=O)C(=N)N12 nan
CHEMBL1533415 46093 None 4 Human Functional pIC50 = 4.6 4.6 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 412 3 1 7 3.8 CC(C)CSC1=NSC2=NC(=O)/C(=C\c3coc4ccccc4c3=O)C(=N)N12 nan
2286812 29474 None 32 Human Functional pIC50 = 5.6 5.6 16 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 nan
CHEMBL1384502 29474 None 32 Human Functional pIC50 = 5.6 5.6 16 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 nan
5768597 20778 None 3 Human Functional pIC50 = 5.6 5.6 3 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 320 3 1 5 3.1 N#C/C(=C/c1ccc(N2CCOCC2)o1)c1nc2ccccc2[nH]1 nan
CHEMBL1309475 20778 None 3 Human Functional pIC50 = 5.6 5.6 3 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 320 3 1 5 3.1 N#C/C(=C/c1ccc(N2CCOCC2)o1)c1nc2ccccc2[nH]1 nan
12005127 44820 None 3 Human Functional pIC50 = 5.6 5.6 -3 4
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 333 6 0 4 4.6 COc1cc(/C=C(/C)[N+](=O)[O-])ccc1OCc1ccccc1Cl nan
CHEMBL1521989 44820 None 3 Human Functional pIC50 = 5.6 5.6 -3 4
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 333 6 0 4 4.6 COc1cc(/C=C(/C)[N+](=O)[O-])ccc1OCc1ccccc1Cl nan
9581008 59565 None 3 Human Functional pIC50 = 5.6 5.6 - 1
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
CHEMBL1716874 59565 None 3 Human Functional pIC50 = 5.6 5.6 - 1
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
154634318 186105 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4870255 186105 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
164627011 186512 None 0 Human Functional pIC50 = 5.6 5.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 186512 None 0 Human Functional pIC50 = 5.6 5.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
1346847 21208 None 6 Human Functional pIC50 = 6.6 6.6 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 412 6 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(O)cc3)C2=O)cc1 nan
CHEMBL1312928 21208 None 6 Human Functional pIC50 = 6.6 6.6 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 412 6 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(O)cc3)C2=O)cc1 nan
154634322 185486 None 0 Human Functional pIC50 = 5.6 5.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4860550 185486 None 0 Human Functional pIC50 = 5.6 5.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
6109309 29989 None 1 Human Functional pIC50 = 5.6 5.6 3 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 355 5 1 4 4.0 CC(NC(=O)/C(C#N)=C/c1ccc(Cl)c([N+](=O)[O-])c1)c1ccccc1 nan
CHEMBL1388639 29989 None 1 Human Functional pIC50 = 5.6 5.6 3 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 355 5 1 4 4.0 CC(NC(=O)/C(C#N)=C/c1ccc(Cl)c([N+](=O)[O-])c1)c1ccccc1 nan
6622007 39053 None 4 Human Functional pIC50 = 4.6 4.6 -9 4
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 489 3 2 7 4.6 CC(C)(C)OC(=O)N1CCC(c2cc(O)n3ncc(C(=O)Nc4ccc(F)c(Cl)c4)c3n2)CC1 nan
CHEMBL1468612 39053 None 4 Human Functional pIC50 = 4.6 4.6 -9 4
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 489 3 2 7 4.6 CC(C)(C)OC(=O)N1CCC(c2cc(O)n3ncc(C(=O)Nc4ccc(F)c(Cl)c4)c3n2)CC1 nan
4798059 31933 None 7 Human Functional pIC50 = 5.6 5.6 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 296 4 1 3 4.3 COc1ccc2nc(C)cc(NCc3ccc(F)cc3)c2c1 nan
CHEMBL1407436 31933 None 7 Human Functional pIC50 = 5.6 5.6 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 296 4 1 3 4.3 COc1ccc2nc(C)cc(NCc3ccc(F)cc3)c2c1 nan
154634335 184589 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4847100 184589 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
154634323 184710 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4848949 184710 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145971442 163122 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4175848 163122 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
145953203 162633 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
CHEMBL4167991 162633 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
145955027 162635 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
CHEMBL4168042 162635 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
6226024 45683 None 4 Human Functional pIC50 = 5.6 5.6 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 442 7 3 6 3.7 O=C(CCCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccc(C(=O)O)c(O)c1 nan
CHEMBL1529781 45683 None 4 Human Functional pIC50 = 5.6 5.6 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 442 7 3 6 3.7 O=C(CCCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccc(C(=O)O)c(O)c1 nan
154634336 186174 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4871203 186174 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634316 186448 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4875009 186448 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
759209 35980 None 10 Human Functional pIC50 = 5.6 5.6 -1 4
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 259 1 0 3 3.5 Cc1c(Cl)sn(-c2ccc(Cl)cc2)c1=O nan
CHEMBL1442788 35980 None 10 Human Functional pIC50 = 5.6 5.6 -1 4
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 259 1 0 3 3.5 Cc1c(Cl)sn(-c2ccc(Cl)cc2)c1=O nan
648447 38811 None 3 Human Functional pIC50 = 5.6 5.6 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 375 3 1 7 2.1 COc1cccc(C2C3CN(C)CC=C3C(C#N)=C(N)C2(C#N)C#N)c1OC nan
CHEMBL1466582 38811 None 3 Human Functional pIC50 = 5.6 5.6 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 375 3 1 7 2.1 COc1cccc(C2C3CN(C)CC=C3C(C#N)=C(N)C2(C#N)C#N)c1OC nan
1527596 43102 None 6 Human Functional pIC50 = 5.6 5.6 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 448 7 2 7 4.9 CCOC(=O)c1c(-c2ccccc2)csc1NC(=O)/C(C#N)=C/c1ccc(O)c(OC)c1 nan
CHEMBL1504949 43102 None 6 Human Functional pIC50 = 5.6 5.6 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 448 7 2 7 4.9 CCOC(=O)c1c(-c2ccccc2)csc1NC(=O)/C(C#N)=C/c1ccc(O)c(OC)c1 nan
4406525 38445 None 3 Human Functional pIC50 = 5.6 5.6 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 294 1 0 4 2.6 CN1CCN(C2=CC3=CC(=C(C#N)C#N)CCC3CC2)CC1 nan
CHEMBL1463795 38445 None 3 Human Functional pIC50 = 5.6 5.6 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 294 1 0 4 2.6 CN1CCN(C2=CC3=CC(=C(C#N)C#N)CCC3CC2)CC1 nan
45489602 59293 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL1704189 59293 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
145971240 163182 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4176719 163182 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
164610101 184981 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 184981 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
1214651 59593 None 6 Human Functional pIC50 = 4.6 4.6 -42 4
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 414 2 0 4 5.7 Cc1nnc(-c2cccc3ccccc23)c2cn(-c3cccc(Br)c3)nc12 nan
CHEMBL1718220 59593 None 6 Human Functional pIC50 = 4.6 4.6 -42 4
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 414 2 0 4 5.7 Cc1nnc(-c2cccc3ccccc23)c2cn(-c3cccc(Br)c3)nc12 nan
154634327 184845 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 184845 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
6619478 25945 None 1 Human Functional pIC50 = 4.5 4.5 -9 2
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 501 4 2 8 4.5 COc1ccc(NC(=O)c2cnn3c(O)cc(C4CCN(C(=O)OC(C)(C)C)CC4)nc23)cc1Cl nan
CHEMBL1354041 25945 None 1 Human Functional pIC50 = 4.5 4.5 -9 2
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 501 4 2 8 4.5 COc1ccc(NC(=O)c2cnn3c(O)cc(C4CCN(C(=O)OC(C)(C)C)CC4)nc23)cc1Cl nan
154634337 185439 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4859764 185439 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
164627011 186512 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 186512 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
1024 16495 None 63 Human Functional pIC50 = 7.5 7.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
CHEMBL1235421 16495 None 63 Human Functional pIC50 = 7.5 7.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
154634320 186716 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4879017 186716 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
154634331 184654 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4848109 184654 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145952453 162883 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
CHEMBL4172188 162883 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
14286542 72244 None 2 Human Functional pIC50 = 5.5 5.5 -4 4
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 401 2 3 4 2.9 CC1=CC2/C=C(\C)CCC(O)C(O)/C=C/C(=O)C23C(=O)NC(CC(C)C)C3C1C nan
CHEMBL1981103 72244 None 2 Human Functional pIC50 = 5.5 5.5 -4 4
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 401 2 3 4 2.9 CC1=CC2/C=C(\C)CCC(O)C(O)/C=C/C(=O)C23C(=O)NC(CC(C)C)C3C1C nan
9581005 59650 None 1 Human Functional pIC50 = 6.5 6.5 21 2
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 359 4 2 6 2.3 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)NC(C)(C)C nan
CHEMBL1720530 59650 None 1 Human Functional pIC50 = 6.5 6.5 21 2
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 359 4 2 6 2.3 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)NC(C)(C)C nan
135650717 108268 None 3 Human Functional pIC50 = 5.5 5.5 -2 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 374 4 3 6 4.3 Oc1ccc(/C=N/Nc2nc(-c3ccccc3F)nc3ccccc23)c(O)c1 nan
CHEMBL3196703 108268 None 3 Human Functional pIC50 = 5.5 5.5 -2 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 374 4 3 6 4.3 Oc1ccc(/C=N/Nc2nc(-c3ccccc3F)nc3ccccc23)c(O)c1 nan
6226345 31153 None 5 Human Functional pIC50 = 5.5 5.5 4 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 5 3 4 2.9 CCCCN1C(=O)NC(=O)/C(=C(O)\C=C\c2c[nH]c3ccccc23)C1=O nan
CHEMBL1400236 31153 None 5 Human Functional pIC50 = 5.5 5.5 4 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 5 3 4 2.9 CCCCN1C(=O)NC(=O)/C(=C(O)\C=C\c2c[nH]c3ccccc23)C1=O nan
6603703 208 None 8 Human Functional pIC50 = 5.5 5.5 -1047 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 329 2 3 4 3.3 NC[C@@H]1O[C@@H](Cc2c1ccc(c2O)O)C12CC3CC(C2)CC(C1)C3 10.6019/CHEMBL5442687
9637 208 None 8 Human Functional pIC50 = 5.5 5.5 -1047 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 329 2 3 4 3.3 NC[C@@H]1O[C@@H](Cc2c1ccc(c2O)O)C12CC3CC(C2)CC(C1)C3 10.6019/CHEMBL5442687
CHEMBL291143 208 None 8 Human Functional pIC50 = 5.5 5.5 -1047 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 329 2 3 4 3.3 NC[C@@H]1O[C@@H](Cc2c1ccc(c2O)O)C12CC3CC(C2)CC(C1)C3 10.6019/CHEMBL5442687
2868490 54333 None 8 Human Functional pIC50 = 5.5 5.5 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 354 3 0 3 5.6 COc1ccc(C=C2C=C(C(C)(C)C)C(=O)C(C(C)(C)C)=C2)cc1OC nan
CHEMBL1608333 54333 None 8 Human Functional pIC50 = 5.5 5.5 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 354 3 0 3 5.6 COc1ccc(C=C2C=C(C(C)(C)C)C(=O)C(C(C)(C)C)=C2)cc1OC nan
9581007 59288 None 1 Human Functional pIC50 = 6.5 6.5 - 1
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
CHEMBL1704074 59288 None 1 Human Functional pIC50 = 6.5 6.5 - 1
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
2286812 29474 None 32 Human Functional pIC50 = 6.5 6.5 16 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.6019/CHEMBL5442687
CHEMBL1384502 29474 None 32 Human Functional pIC50 = 6.5 6.5 16 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.6019/CHEMBL5442687
16437205 32011 None 8 Human Functional pIC50 = 5.5 5.5 -2 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 486 6 1 7 2.7 CCC1CCCCN1S(=O)(=O)c1ccc(NC(=O)c2nc(S(C)(=O)=O)ncc2Cl)cc1 nan
CHEMBL1407961 32011 None 8 Human Functional pIC50 = 5.5 5.5 -2 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 486 6 1 7 2.7 CCC1CCCCN1S(=O)(=O)c1ccc(NC(=O)c2nc(S(C)(=O)=O)ncc2Cl)cc1 nan
1416931 23426 None 2 Human Functional pIC50 = 5.5 5.5 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1333032 23426 None 2 Human Functional pIC50 = 5.5 5.5 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccc(C(=O)O)cc1 nan
150149078 186450 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875041 186450 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
156419 938 None 48 Human Functional pIC50 = 5.5 5.5 -79 20
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 357 6 1 1 6.1 C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F 10.6019/CHEMBL5442687
156419.0 938 None 48 Human Functional pIC50 = 5.5 5.5 -79 20
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 357 6 1 1 6.1 C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F 10.6019/CHEMBL5442687
3308 938 None 48 Human Functional pIC50 = 5.5 5.5 -79 20
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 357 6 1 1 6.1 C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F 10.6019/CHEMBL5442687
647 938 None 48 Human Functional pIC50 = 5.5 5.5 -79 20
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 357 6 1 1 6.1 C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F 10.6019/CHEMBL5442687
CHEMBL1201284 938 None 48 Human Functional pIC50 = 5.5 5.5 -79 20
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 357 6 1 1 6.1 C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F 10.6019/CHEMBL5442687
DB01012 938 None 48 Human Functional pIC50 = 5.5 5.5 -79 20
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 357 6 1 1 6.1 C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F 10.6019/CHEMBL5442687
2286812 29474 None 32 Human Functional pIC50 = 6.5 6.5 16 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.6019/CHEMBL5442687
CHEMBL1384502 29474 None 32 Human Functional pIC50 = 6.5 6.5 16 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.6019/CHEMBL5442687
1890 2759 None 31 Human Functional pIC50 = 5.5 5.5 -26 28
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.6019/CHEMBL5442687
4449 2759 None 31 Human Functional pIC50 = 5.5 5.5 -26 28
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.6019/CHEMBL5442687
7247 2759 None 31 Human Functional pIC50 = 5.5 5.5 -26 28
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.6019/CHEMBL5442687
CHEMBL623 2759 None 31 Human Functional pIC50 = 5.5 5.5 -26 28
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.6019/CHEMBL5442687
DB01149 2759 None 31 Human Functional pIC50 = 5.5 5.5 -26 28
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.6019/CHEMBL5442687
42642645 16406 None 50 Human Functional pIC50 = 5.5 5.5 1 5
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 632 12 2 8 5.8 COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1 10.6019/CHEMBL5442687
CHEMBL1230609 16406 None 50 Human Functional pIC50 = 5.5 5.5 1 5
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 632 12 2 8 5.8 COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1 10.6019/CHEMBL5442687
12533774 185624 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4862654 185624 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634316 186448 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4875009 186448 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
10219 188904 None 34 Human Functional pIC50 = 6.5 6.5 -2 11
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.6019/CHEMBL5442687
CHEMBL493439 188904 None 34 Human Functional pIC50 = 6.5 6.5 -2 11
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.6019/CHEMBL5442687
CHEMBL50588 188904 None 34 Human Functional pIC50 = 6.5 6.5 -2 11
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.6019/CHEMBL5442687
24792182 55100 None 0 Human Functional pIC50 = 5.5 5.5 -1 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 6 1 5 5.2 COc1ccc(C)cc1Nc1n[n+](-c2ccccc2)c(-c2ccc(N(C)C)cc2)s1 nan
CHEMBL1306983 55100 None 0 Human Functional pIC50 = 5.5 5.5 -1 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 6 1 5 5.2 COc1ccc(C)cc1Nc1n[n+](-c2ccccc2)c(-c2ccc(N(C)C)cc2)s1 nan
CHEMBL1616747 55100 None 0 Human Functional pIC50 = 5.5 5.5 -1 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 6 1 5 5.2 COc1ccc(C)cc1Nc1n[n+](-c2ccccc2)c(-c2ccc(N(C)C)cc2)s1 nan
57134579 162727 None 21 Human Functional pIC50 = 4.5 4.5 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 239 1 2 4 1.2 Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4169520 162727 None 21 Human Functional pIC50 = 4.5 4.5 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 239 1 2 4 1.2 Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145974046 163107 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4175617 163107 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
42611190 3156 None 14 Human Functional pIC50 = 5.4 5.4 -933 21
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 475 4 2 2 7.4 OC(=O)c1cc2cc(ccc2c(c1)c1ccc(cc1)C1CCNCC1)c1ccc(cc1)C(F)(F)F 10.6019/CHEMBL5442687
5802 3156 None 14 Human Functional pIC50 = 5.4 5.4 -933 21
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 475 4 2 2 7.4 OC(=O)c1cc2cc(ccc2c(c1)c1ccc(cc1)C1CCNCC1)c1ccc(cc1)C(F)(F)F 10.6019/CHEMBL5442687
CHEMBL1800685 3156 None 14 Human Functional pIC50 = 5.4 5.4 -933 21
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 475 4 2 2 7.4 OC(=O)c1cc2cc(ccc2c(c1)c1ccc(cc1)C1CCNCC1)c1ccc(cc1)C(F)(F)F 10.6019/CHEMBL5442687
25074316 186476 None 25 Human Functional pIC50 = 5.4 5.4 1 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 421 5 1 8 2.9 COC1CCN(c2cccc(-c3cc(NC(C)=O)nc(-n4nc(C)cc4C)n3)n2)CC1 10.6019/CHEMBL5442687
CHEMBL487553 186476 None 25 Human Functional pIC50 = 5.4 5.4 1 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 421 5 1 8 2.9 COC1CCN(c2cccc(-c3cc(NC(C)=O)nc(-n4nc(C)cc4C)n3)n2)CC1 10.6019/CHEMBL5442687
487 3634 None 20 Human Functional pIC50 = 5.4 5.4 -1 9
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.6019/CHEMBL5442687
60602 3634 None 20 Human Functional pIC50 = 5.4 5.4 -1 9
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.6019/CHEMBL5442687
CHEMBL405355 3634 None 20 Human Functional pIC50 = 5.4 5.4 -1 9
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.6019/CHEMBL5442687
DB09239 3634 None 20 Human Functional pIC50 = 5.4 5.4 -1 9
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.6019/CHEMBL5442687
13950957 157420 None 8 Human Functional pIC50 = 5.4 5.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4077503 157420 None 8 Human Functional pIC50 = 5.4 5.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
9581012 59607 None 3 Human Functional pIC50 = 6.4 6.4 - 1
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 415 5 2 6 3.3 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccccc1 nan
CHEMBL1718866 59607 None 3 Human Functional pIC50 = 6.4 6.4 - 1
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 415 5 2 6 3.3 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccccc1 nan
6393553 47100 None 4 Human Functional pIC50 = 5.4 5.4 5 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 311 5 1 5 3.0 CC(NC(=O)/C(C#N)=C/c1ccc([N+](=O)[O-])o1)c1ccccc1 nan
CHEMBL1542492 47100 None 4 Human Functional pIC50 = 5.4 5.4 5 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 311 5 1 5 3.0 CC(NC(=O)/C(C#N)=C/c1ccc([N+](=O)[O-])o1)c1ccccc1 nan
52936725 61270 None 22 Human Functional pIC50 = 5.4 5.4 -812 10
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 432 6 2 4 6.3 Cc1cc(C)cc(-c2cnc3cc(Cl)c(-c4cccc(O)c4)cc3c2OCCCN)c1 10.6019/CHEMBL5442687
CHEMBL1766103 61270 None 22 Human Functional pIC50 = 5.4 5.4 -812 10
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 432 6 2 4 6.3 Cc1cc(C)cc(-c2cnc3cc(Cl)c(-c4cccc(O)c4)cc3c2OCCCN)c1 10.6019/CHEMBL5442687
145952039 162903 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4172440 162903 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
28 3496 None 35 Human Functional pIC50 = 5.4 5.4 -1 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 486 9 1 7 5.2 COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C 10.6019/CHEMBL5442687
3292447 3496 None 35 Human Functional pIC50 = 5.4 5.4 -1 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 486 9 1 7 5.2 COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C 10.6019/CHEMBL5442687
CHEMBL20963 3496 None 35 Human Functional pIC50 = 5.4 5.4 -1 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 486 9 1 7 5.2 COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C 10.6019/CHEMBL5442687
2269231 45934 None 6 Human Functional pIC50 = 5.4 5.4 13 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1532025 45934 None 6 Human Functional pIC50 = 5.4 5.4 13 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)cc1 nan
145959908 162156 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4160515 162156 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
9581013 59730 None 3 Human Functional pIC50 = 5.4 5.4 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 351 4 2 6 1.7 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(Cl)cc1 nan
CHEMBL1723578 59730 None 3 Human Functional pIC50 = 5.4 5.4 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 351 4 2 6 1.7 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(Cl)cc1 nan
11498 3019 None 34 Human Functional pIC50 = 5.4 5.4 -57 8
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 392 3 1 5 4.1 CCOC(=O)c1c(C)[nH]c2c1c1CN3CCc4c(C3Oc1cc2)ccc(c4)OC 10.6019/CHEMBL5442687
4995951 3019 None 34 Human Functional pIC50 = 5.4 5.4 -57 8
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 392 3 1 5 4.1 CCOC(=O)c1c(C)[nH]c2c1c1CN3CCc4c(C3Oc1cc2)ccc(c4)OC 10.6019/CHEMBL5442687
CHEMBL59898 3019 None 34 Human Functional pIC50 = 5.4 5.4 -57 8
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 392 3 1 5 4.1 CCOC(=O)c1c(C)[nH]c2c1c1CN3CCc4c(C3Oc1cc2)ccc(c4)OC 10.6019/CHEMBL5442687
44634573 2748 None 1 Human Functional pIC50 = 5.4 5.4 -489 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 465 6 0 2 5.0 Cc1n(C/C=C/c2ccccc2)c2[n+](c1P(=S)(c1ccccc1)c1ccccc1)cccc2 10.6019/CHEMBL5442687
9168 2748 None 1 Human Functional pIC50 = 5.4 5.4 -489 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 465 6 0 2 5.0 Cc1n(C/C=C/c2ccccc2)c2[n+](c1P(=S)(c1ccccc1)c1ccccc1)cccc2 10.6019/CHEMBL5442687
CHEMBL1474387 2748 None 1 Human Functional pIC50 = 5.4 5.4 -489 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 465 6 0 2 5.0 Cc1n(C/C=C/c2ccccc2)c2[n+](c1P(=S)(c1ccccc1)c1ccccc1)cccc2 10.6019/CHEMBL5442687
CHEMBL1622930 2748 None 1 Human Functional pIC50 = 5.4 5.4 -489 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 465 6 0 2 5.0 Cc1n(C/C=C/c2ccccc2)c2[n+](c1P(=S)(c1ccccc1)c1ccccc1)cccc2 10.6019/CHEMBL5442687
12533774 185624 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4862654 185624 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
24901704 95043 None 55 Human Functional pIC50 = 5.4 5.4 -2 4
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 517 6 2 7 5.7 Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1 10.6019/CHEMBL5442687
CHEMBL254760 95043 None 55 Human Functional pIC50 = 5.4 5.4 -2 4
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 517 6 2 7 5.7 Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1 10.6019/CHEMBL5442687
2841621 27708 None 4 Human Functional pIC50 = 5.4 5.4 2 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 354 4 0 4 3.8 CCOC(=O)C1=C(Cc2ccc(Cl)cc2)C(=O)c2ccccc2C1=O nan
CHEMBL1370183 27708 None 4 Human Functional pIC50 = 5.4 5.4 2 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 354 4 0 4 3.8 CCOC(=O)C1=C(Cc2ccc(Cl)cc2)C(=O)c2ccccc2C1=O nan
154634320 186716 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4879017 186716 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
154634334 185531 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4861414 185531 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145950576 162974 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 333 3 2 5 2.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccco1 10.1021/acsmedchemlett.7b00510
CHEMBL4173352 162974 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 333 3 2 5 2.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccco1 10.1021/acsmedchemlett.7b00510
9901086 187737 None 28 Human Functional pIC50 = 5.4 5.4 -3630 6
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 304 4 1 5 2.1 Clc1cccc(COc2cncc(N3CCNCC3)n2)c1 10.6019/CHEMBL5442687
CHEMBL4743049 187737 None 28 Human Functional pIC50 = 5.4 5.4 -3630 6
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 304 4 1 5 2.1 Clc1cccc(COc2cncc(N3CCNCC3)n2)c1 10.6019/CHEMBL5442687
CHEMBL494947 187737 None 28 Human Functional pIC50 = 5.4 5.4 -3630 6
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 304 4 1 5 2.1 Clc1cccc(COc2cncc(N3CCNCC3)n2)c1 10.6019/CHEMBL5442687
1692 2154 None 25 Human Functional pIC50 = 5.4 5.4 -147 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 411 6 2 4 5.5 CCc1ccc(cc1)OCc1ccccc1C(=O)Nc1ccc2c(c1)c(N)cc(n2)C 10.6019/CHEMBL5442687
5311340 2154 None 25 Human Functional pIC50 = 5.4 5.4 -147 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 411 6 2 4 5.5 CCc1ccc(cc1)OCc1ccccc1C(=O)Nc1ccc2c(c1)c(N)cc(n2)C 10.6019/CHEMBL5442687
CHEMBL140979 2154 None 25 Human Functional pIC50 = 5.4 5.4 -147 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 411 6 2 4 5.5 CCc1ccc(cc1)OCc1ccccc1C(=O)Nc1ccc2c(c1)c(N)cc(n2)C 10.6019/CHEMBL5442687
56646802 68080 None 0 Human Functional pIC50 = 5.4 5.4 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 351 1 0 4 3.8 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1c(F)c(F)c(F)c(F)c1F 10.1021/jm200999f
CHEMBL1914577 68080 None 0 Human Functional pIC50 = 5.4 5.4 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 351 1 0 4 3.8 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1c(F)c(F)c(F)c(F)c1F 10.1021/jm200999f
130 3500 None 32 Human Functional pIC50 = 5.3 5.3 -2290 10
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 520 3 0 6 5.6 CN1CCC2(CC1)COc1c2cc2c(c1)CCN2C(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C 10.6019/CHEMBL5442687
3378093 3500 None 32 Human Functional pIC50 = 5.3 5.3 -2290 10
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 520 3 0 6 5.6 CN1CCC2(CC1)COc1c2cc2c(c1)CCN2C(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C 10.6019/CHEMBL5442687
CHEMBL281350 3500 None 32 Human Functional pIC50 = 5.3 5.3 -2290 10
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 520 3 0 6 5.6 CN1CCC2(CC1)COc1c2cc2c(c1)CCN2C(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C 10.6019/CHEMBL5442687
5346366 41511 None 4 Human Functional pIC50 = 5.3 5.3 2 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 489 6 1 6 5.3 O=C(Nc1ccc2nc(SCc3ccccc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
CHEMBL1490915 41511 None 4 Human Functional pIC50 = 5.3 5.3 2 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 489 6 1 6 5.3 O=C(Nc1ccc2nc(SCc3ccccc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
154634333 185321 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 185321 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
9581014 60016 None 1 Human Functional pIC50 = 5.3 5.3 - 1
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 337 4 2 6 1.5 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(N)=S nan
CHEMBL1734603 60016 None 1 Human Functional pIC50 = 5.3 5.3 - 1
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 337 4 2 6 1.5 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(N)=S nan
662 3680 None 7 Human Functional pIC50 = 5.3 5.3 -2 12
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 10.6019/CHEMBL5442687
9853583 3680 None 7 Human Functional pIC50 = 5.3 5.3 -2 12
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 10.6019/CHEMBL5442687
CHEMBL2021721 3680 None 7 Human Functional pIC50 = 5.3 5.3 -2 12
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 10.6019/CHEMBL5442687
53258899 68089 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1csc2cc(C(=O)O)sc12 10.1021/jm200999f
CHEMBL1914586 68089 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1csc2cc(C(=O)O)sc12 10.1021/jm200999f
152243845 185005 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4853043 185005 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
154634332 185233 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 185233 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
154634330 186058 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4869539 186058 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
1214658 59491 None 8 Human Functional pIC50 = 5.3 5.3 -4 3
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 392 4 0 5 5.5 COc1ccc(-n2cc3c(-c4ccc(-c5ccccc5)cc4)nnc(C)c3n2)cc1 nan
CHEMBL1713756 59491 None 8 Human Functional pIC50 = 5.3 5.3 -4 3
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 392 4 0 5 5.5 COc1ccc(-n2cc3c(-c4ccc(-c5ccccc5)cc4)nnc(C)c3n2)cc1 nan
135399235 4134 None 41 Human Functional pIC50 = 7.3 7.3 -18 3
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
2919 4134 None 41 Human Functional pIC50 = 7.3 7.3 -18 3
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
5722 4134 None 41 Human Functional pIC50 = 7.3 7.3 -18 3
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
CHEMBL28079 4134 None 41 Human Functional pIC50 = 7.3 7.3 -18 3
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
154634321 186103 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 186103 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
154634336 186174 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4871203 186174 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634314 186715 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4878979 186715 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145955278 162654 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(Cl)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4168406 162654 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(Cl)c1 10.1021/acsmedchemlett.7b00510
21337671 68086 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 297 1 0 4 3.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(F)cc1F 10.1021/jm200999f
CHEMBL1914583 68086 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 297 1 0 4 3.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(F)cc1F 10.1021/jm200999f
68324914 185837 None 34 Human Functional pIC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
CHEMBL4865971 185837 None 34 Human Functional pIC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
7424594 53005 None 2 Human Functional pIC50 = 5.3 5.3 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 375 5 1 3 5.3 O=C(/C=C/c1ccco1)c1ccc(NC(=O)C23CC4CC(CC(C4)C2)C3)cc1 nan
CHEMBL1596753 53005 None 2 Human Functional pIC50 = 5.3 5.3 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 375 5 1 3 5.3 O=C(/C=C/c1ccco1)c1ccc(NC(=O)C23CC4CC(CC(C4)C2)C3)cc1 nan
145959592 162444 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4164993 162444 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
6202912 48223 None 5 Human Functional pIC50 = 6.3 6.3 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 502 9 3 8 3.7 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)c(O)c3)C2=O)cc1OC nan
CHEMBL1552304 48223 None 5 Human Functional pIC50 = 6.3 6.3 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 502 9 3 8 3.7 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)c(O)c3)C2=O)cc1OC nan
10150497 4074 None 40 Human Functional pIC50 = 5.3 5.3 -812 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 380 4 1 7 2.7 NCCc1cn(c2c1cccc2)S(=O)(=O)c1c(Cl)nc2n1ccs2 10.6019/CHEMBL5442687
3240 4074 None 40 Human Functional pIC50 = 5.3 5.3 -812 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 380 4 1 7 2.7 NCCc1cn(c2c1cccc2)S(=O)(=O)c1c(Cl)nc2n1ccs2 10.6019/CHEMBL5442687
CHEMBL392760 4074 None 40 Human Functional pIC50 = 5.3 5.3 -812 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 380 4 1 7 2.7 NCCc1cn(c2c1cccc2)S(=O)(=O)c1c(Cl)nc2n1ccs2 10.6019/CHEMBL5442687
1477048 29742 None 17 Human Functional pIC50 = 6.3 6.3 23 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 438 5 0 5 4.3 CN(C)/C=C/C(=O)c1ccc(N2CCN(c3ncc(C(F)(F)F)cc3Cl)CC2)cc1 nan
CHEMBL1386711 29742 None 17 Human Functional pIC50 = 6.3 6.3 23 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 438 5 0 5 4.3 CN(C)/C=C/C(=O)c1ccc(N2CCN(c3ncc(C(F)(F)F)cc3Cl)CC2)cc1 nan
5936070 34062 None 5 Human Functional pIC50 = 6.3 6.3 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 427 4 1 4 6.4 CC(=O)Nc1sc(/C(C#N)=C/c2ccc(Cl)c(Cl)c2)nc1-c1ccc(C)cc1 nan
CHEMBL1424929 34062 None 5 Human Functional pIC50 = 6.3 6.3 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 427 4 1 4 6.4 CC(=O)Nc1sc(/C(C#N)=C/c2ccc(Cl)c(Cl)c2)nc1-c1ccc(C)cc1 nan
22475020 96056 None 19 Human Functional pIC50 = 5.3 5.3 -489 4
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 491 3 0 4 5.4 O=C(c1cc2c(cc1F)OC(c1ccc(F)cc1)(c1ccc(Cl)cc1Cl)O2)N1CCOCC1 10.6019/CHEMBL5442687
CHEMBL259656 96056 None 19 Human Functional pIC50 = 5.3 5.3 -489 4
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 491 3 0 4 5.4 O=C(c1cc2c(cc1F)OC(c1ccc(F)cc1)(c1ccc(Cl)cc1Cl)O2)N1CCOCC1 10.6019/CHEMBL5442687
154634323 184710 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4848949 184710 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
151271218 186261 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4872368 186261 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
1609318 42645 None 7 Human Functional pIC50 = 6.3 6.3 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 297 12 2 4 3.4 C=CCCCCCCCCc1nc(SCC(=O)O)n[nH]1 nan
CHEMBL1500763 42645 None 7 Human Functional pIC50 = 6.3 6.3 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 297 12 2 4 3.4 C=CCCCCCCCCc1nc(SCC(=O)O)n[nH]1 nan
282594 45361 None 12 Human Functional pIC50 = 5.3 5.3 -2 5
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 331 2 0 3 3.7 CC(=O)N(C1=C(Cl)C(=O)c2ccccc2C1=O)C1CCCCC1 nan
CHEMBL1526855 45361 None 12 Human Functional pIC50 = 5.3 5.3 -2 5
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 331 2 0 3 3.7 CC(=O)N(C1=C(Cl)C(=O)c2ccccc2C1=O)C1CCCCC1 nan
5334290 25931 None 7 Human Functional pIC50 = 6.3 6.3 7 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 388 7 1 4 5.6 CCN(CC)c1ccc(/C=C(/C#N)c2nc3cc(C)ccc3[nH]2)c(OC(C)C)c1 nan
CHEMBL1353925 25931 None 7 Human Functional pIC50 = 6.3 6.3 7 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 388 7 1 4 5.6 CCN(CC)c1ccc(/C=C(/C#N)c2nc3cc(C)ccc3[nH]2)c(OC(C)C)c1 nan
4189659 28061 None 3 Human Functional pIC50 = 6.3 6.3 6 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 493 8 2 7 5.1 CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
CHEMBL1372770 28061 None 3 Human Functional pIC50 = 6.3 6.3 6 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 493 8 2 7 5.1 CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
2269231 45934 None 6 Human Functional pIC50 = 6.3 6.3 13 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1532025 45934 None 6 Human Functional pIC50 = 6.3 6.3 13 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)cc1 nan
5733585 40983 None 6 Human Functional pIC50 = 6.3 6.3 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 486 9 2 7 4.0 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1OC nan
CHEMBL1487024 40983 None 6 Human Functional pIC50 = 6.3 6.3 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 486 9 2 7 4.0 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1OC nan
10071196 3124 None 53 Human Functional pIC50 = 5.3 5.3 -380 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.6019/CHEMBL5442687
10071196.0 3124 None 53 Human Functional pIC50 = 5.3 5.3 -380 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.6019/CHEMBL5442687
5142 3124 None 53 Human Functional pIC50 = 5.3 5.3 -380 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.6019/CHEMBL5442687
8423 3124 None 53 Human Functional pIC50 = 5.3 5.3 -380 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.6019/CHEMBL5442687
CHEMBL2111101 3124 None 53 Human Functional pIC50 = 5.3 5.3 -380 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.6019/CHEMBL5442687
DB05316 3124 None 53 Human Functional pIC50 = 5.3 5.3 -380 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.6019/CHEMBL5442687
4189659 28061 None 3 Human Functional pIC50 = 5.3 5.3 6 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 493 8 2 7 5.1 CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
CHEMBL1372770 28061 None 3 Human Functional pIC50 = 5.3 5.3 6 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 493 8 2 7 5.1 CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
53258795 68093 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914590 68093 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
660319 11007 None 59 Human Functional pIC50 = 4.2 4.2 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 184 1 1 3 2.7 O=C(O)c1cc2sccc2s1 10.1021/jm200999f
CHEMBL1173787 11007 None 59 Human Functional pIC50 = 4.2 4.2 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 184 1 1 3 2.7 O=C(O)c1cc2sccc2s1 10.1021/jm200999f
5722655 20117 None 3 Human Functional pIC50 = 6.2 6.2 17 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 388 8 1 4 5.6 CCCOc1cc(N(CC)CC)ccc1/C=C(/C#N)c1nc2cc(C)ccc2[nH]1 nan
CHEMBL1304179 20117 None 3 Human Functional pIC50 = 6.2 6.2 17 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 388 8 1 4 5.6 CCCOc1cc(N(CC)CC)ccc1/C=C(/C#N)c1nc2cc(C)ccc2[nH]1 nan
1024 16495 None 63 Human Functional pIC50 = 6.2 6.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
CHEMBL1235421 16495 None 63 Human Functional pIC50 = 6.2 6.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
154634318 186105 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4870255 186105 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
53258898 68095 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 472 15 1 3 9.1 CCCCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914592 68095 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 472 15 1 3 9.1 CCCCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
209 3057 None 57 Human Functional pIC50 = 5.2 5.2 -2630 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.6019/CHEMBL5442687
2113 3057 None 57 Human Functional pIC50 = 5.2 5.2 -2630 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.6019/CHEMBL5442687
4748 3057 None 57 Human Functional pIC50 = 5.2 5.2 -2630 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.6019/CHEMBL5442687
4748.0 3057 None 57 Human Functional pIC50 = 5.2 5.2 -2630 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.6019/CHEMBL5442687
CHEMBL567 3057 None 57 Human Functional pIC50 = 5.2 5.2 -2630 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.6019/CHEMBL5442687
DB00850 3057 None 57 Human Functional pIC50 = 5.2 5.2 -2630 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.6019/CHEMBL5442687
154634334 185531 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4861414 185531 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634330 186058 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4869539 186058 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
164610101 184981 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 184981 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
12138435 68079 None 26 Human Functional pIC50 = 7.2 7.2 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
CHEMBL1914576 68079 None 26 Human Functional pIC50 = 7.2 7.2 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
145951566 162860 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4171782 162860 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
11656002 83044 None 22 Human Functional pIC50 = 5.2 5.2 -2884 8
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 484 3 0 3 5.8 O=C1COc2nccc(-c3ccccc3F)c2CN1Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1 10.6019/CHEMBL5442687
CHEMBL2181247 83044 None 22 Human Functional pIC50 = 5.2 5.2 -2884 8
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 484 3 0 3 5.8 O=C1COc2nccc(-c3ccccc3F)c2CN1Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1 10.6019/CHEMBL5442687
9893924 4750 None 24 Human Functional pIC50 = 5.2 5.2 -213 9
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 554 11 3 4 5.4 S=C(NCCCc1c[nH]cn1)NCCCN(Cc1ccc(Cl)c(Cl)c1)c1ccc(Br)cn1 10.6019/CHEMBL5442687
CHEMBL103769 4750 None 24 Human Functional pIC50 = 5.2 5.2 -213 9
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 554 11 3 4 5.4 S=C(NCCCc1c[nH]cn1)NCCCN(Cc1ccc(Cl)c(Cl)c1)c1ccc(Br)cn1 10.6019/CHEMBL5442687
16103465 68090 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 254 1 1 4 4.2 Cc1csc2c1sc1cc(C(=O)O)sc12 10.1021/jm200999f
CHEMBL1914587 68090 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 254 1 1 4 4.2 Cc1csc2c1sc1cc(C(=O)O)sc12 10.1021/jm200999f
24882686 95359 None 35 Human Functional pIC50 = 6.2 6.2 -5 6
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 499 6 1 7 4.1 Cc1csc2c(N[C@@H](C)CN3CCN(S(=O)(=O)c4ccc(Cl)c(Cl)c4)CC3)ncnc12 10.6019/CHEMBL5442687
CHEMBL256470 95359 None 35 Human Functional pIC50 = 6.2 6.2 -5 6
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 499 6 1 7 4.1 Cc1csc2c(N[C@@H](C)CN3CCN(S(=O)(=O)c4ccc(Cl)c(Cl)c4)CC3)ncnc12 10.6019/CHEMBL5442687
11957284 35945 None 3 Human Functional pIC50 = 6.2 6.2 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 3 2 8 5.0 Cc1nnc(NC(=O)c2sc3nc(-c4cccs4)cc(C(F)(F)F)c3c2N)s1 nan
CHEMBL1442537 35945 None 3 Human Functional pIC50 = 6.2 6.2 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 3 2 8 5.0 Cc1nnc(NC(=O)c2sc3nc(-c4cccs4)cc(C(F)(F)F)c3c2N)s1 nan
1542103 22491 None 20 Human Functional pIC50 = 6.2 6.2 2 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 418 4 0 6 4.2 Cc1ccccc1N1CCN(c2ncnc3c2cnn3Cc2ccc(Cl)cc2)CC1 nan
CHEMBL1325250 22491 None 20 Human Functional pIC50 = 6.2 6.2 2 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 418 4 0 6 4.2 Cc1ccccc1N1CCN(c2ncnc3c2cnn3Cc2ccc(Cl)cc2)CC1 nan
154634335 184589 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4847100 184589 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
20992 199528 None 52 Human Functional pIC50 = 5.2 5.2 1 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 276 7 0 4 0.4 O=C1C=CC(=O)N1CCCCCCN1C(=O)C=CC1=O nan
CHEMBL567422 199528 None 52 Human Functional pIC50 = 5.2 5.2 1 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 276 7 0 4 0.4 O=C1C=CC(=O)N1CCCCCCN1C(=O)C=CC1=O nan
135413536 448 None 58 Human Functional pIC50 = 5.2 5.2 -26302 7
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 534 6 2 5 5.0 Fc1ccc(cc1)[C@H]1[C@H](OCCN1Cc1[nH][nH]c(=O)n1)O[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C 10.6019/CHEMBL5442687
230 448 None 58 Human Functional pIC50 = 5.2 5.2 -26302 7
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 534 6 2 5 5.0 Fc1ccc(cc1)[C@H]1[C@H](OCCN1Cc1[nH][nH]c(=O)n1)O[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C 10.6019/CHEMBL5442687
3490 448 None 58 Human Functional pIC50 = 5.2 5.2 -26302 7
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 534 6 2 5 5.0 Fc1ccc(cc1)[C@H]1[C@H](OCCN1Cc1[nH][nH]c(=O)n1)O[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C 10.6019/CHEMBL5442687
6918365 448 None 58 Human Functional pIC50 = 5.2 5.2 -26302 7
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 534 6 2 5 5.0 Fc1ccc(cc1)[C@H]1[C@H](OCCN1Cc1[nH][nH]c(=O)n1)O[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C 10.6019/CHEMBL5442687
CHEMBL1471 448 None 58 Human Functional pIC50 = 5.2 5.2 -26302 7
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 534 6 2 5 5.0 Fc1ccc(cc1)[C@H]1[C@H](OCCN1Cc1[nH][nH]c(=O)n1)O[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C 10.6019/CHEMBL5442687
DB00673 448 None 58 Human Functional pIC50 = 5.2 5.2 -26302 7
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 534 6 2 5 5.0 Fc1ccc(cc1)[C@H]1[C@H](OCCN1Cc1[nH][nH]c(=O)n1)O[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C 10.6019/CHEMBL5442687
24789826 55081 None 0 Human Functional pIC50 = 6.2 6.2 56 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 419 7 1 4 5.8 CCN(CC)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
CHEMBL1307717 55081 None 0 Human Functional pIC50 = 6.2 6.2 56 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 419 7 1 4 5.8 CCN(CC)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
CHEMBL1616626 55081 None 0 Human Functional pIC50 = 6.2 6.2 56 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 419 7 1 4 5.8 CCN(CC)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
1985027 32725 None 8 Human Functional pIC50 = 6.2 6.2 27 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 454 8 2 5 4.6 CCc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)cc1 nan
CHEMBL1413629 32725 None 8 Human Functional pIC50 = 6.2 6.2 27 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 454 8 2 5 4.6 CCc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)cc1 nan
12138434 68084 None 1 Human Functional pIC50 = 5.2 5.2 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 317 4 0 4 4.4 CCCCc1ccc(C2(C)OC(=C(C#N)C#N)C(C#N)=C2C)cc1 10.1021/jm200999f
CHEMBL1914581 68084 None 1 Human Functional pIC50 = 5.2 5.2 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 317 4 0 4 4.4 CCCCc1ccc(C2(C)OC(=C(C#N)C#N)C(C#N)=C2C)cc1 10.1021/jm200999f
164610101 184981 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 184981 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
1803281 20072 None 6 Human Functional pIC50 = 6.2 6.2 15 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 337 4 1 3 3.0 CN(C)c1ccc(/C=C2\NC(=S)N(Cc3ccccc3)C2=O)cc1 nan
CHEMBL1303807 20072 None 6 Human Functional pIC50 = 6.2 6.2 15 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 337 4 1 3 3.0 CN(C)c1ccc(/C=C2\NC(=S)N(Cc3ccccc3)C2=O)cc1 nan
798024 35433 None 2 Human Functional pIC50 = 5.2 5.2 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 245 3 1 4 1.7 N#C/C(=C\c1ccc(N2CCCCC2)o1)C(N)=O nan
CHEMBL1437947 35433 None 2 Human Functional pIC50 = 5.2 5.2 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 245 3 1 4 1.7 N#C/C(=C\c1ccc(N2CCCCC2)o1)C(N)=O nan
6201879 27396 None 12 Human Functional pIC50 = 6.2 6.2 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 456 8 2 6 4.0 COc1cccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)c1 nan
CHEMBL1367928 27396 None 12 Human Functional pIC50 = 6.2 6.2 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 456 8 2 6 4.0 COc1cccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)c1 nan
154634332 185233 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 185233 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145954727 162516 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4166100 162516 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
5767616 19606 None 2 Human Functional pIC50 = 6.2 6.2 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 370 5 1 5 4.3 CCOc1ccc(N(C)c2ccc(/C=C3/SC(=S)NC3=O)cc2)cc1 nan
CHEMBL1300169 19606 None 2 Human Functional pIC50 = 6.2 6.2 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 370 5 1 5 4.3 CCOc1ccc(N(C)c2ccc(/C=C3/SC(=S)NC3=O)cc2)cc1 nan
152550147 185434 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4859675 185434 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
154634322 185486 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4860550 185486 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
1346847 21208 None 6 Human Functional pIC50 = 6.1 6.1 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 412 6 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(O)cc3)C2=O)cc1 nan
CHEMBL1312928 21208 None 6 Human Functional pIC50 = 6.1 6.1 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 412 6 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(O)cc3)C2=O)cc1 nan
10868388 162227 None 37 Human Functional pIC50 = 4.1 4.1 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 239 1 2 4 1.2 Nc1ccc(Br)cc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4161599 162227 None 37 Human Functional pIC50 = 4.1 4.1 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 239 1 2 4 1.2 Nc1ccc(Br)cc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
10077130 4007 None 47 Human Functional pIC50 = 5.1 5.1 -275 6
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 492 5 1 5 5.6 CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]1[C@H]([C@H]2/C=C/c2ccc(cn2)c2cccc(c2)F)[C@H](OC1=O)C 10.6019/CHEMBL5442687
10077130.0 4007 None 47 Human Functional pIC50 = 5.1 5.1 -275 6
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 492 5 1 5 5.6 CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]1[C@H]([C@H]2/C=C/c2ccc(cn2)c2cccc(c2)F)[C@H](OC1=O)C 10.6019/CHEMBL5442687
4047 4007 None 47 Human Functional pIC50 = 5.1 5.1 -275 6
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 492 5 1 5 5.6 CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]1[C@H]([C@H]2/C=C/c2ccc(cn2)c2cccc(c2)F)[C@H](OC1=O)C 10.6019/CHEMBL5442687
4870 4007 None 47 Human Functional pIC50 = 5.1 5.1 -275 6
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 492 5 1 5 5.6 CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]1[C@H]([C@H]2/C=C/c2ccc(cn2)c2cccc(c2)F)[C@H](OC1=O)C 10.6019/CHEMBL5442687
CHEMBL493982 4007 None 47 Human Functional pIC50 = 5.1 5.1 -275 6
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 492 5 1 5 5.6 CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]1[C@H]([C@H]2/C=C/c2ccc(cn2)c2cccc(c2)F)[C@H](OC1=O)C 10.6019/CHEMBL5442687
DB09030 4007 None 47 Human Functional pIC50 = 5.1 5.1 -275 6
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 492 5 1 5 5.6 CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]1[C@H]([C@H]2/C=C/c2ccc(cn2)c2cccc(c2)F)[C@H](OC1=O)C 10.6019/CHEMBL5442687
1502520 34510 None 16 Human Functional pIC50 = 6.1 6.1 -9 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 398 4 0 6 3.8 Cc1ccc(Cn2ncc3c(N4CCN(c5ccccc5C)CC4)ncnc32)cc1 nan
CHEMBL1428840 34510 None 16 Human Functional pIC50 = 6.1 6.1 -9 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 398 4 0 6 3.8 Cc1ccc(Cn2ncc3c(N4CCN(c5ccccc5C)CC4)ncnc32)cc1 nan
3860640 149919 None 38 Human Functional pIC50 = 5.1 5.1 -13 3
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 331 2 3 3 3.7 Cc1cccc2c1NC(=O)C2(c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL394883 149919 None 38 Human Functional pIC50 = 5.1 5.1 -13 3
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 331 2 3 3 3.7 Cc1cccc2c1NC(=O)C2(c1ccc(O)cc1)c1ccc(O)cc1 nan
1231538 27526 None 29 Human Functional pIC50 = 6.1 6.1 -1 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
CHEMBL1368962 27526 None 29 Human Functional pIC50 = 6.1 6.1 -1 3
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
4559736 34682 None 1 Human Functional pIC50 = 6.1 6.1 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 254 2 2 4 2.7 Nc1[nH]c2cc([N+](=O)[O-])ccc2c1-c1ccccn1 nan
CHEMBL1430125 34682 None 1 Human Functional pIC50 = 6.1 6.1 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 254 2 2 4 2.7 Nc1[nH]c2cc([N+](=O)[O-])ccc2c1-c1ccccn1 nan
326869 112874 None 2 Human Functional pIC50 = 6.1 6.1 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 112874 None 2 Human Functional pIC50 = 6.1 6.1 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
11646823 1215 None 50 Human Functional pIC50 = 5.1 5.1 -851 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 391 2 0 4 4.8 Clc1nccc(c1)C#Cc1nc(n(c1C)c1ccc(cc1)OC(F)(F)F)C 10.6019/CHEMBL5442687
6408 1215 None 50 Human Functional pIC50 = 5.1 5.1 -851 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 391 2 0 4 4.8 Clc1nccc(c1)C#Cc1nc(n(c1C)c1ccc(cc1)OC(F)(F)F)C 10.6019/CHEMBL5442687
6409 1215 None 50 Human Functional pIC50 = 5.1 5.1 -851 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 391 2 0 4 4.8 Clc1nccc(c1)C#Cc1nc(n(c1C)c1ccc(cc1)OC(F)(F)F)C 10.6019/CHEMBL5442687
CHEMBL3410223 1215 None 50 Human Functional pIC50 = 5.1 5.1 -851 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 391 2 0 4 4.8 Clc1nccc(c1)C#Cc1nc(n(c1C)c1ccc(cc1)OC(F)(F)F)C 10.6019/CHEMBL5442687
154634331 184654 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4848109 184654 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
149708825 186497 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875771 186497 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
2277094 49030 None 6 Human Functional pIC50 = 6.1 6.1 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1cccc(C(=O)O)c1 nan
CHEMBL1560901 49030 None 6 Human Functional pIC50 = 6.1 6.1 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1cccc(C(=O)O)c1 nan
1205881 36175 None 2 Human Functional pIC50 = 6.1 6.1 23 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1cccc(C(=O)O)c1 nan
CHEMBL1444708 36175 None 2 Human Functional pIC50 = 6.1 6.1 23 2
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1cccc(C(=O)O)c1 nan
145958445 162225 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4161574 162225 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145959306 162409 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4164556 162409 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
145949189 162832 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4171326 162832 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
1209 1658 None 52 Human Functional pIC50 = 5.1 5.1 -69 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.6019/CHEMBL5442687
203 1658 None 52 Human Functional pIC50 = 5.1 5.1 -69 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.6019/CHEMBL5442687
3386 1658 None 52 Human Functional pIC50 = 5.1 5.1 -69 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.6019/CHEMBL5442687
CHEMBL41 1658 None 52 Human Functional pIC50 = 5.1 5.1 -69 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.6019/CHEMBL5442687
DB00472 1658 None 52 Human Functional pIC50 = 5.1 5.1 -69 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.6019/CHEMBL5442687
154634326 185198 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 185198 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
2732121 38539 None 2 Human Functional pIC50 = 6.1 6.1 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 306 3 0 4 3.6 CC(C)c1ccc(N2C(=O)/C(=C/N(C)C)SC2=S)cc1 nan
CHEMBL1464544 38539 None 2 Human Functional pIC50 = 6.1 6.1 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 306 3 0 4 3.6 CC(C)c1ccc(N2C(=O)/C(=C/N(C)C)SC2=S)cc1 nan
110720191 162552 None 1 Human Functional pIC50 = 5.1 5.1 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccc(-c3nnn[nH]3)cc2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4166802 162552 None 1 Human Functional pIC50 = 5.1 5.1 - 1
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccc(-c3nnn[nH]3)cc2)cc1 10.1021/acsmedchemlett.7b00510
3276705 46407 None 6 Human Functional pIC50 = 5.1 5.1 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 521 8 2 6 4.3 CCN(CC)S(=O)(=O)c1ccc(NC(=O)c2cccnc2Cl)c(NC(=O)c2cccnc2Cl)c1 nan
CHEMBL1536628 46407 None 6 Human Functional pIC50 = 5.1 5.1 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 521 8 2 6 4.3 CCN(CC)S(=O)(=O)c1ccc(NC(=O)c2cccnc2Cl)c(NC(=O)c2cccnc2Cl)c1 nan
6974996 72043 None 6 Human Functional pIC50 = 6.1 6.1 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 389 6 0 6 3.6 CC/N=C1\S/C(=C\c2cc(OC)c(N3CCCC3)cc2OC)C(=O)N1CC nan
CHEMBL1975147 72043 None 6 Human Functional pIC50 = 6.1 6.1 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 389 6 0 6 3.6 CC/N=C1\S/C(=C\c2cc(OC)c(N3CCCC3)cc2OC)C(=O)N1CC nan
154634327 184845 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 184845 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
18158890 23526 None 2 Human Functional pIC50 = 6.0 6.0 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 404 8 2 4 2.8 CC(C)(C)c1ccc(OCCC(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1 nan
CHEMBL1333832 23526 None 2 Human Functional pIC50 = 6.0 6.0 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 404 8 2 4 2.8 CC(C)(C)c1ccc(OCCC(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1 nan
1348329 26256 None 8 Human Functional pIC50 = 5.0 5.0 3 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C\C=C\c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1357976 26256 None 8 Human Functional pIC50 = 5.0 5.0 3 2
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C\C=C\c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
456214 87380 None 43 Human Functional pIC50 = 5.0 5.0 -776 6
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 388 7 3 7 4.2 CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1 10.6019/CHEMBL5442687
CHEMBL23327 87380 None 43 Human Functional pIC50 = 5.0 5.0 -776 6
GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35GPCR PRESTO-Tango dose-response in antagonist mode with target: GPR35
ChEMBL 388 7 3 7 4.2 CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1 10.6019/CHEMBL5442687
3804843 42260 None 5 Human Functional pIC50 = 6 6.0 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 321 1 1 6 2.1 CN1CC=C2C(C#N)=C(N)C(C#N)(C#N)C(c3ccsc3)C2C1 nan
CHEMBL1497386 42260 None 5 Human Functional pIC50 = 6 6.0 - 1
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 321 1 1 6 2.1 CN1CC=C2C(C#N)=C(N)C(C#N)(C#N)C(c3ccsc3)C2C1 nan
18158890 23526 None 2 Human Functional pIC50 = 5 5.0 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 404 8 2 4 2.8 CC(C)(C)c1ccc(OCCC(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1 nan
CHEMBL1333832 23526 None 2 Human Functional pIC50 = 5 5.0 - 1
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 404 8 2 4 2.8 CC(C)(C)c1ccc(OCCC(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1 nan
4659569 22338 None 65 Human Functional pEC50 = 8.3 8.3 4 5
NoneNone
Drug Central 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 None
CHEMBL1324 22338 None 65 Human Functional pEC50 = 8.3 8.3 4 5
NoneNone
Drug Central 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 None
5281081 210115 None 57 Human Functional pEC50 = 8.3 8.3 - 1
NoneNone
Drug Central 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 None
CHEMBL953 210115 None 57 Human Functional pEC50 = 8.3 8.3 - 1
NoneNone
Drug Central 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 None
2882 1208 None 41 Mouse Functional pEC50 = 8.3 8.3 -15 5
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
741 1208 None 41 Mouse Functional pEC50 = 8.3 8.3 -15 5
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
7608 1208 None 41 Mouse Functional pEC50 = 8.3 8.3 -15 5
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
CHEMBL428880 1208 None 41 Mouse Functional pEC50 = 8.3 8.3 -15 5
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
DB01003 1208 None 41 Mouse Functional pEC50 = 8.3 8.3 -15 5
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
2161 8735 None 73 Human Functional pEC50 = 8.3 8.3 154 3
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
Drug Central 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 None
CHEMBL1096 8735 None 73 Human Functional pEC50 = 8.3 8.3 154 3
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
Drug Central 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 None
2471 739 None 56 Human Functional pEC50 = 8.3 8.3 18 3
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
427 739 None 56 Human Functional pEC50 = 8.3 8.3 18 3
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
4837 739 None 56 Human Functional pEC50 = 8.3 8.3 18 3
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
CHEMBL1072 739 None 56 Human Functional pEC50 = 8.3 8.3 18 3
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
DB00887 739 None 56 Human Functional pEC50 = 8.3 8.3 18 3
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
2882 1208 None 41 Rat Functional pEC50 = 8.2 8.2 11 5
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
741 1208 None 41 Rat Functional pEC50 = 8.2 8.2 11 5
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
7608 1208 None 41 Rat Functional pEC50 = 8.2 8.2 11 5
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
CHEMBL428880 1208 None 41 Rat Functional pEC50 = 8.2 8.2 11 5
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
DB01003 1208 None 41 Rat Functional pEC50 = 8.2 8.2 11 5
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
50294 220204 None 0 Human Functional pEC50 = 8.2 8.2 - 1
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 371 5 2 6 2.5 CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O None
50294.0 220204 None 0 Human Functional pEC50 = 8.2 8.2 - 1
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 371 5 2 6 2.5 CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O None
CHEMBL746 220204 None 0 Human Functional pEC50 = 8.2 8.2 - 1
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 371 5 2 6 2.5 CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O None
DB00716 220204 None 0 Human Functional pEC50 = 8.2 8.2 - 1
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 371 5 2 6 2.5 CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O None
3325 2338 None 44 Human Functional pEC50 = 8.1 8.1 12 2
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
44564 2338 None 44 Human Functional pEC50 = 8.1 8.1 12 2
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
9743 2338 None 44 Human Functional pEC50 = 8.1 8.1 12 2
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
CHEMBL1201266 2338 None 44 Human Functional pEC50 = 8.1 8.1 12 2
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
DB06794 2338 None 44 Human Functional pEC50 = 8.1 8.1 12 2
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
3325 2338 None 44 Human Functional pEC50 = 9 9.0 12 2
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
44564 2338 None 44 Human Functional pEC50 = 9 9.0 12 2
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
9743 2338 None 44 Human Functional pEC50 = 9 9.0 12 2
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
CHEMBL1201266 2338 None 44 Human Functional pEC50 = 9 9.0 12 2
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
DB06794 2338 None 44 Human Functional pEC50 = 9 9.0 12 2
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
2918 2204 None 75 Human Functional pEC50 = 4.2 4.2 -2630 4
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
2918 2204 None 75 Human Functional pEC50 = 4.2 4.2 -2630 4
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 23396314
3845 2204 None 75 Human Functional pEC50 = 4.2 4.2 -2630 4
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
3845 2204 None 75 Human Functional pEC50 = 4.2 4.2 -2630 4
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 23396314
CHEMBL299155 2204 None 75 Human Functional pEC50 = 4.2 4.2 -2630 4
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
CHEMBL299155 2204 None 75 Human Functional pEC50 = 4.2 4.2 -2630 4
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 23396314
DB11937 2204 None 75 Human Functional pEC50 = 4.2 4.2 -2630 4
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
DB11937 2204 None 75 Human Functional pEC50 = 4.2 4.2 -2630 4
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 23396314
2471 739 None 56 Human Functional pEC50 = 5.3 5.3 18 3
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
427 739 None 56 Human Functional pEC50 = 5.3 5.3 18 3
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
4837 739 None 56 Human Functional pEC50 = 5.3 5.3 18 3
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
CHEMBL1072 739 None 56 Human Functional pEC50 = 5.3 5.3 18 3
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
DB00887 739 None 56 Human Functional pEC50 = 5.3 5.3 18 3
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
118985385 1701 None 63 Human Functional pEC50 = 5.4 5.4 7 2
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
1258 1701 None 63 Human Functional pEC50 = 5.4 5.4 7 2
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
3440 1701 None 63 Human Functional pEC50 = 5.4 5.4 7 2
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
4839 1701 None 63 Human Functional pEC50 = 5.4 5.4 7 2
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
CHEMBL35 1701 None 63 Human Functional pEC50 = 5.4 5.4 7 2
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
DB00695 1701 None 63 Human Functional pEC50 = 5.4 5.4 7 2
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
2936 85 None 0 Human Functional pEC50 = 7.4 7.4 -3 4
UnclassifiedUnclassified
Guide to Pharmacology 436 20 3 5 5.0 CCCCCCCC/C=C\CCCCCCCC(=O)OC(COP(=O)(O)O)CO 20361937
56947016 85 None 0 Human Functional pEC50 = 7.4 7.4 -3 4
UnclassifiedUnclassified
Guide to Pharmacology 436 20 3 5 5.0 CCCCCCCC/C=C\CCCCCCCC(=O)OC(COP(=O)(O)O)CO 20361937
2920 2997 None 64 Rat Functional pEC50 None 4 4.0 -2398 2
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
54742459 2997 None 64 Rat Functional pEC50 None 4 4.0 -2398 2
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
8546 2997 None 64 Rat Functional pEC50 None 4 4.0 -2398 2
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
CHEMBL177880 2997 None 64 Rat Functional pEC50 None 4 4.0 -2398 2
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
2918 2204 None 75 Mouse Functional pEC50 None 5.0 5.0 -616 4
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
3845 2204 None 75 Mouse Functional pEC50 None 5.0 5.0 -616 4
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
CHEMBL299155 2204 None 75 Mouse Functional pEC50 None 5.0 5.0 -616 4
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
DB11937 2204 None 75 Mouse Functional pEC50 None 5.0 5.0 -616 4
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
2918 2204 None 75 Rat Functional pEC50 None 5.2 5.2 -1202 4
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
3845 2204 None 75 Rat Functional pEC50 None 5.2 5.2 -1202 4
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
CHEMBL299155 2204 None 75 Rat Functional pEC50 None 5.2 5.2 -1202 4
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
DB11937 2204 None 75 Rat Functional pEC50 None 5.2 5.2 -1202 4
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
135399235 4134 None 41 Human Functional pEC50 None 6.1 6.1 -18 3
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
2919 4134 None 41 Human Functional pEC50 None 6.1 6.1 -18 3
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
5722 4134 None 41 Human Functional pEC50 None 6.1 6.1 -18 3
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
CHEMBL28079 4134 None 41 Human Functional pEC50 None 6.1 6.1 -18 3
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
2920 2997 None 64 Human Functional pEC50 None 7.3 7.3 2398 2
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
54742459 2997 None 64 Human Functional pEC50 None 7.3 7.3 2398 2
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
8546 2997 None 64 Human Functional pEC50 None 7.3 7.3 2398 2
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
CHEMBL177880 2997 None 64 Human Functional pEC50 None 7.3 7.3 2398 2
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
135399235 4134 None 41 Rat Functional pEC50 None 7.8 7.8 18 3
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
2919 4134 None 41 Rat Functional pEC50 None 7.8 7.8 18 3
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
5722 4134 None 41 Rat Functional pEC50 None 7.8 7.8 18 3
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
CHEMBL28079 4134 None 41 Rat Functional pEC50 None 7.8 7.8 18 3
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
5280343 188382 None 69 Human Functional pIC50 = 8.3 8.3 -8 12
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
Drug Central 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
CHEMBL1520590 188382 None 69 Human Functional pIC50 = 8.3 8.3 -8 12
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
Drug Central 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
CHEMBL50 188382 None 69 Human Functional pIC50 = 8.3 8.3 -8 12
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
Drug Central 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
2745687 933 None 27 Human Functional pIC50 = 6.7 6.7 10 3
Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
9741 933 None 27 Human Functional pIC50 = 6.7 6.7 10 3
Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
CHEMBL1708510 933 None 27 Human Functional pIC50 = 6.7 6.7 10 3
Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
2745687 933 None 27 Human Functional pIC50 = 5.0 5.0 10 3
Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
9741 933 None 27 Human Functional pIC50 = 5.0 5.0 10 3
Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
CHEMBL1708510 933 None 27 Human Functional pIC50 = 5.0 5.0 10 3
Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932




Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type
Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

135399235 4134 None 41 Human Binding pEC50 = 9.2 9.2 - 1
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
2919 4134 None 41 Human Binding pEC50 = 9.2 9.2 - 1
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
5722 4134 None 41 Human Binding pEC50 = 9.2 9.2 - 1
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
CHEMBL28079 4134 None 41 Human Binding pEC50 = 9.2 9.2 - 1
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
12138435 68079 None 26 Human Binding pEC50 = 5.0 5.0 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.6b01431
CHEMBL1914576 68079 None 26 Human Binding pEC50 = 5.0 5.0 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.6b01431
71733650 90877 None 0 Human Binding pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392161 90877 None 0 Human Binding pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
694463 87514 None 63 Human Binding pEC50 = 5.0 5.0 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 268 1 1 3 2.3 O=C(O)c1cc2cc(Br)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL2333943 87514 None 63 Human Binding pEC50 = 5.0 5.0 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 268 1 1 3 2.3 O=C(O)c1cc2cc(Br)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
71733848 90895 None 0 Human Binding pEC50 = 8.0 8.0 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm4009373
CHEMBL2392179 90895 None 0 Human Binding pEC50 = 8.0 8.0 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm4009373
71733848 90895 None 0 Human Binding pEC50 = 8.0 8.0 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
CHEMBL2392179 90895 None 0 Human Binding pEC50 = 8.0 8.0 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
71733848 90895 None 0 Human Binding pEC50 = 8.0 8.0 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
CHEMBL2392179 90895 None 0 Human Binding pEC50 = 8.0 8.0 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
135399235 4134 None 41 Human Binding pEC50 = 7.0 7.0 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
2919 4134 None 41 Human Binding pEC50 = 7.0 7.0 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
5722 4134 None 41 Human Binding pEC50 = 7.0 7.0 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
CHEMBL28079 4134 None 41 Human Binding pEC50 = 7.0 7.0 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
71733845 90892 None 0 Rat Binding pEC50 = 6.0 6.0 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392176 90892 None 0 Rat Binding pEC50 = 6.0 6.0 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
4488 205479 None 66 Human Binding pEC50 = 6.0 6.0 - 1
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
CHEMBL63323 205479 None 66 Human Binding pEC50 = 6.0 6.0 - 1
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
71733651 90878 None 0 Human Binding pEC50 = 7.0 7.0 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392162 90878 None 0 Human Binding pEC50 = 7.0 7.0 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733651 90878 None 0 Human Binding pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392162 90878 None 0 Human Binding pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71734940 90879 None 0 Human Binding pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 385 5 1 6 3.4 CCOC(=O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(OC)cc3)c2o1 10.1021/jm400587g
CHEMBL2392163 90879 None 0 Human Binding pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 385 5 1 6 3.4 CCOC(=O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(OC)cc3)c2o1 10.1021/jm400587g
118985385 1701 None 63 Human Binding pEC50 = 5.0 5.0 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
1258 1701 None 63 Human Binding pEC50 = 5.0 5.0 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
3440 1701 None 63 Human Binding pEC50 = 5.0 5.0 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
4839 1701 None 63 Human Binding pEC50 = 5.0 5.0 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
CHEMBL35 1701 None 63 Human Binding pEC50 = 5.0 5.0 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
DB00695 1701 None 63 Human Binding pEC50 = 5.0 5.0 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
71733650 90877 None 0 Human Binding pEC50 = 6.9 6.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392161 90877 None 0 Human Binding pEC50 = 6.9 6.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
71733843 90890 None 7 Human Binding pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392174 90890 None 7 Human Binding pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2425818 90890 None 7 Human Binding pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733843 90890 None 7 Human Binding pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392174 90890 None 7 Human Binding pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2425818 90890 None 7 Human Binding pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733843 90890 None 7 Human Binding pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/acs.jmedchem.6b01431
CHEMBL2392174 90890 None 7 Human Binding pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/acs.jmedchem.6b01431
CHEMBL2425818 90890 None 7 Human Binding pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/acs.jmedchem.6b01431
2920 2997 None 64 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
54742459 2997 None 64 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
8546 2997 None 64 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
CHEMBL177880 2997 None 64 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
2920 2997 None 64 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 2997 None 64 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 2997 None 64 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 2997 None 64 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71734944 90864 None 0 Rat Binding pEC50 = 5.9 5.9 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm400587g
CHEMBL2392148 90864 None 0 Rat Binding pEC50 = 5.9 5.9 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm400587g
71733653 90881 None 0 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392165 90881 None 0 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
2882 1208 None 41 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
741 1208 None 41 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
7608 1208 None 41 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
CHEMBL428880 1208 None 41 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
DB01003 1208 None 41 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
71734939 90860 None 1 Human Binding pEC50 = 4.9 4.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 283 1 2 4 1.8 Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392144 90860 None 1 Human Binding pEC50 = 4.9 4.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 283 1 2 4 1.8 Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733847 90894 None 0 Human Binding pEC50 = 6.9 6.9 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
CHEMBL2392178 90894 None 0 Human Binding pEC50 = 6.9 6.9 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
92934 169760 None 56 Human Binding pEC50 = 4.9 4.9 - 1
Agonist activity at human GPR35 expressed in human HT29 cells by DMR assayAgonist activity at human GPR35 expressed in human HT29 cells by DMR assay
ChEMBL 280 2 2 6 1.9 O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1 10.1021/jm4009373
CHEMBL443738 169760 None 56 Human Binding pEC50 = 4.9 4.9 - 1
Agonist activity at human GPR35 expressed in human HT29 cells by DMR assayAgonist activity at human GPR35 expressed in human HT29 cells by DMR assay
ChEMBL 280 2 2 6 1.9 O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1 10.1021/jm4009373
12403015 111559 None 0 Human Binding pEC50 = 7.9 7.9 - 0
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 300 2 4 4 0.8 O=C(O)c1cc(=O)c2c(ccc3c(=O)cc(C(=O)O)[nH]c32)[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL3277775 111559 None 0 Human Binding pEC50 = 7.9 7.9 - 0
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 300 2 4 4 0.8 O=C(O)c1cc(=O)c2c(ccc3c(=O)cc(C(=O)O)[nH]c32)[nH]1 10.1021/acs.jmedchem.6b01431
135399235 4134 None 41 Human Binding pEC50 = 6.9 6.9 - 1
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
2919 4134 None 41 Human Binding pEC50 = 6.9 6.9 - 1
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
5722 4134 None 41 Human Binding pEC50 = 6.9 6.9 - 1
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
CHEMBL28079 4134 None 41 Human Binding pEC50 = 6.9 6.9 - 1
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
54676038 38734 None 51 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1466 38734 None 51 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
54676038 38734 None 51 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
CHEMBL1466 38734 None 51 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
71733846 90893 None 0 Rat Binding pEC50 = 5.9 5.9 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 90893 None 0 Rat Binding pEC50 = 5.9 5.9 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
71735030 90868 None 0 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm4009373
CHEMBL2392152 90868 None 0 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm4009373
71735030 90868 None 0 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm400587g
CHEMBL2392152 90868 None 0 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm400587g
71734942 90862 None 0 Human Binding pEC50 = 4.9 4.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 261 3 2 4 1.8 CCC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392146 90862 None 0 Human Binding pEC50 = 4.9 4.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 261 3 2 4 1.8 CCC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
271643 32788 None 45 Human Binding pEC50 = 4.9 4.9 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 224 1 1 3 2.1 O=C(O)c1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1414071 32788 None 45 Human Binding pEC50 = 4.9 4.9 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 224 1 1 3 2.1 O=C(O)c1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
71733844 90891 None 0 Rat Binding pEC50 = 5.9 5.9 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392175 90891 None 0 Rat Binding pEC50 = 5.9 5.9 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71735034 90871 None 0 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392155 90871 None 0 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
10857978 115309 None 5 Human Binding pEC50 = 5.9 5.9 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 252 2 1 5 2.5 O=[N+]([O-])c1cc([N+](=O)[O-])c(Cl)c(Cl)c1O 10.1039/C2MD20210G
CHEMBL3347429 115309 None 5 Human Binding pEC50 = 5.9 5.9 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 252 2 1 5 2.5 O=[N+]([O-])c1cc([N+](=O)[O-])c(Cl)c(Cl)c1O 10.1039/C2MD20210G
137652009 157606 None 0 Human Binding pEC50 = 7.9 7.9 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4079816 157606 None 0 Human Binding pEC50 = 7.9 7.9 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137652009 157606 None 0 Human Binding pEC50 = 7.9 7.9 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4079816 157606 None 0 Human Binding pEC50 = 7.9 7.9 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
71733848 90895 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
CHEMBL2392179 90895 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
2295463 92255 None 29 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
CHEMBL2425825 92255 None 29 Human Binding pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
71733843 90890 None 7 Rat Binding pEC50 = 5.9 5.9 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392174 90890 None 7 Rat Binding pEC50 = 5.9 5.9 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2425818 90890 None 7 Rat Binding pEC50 = 5.9 5.9 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137657450 159689 None 4 Human Binding pEC50 = 4.9 4.9 - 0
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4103143 159689 None 4 Human Binding pEC50 = 4.9 4.9 - 0
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
137657450 159689 None 4 Human Binding pEC50 = 5.9 5.9 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4103143 159689 None 4 Human Binding pEC50 = 5.9 5.9 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
137657450 159689 None 4 Human Binding pEC50 = 5.9 5.9 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4103143 159689 None 4 Human Binding pEC50 = 5.9 5.9 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
71733651 90878 None 0 Human Binding pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392162 90878 None 0 Human Binding pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733939 90898 None 0 Human Binding pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm400587g
CHEMBL2392182 90898 None 0 Human Binding pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm400587g
137636652 156140 None 4 Human Binding pEC50 = 4.8 4.8 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 322 2 1 6 1.7 COc1cc2oc(=O)c(-c3nnn[nH]3)cc2cc1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4062531 156140 None 4 Human Binding pEC50 = 4.8 4.8 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 322 2 1 6 1.7 COc1cc2oc(=O)c(-c3nnn[nH]3)cc2cc1Br 10.1021/acs.jmedchem.6b01431
13950958 157720 None 4 Human Binding pEC50 = 6.8 6.8 - 1
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4081238 157720 None 4 Human Binding pEC50 = 6.8 6.8 - 1
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
71733749 90888 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392172 90888 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
71733749 90888 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392172 90888 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
13950958 157720 None 4 Human Binding pEC50 = 6.8 6.8 - 1
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4081238 157720 None 4 Human Binding pEC50 = 6.8 6.8 - 1
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
4488 205479 None 66 Human Binding pEC50 = 4.8 4.8 - 1
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
CHEMBL63323 205479 None 66 Human Binding pEC50 = 4.8 4.8 - 1
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
137653726 158768 None 4 Human Binding pEC50 = 5.8 5.8 - 0
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4092954 158768 None 4 Human Binding pEC50 = 5.8 5.8 - 0
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
71733939 90898 None 0 Rat Binding pEC50 = 5.8 5.8 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm400587g
CHEMBL2392182 90898 None 0 Rat Binding pEC50 = 5.8 5.8 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm400587g
71735035 90872 None 0 Human Binding pEC50 = 4.8 4.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 377 3 2 4 3.8 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(C(F)(F)F)cc1 10.1021/jm400587g
CHEMBL2392156 90872 None 0 Human Binding pEC50 = 4.8 4.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 377 3 2 4 3.8 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(C(F)(F)F)cc1 10.1021/jm400587g
71733748 90887 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392171 90887 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
71733748 90887 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
CHEMBL2392171 90887 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
71733748 90887 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392171 90887 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
71733744 90883 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392167 90883 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733744 90883 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392167 90883 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733649 90876 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392160 90876 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
71733744 90883 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392167 90883 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
135399235 4134 None 41 Human Binding pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
2919 4134 None 41 Human Binding pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
5722 4134 None 41 Human Binding pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
CHEMBL28079 4134 None 41 Human Binding pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
71733845 90892 None 0 Human Binding pEC50 = 5.8 5.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392176 90892 None 0 Human Binding pEC50 = 5.8 5.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733845 90892 None 0 Human Binding pEC50 = 5.8 5.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392176 90892 None 0 Human Binding pEC50 = 5.8 5.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733649 90876 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392160 90876 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
135468531 90858 None 19 Mouse Binding pEC50 = 4.8 4.8 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
CHEMBL2392141 90858 None 19 Mouse Binding pEC50 = 4.8 4.8 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
71733743 90882 None 0 Human Binding pEC50 = 5.8 5.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm400587g
CHEMBL2392166 90882 None 0 Human Binding pEC50 = 5.8 5.8 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm400587g
5464105 57849 None 47 Human Binding pEC50 = 4.8 4.8 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 265 4 2 6 1.6 CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O 10.1039/C2MD20210G
CHEMBL167055 57849 None 47 Human Binding pEC50 = 4.8 4.8 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 265 4 2 6 1.6 CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O 10.1039/C2MD20210G
725495 65557 None 43 Human Binding pEC50 = 5.8 5.8 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1830823 65557 None 43 Human Binding pEC50 = 5.8 5.8 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
725495 65557 None 43 Human Binding pEC50 = 5.8 5.8 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1830823 65557 None 43 Human Binding pEC50 = 5.8 5.8 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
71733651 90878 None 0 Rat Binding pEC50 = 5.8 5.8 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392162 90878 None 0 Rat Binding pEC50 = 5.8 5.8 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137655259 159060 None 4 Human Binding pEC50 = 4.8 4.8 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 327 0 0 3 3.2 N#Cc1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4096105 159060 None 4 Human Binding pEC50 = 4.8 4.8 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 327 0 0 3 3.2 N#Cc1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
11312 111581 None 28 Human Binding pEC50 = 4.7 4.7 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3278560 111581 None 28 Human Binding pEC50 = 4.7 4.7 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc([N+](=O)[O-])c1O 10.1039/C2MD20210G
71733744 90883 None 0 Rat Binding pEC50 = 5.7 5.7 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392167 90883 None 0 Rat Binding pEC50 = 5.7 5.7 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
4921319 107517 None 34 Human Binding pEC50 = 6.7 6.7 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 199 2 2 6 0.8 Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3183248 107517 None 34 Human Binding pEC50 = 6.7 6.7 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 199 2 2 6 0.8 Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
135399235 4134 None 41 Human Binding pEC50 = 5.7 5.7 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2919 4134 None 41 Human Binding pEC50 = 5.7 5.7 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
5722 4134 None 41 Human Binding pEC50 = 5.7 5.7 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
CHEMBL28079 4134 None 41 Human Binding pEC50 = 5.7 5.7 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
137662152 159485 None 11 Human Binding pEC50 = 6.7 6.7 - 1
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4100677 159485 None 11 Human Binding pEC50 = 6.7 6.7 - 1
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
2920 2997 None 64 Human Binding pEC50 = 8.7 8.7 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
54742459 2997 None 64 Human Binding pEC50 = 8.7 8.7 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
8546 2997 None 64 Human Binding pEC50 = 8.7 8.7 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
CHEMBL177880 2997 None 64 Human Binding pEC50 = 8.7 8.7 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
2920 2997 None 64 Human Binding pEC50 = 8.7 8.7 - 1
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
54742459 2997 None 64 Human Binding pEC50 = 8.7 8.7 - 1
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
8546 2997 None 64 Human Binding pEC50 = 8.7 8.7 - 1
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
CHEMBL177880 2997 None 64 Human Binding pEC50 = 8.7 8.7 - 1
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
71733649 90876 None 0 Human Binding pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392160 90876 None 0 Human Binding pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
657910 53468 None 35 Human Binding pEC50 = 5.7 5.7 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 258 1 1 3 2.8 O=C(O)c1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1600989 53468 None 35 Human Binding pEC50 = 5.7 5.7 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 258 1 1 3 2.8 O=C(O)c1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
71734943 90863 None 0 Human Binding pEC50 = 4.7 4.7 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392147 90863 None 0 Human Binding pEC50 = 4.7 4.7 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733847 90894 None 0 Rat Binding pEC50 = 5.7 5.7 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
CHEMBL2392178 90894 None 0 Rat Binding pEC50 = 5.7 5.7 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
71733746 90885 None 0 Rat Binding pEC50 = 5.7 5.7 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392169 90885 None 0 Rat Binding pEC50 = 5.7 5.7 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
2882 1208 None 41 Human Binding pEC50 = 6.7 6.7 - 1
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
741 1208 None 41 Human Binding pEC50 = 6.7 6.7 - 1
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
7608 1208 None 41 Human Binding pEC50 = 6.7 6.7 - 1
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
CHEMBL428880 1208 None 41 Human Binding pEC50 = 6.7 6.7 - 1
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
DB01003 1208 None 41 Human Binding pEC50 = 6.7 6.7 - 1
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
71733653 90881 None 0 Rat Binding pEC50 = 5.7 5.7 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392165 90881 None 0 Rat Binding pEC50 = 5.7 5.7 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
3254949 115310 None 3 Human Binding pEC50 = 5.7 5.7 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 460 6 2 10 3.9 O=[N+]([O-])c1cc(C(=C(Cl)Cl)c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3347474 115310 None 3 Human Binding pEC50 = 5.7 5.7 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 460 6 2 10 3.9 O=[N+]([O-])c1cc(C(=C(Cl)Cl)c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
782693 158333 None 19 Human Binding pEC50 = 4.7 4.7 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 205 0 0 3 2.3 N#Cc1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4088382 158333 None 19 Human Binding pEC50 = 4.7 4.7 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 205 0 0 3 2.3 N#Cc1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
71735036 90873 None 0 Rat Binding pEC50 = 5.7 5.7 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 90873 None 0 Rat Binding pEC50 = 5.7 5.7 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733843 90890 None 7 Human Binding pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392174 90890 None 7 Human Binding pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2425818 90890 None 7 Human Binding pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
3870203 58347 None 41 Human Binding pEC50 = 4.7 4.7 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 200 2 2 6 0.9 O=[N+]([O-])c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL168276 58347 None 41 Human Binding pEC50 = 4.7 4.7 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 200 2 2 6 0.9 O=[N+]([O-])c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
135399235 4134 None 41 Human Binding pEC50 = 5.7 5.7 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2919 4134 None 41 Human Binding pEC50 = 5.7 5.7 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
5722 4134 None 41 Human Binding pEC50 = 5.7 5.7 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
CHEMBL28079 4134 None 41 Human Binding pEC50 = 5.7 5.7 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
71733842 90889 None 0 Rat Binding pEC50 = 5.7 5.7 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392173 90889 None 0 Rat Binding pEC50 = 5.7 5.7 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137658268 159756 None 4 Human Binding pEC50 = 5.6 5.6 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4103860 159756 None 4 Human Binding pEC50 = 5.6 5.6 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
137658268 159756 None 4 Human Binding pEC50 = 5.6 5.6 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4103860 159756 None 4 Human Binding pEC50 = 5.6 5.6 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
633803 115311 None 8 Human Binding pEC50 = 5.6 5.6 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 408 6 2 10 3.1 CC(C)(c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1)c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3347475 115311 None 8 Human Binding pEC50 = 5.6 5.6 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 408 6 2 10 3.1 CC(C)(c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1)c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
71734941 90861 None 0 Human Binding pEC50 = 4.6 4.6 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 247 2 2 4 1.5 CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392145 90861 None 0 Human Binding pEC50 = 4.6 4.6 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 247 2 2 4 1.5 CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
10857978 115309 None 5 Human Binding pEC50 = 4.6 4.6 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 252 2 1 5 2.5 O=[N+]([O-])c1cc([N+](=O)[O-])c(Cl)c(Cl)c1O 10.1039/C2MD20210G
CHEMBL3347429 115309 None 5 Human Binding pEC50 = 4.6 4.6 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 252 2 1 5 2.5 O=[N+]([O-])c1cc([N+](=O)[O-])c(Cl)c(Cl)c1O 10.1039/C2MD20210G
71733747 90886 None 0 Human Binding pEC50 = 7.6 7.6 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm4009373
CHEMBL2392170 90886 None 0 Human Binding pEC50 = 7.6 7.6 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm4009373
71733749 90888 None 0 Human Binding pEC50 = 7.6 7.6 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
CHEMBL2392172 90888 None 0 Human Binding pEC50 = 7.6 7.6 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
71733747 90886 None 0 Human Binding pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm400587g
CHEMBL2392170 90886 None 0 Human Binding pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm400587g
73294510 92253 None 0 Human Binding pEC50 = 7.6 7.6 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 369 5 2 6 2.8 COc1ccc(C(=O)Nc2cc(OC)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425823 92253 None 0 Human Binding pEC50 = 7.6 7.6 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 369 5 2 6 2.8 COc1ccc(C(=O)Nc2cc(OC)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
135468531 90858 None 19 Human Binding pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
CHEMBL2392141 90858 None 19 Human Binding pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
135468531 90858 None 19 Human Binding pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
CHEMBL2392141 90858 None 19 Human Binding pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
71733650 90877 None 0 Rat Binding pEC50 = 5.6 5.6 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392161 90877 None 0 Rat Binding pEC50 = 5.6 5.6 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
137646097 157992 None 4 Human Binding pEC50 = 5.6 5.6 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 367 3 1 8 1.7 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
CHEMBL4084237 157992 None 4 Human Binding pEC50 = 5.6 5.6 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 367 3 1 8 1.7 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
71733749 90888 None 0 Human Binding pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392172 90888 None 0 Human Binding pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
71735032 90869 None 0 Rat Binding pEC50 = 5.6 5.6 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392153 90869 None 0 Rat Binding pEC50 = 5.6 5.6 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
71733745 90884 None 0 Rat Binding pEC50 = 5.6 5.6 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392168 90884 None 0 Rat Binding pEC50 = 5.6 5.6 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
71733744 90883 None 0 Human Binding pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392167 90883 None 0 Human Binding pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733652 90880 None 0 Rat Binding pEC50 = 5.6 5.6 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392164 90880 None 0 Rat Binding pEC50 = 5.6 5.6 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
137652009 157606 None 0 Human Binding pEC50 = 6.5 6.5 - 0
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4079816 157606 None 0 Human Binding pEC50 = 6.5 6.5 - 0
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137647862 157745 None 4 Human Binding pEC50 = 5.5 5.5 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 324 2 0 6 2.3 COc1c(Br)cc2cc(C#N)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
CHEMBL4081445 157745 None 4 Human Binding pEC50 = 5.5 5.5 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 324 2 0 6 2.3 COc1c(Br)cc2cc(C#N)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
633803 115311 None 8 Human Binding pEC50 = 4.5 4.5 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 408 6 2 10 3.1 CC(C)(c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1)c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3347475 115311 None 8 Human Binding pEC50 = 4.5 4.5 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 408 6 2 10 3.1 CC(C)(c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1)c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
71734946 90867 None 0 Mouse Binding pEC50 = 5.5 5.5 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm400587g
CHEMBL2392151 90867 None 0 Mouse Binding pEC50 = 5.5 5.5 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm400587g
2920 2997 None 64 Human Binding pEC50 = 8.5 8.5 - 1
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 2997 None 64 Human Binding pEC50 = 8.5 8.5 - 1
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 2997 None 64 Human Binding pEC50 = 8.5 8.5 - 1
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 2997 None 64 Human Binding pEC50 = 8.5 8.5 - 1
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
137662152 159485 None 11 Human Binding pEC50 = 8.5 8.5 - 1
Agonist activity at GPR-35 in human HT-29 cells incubated for 1 hr by DMR assayAgonist activity at GPR-35 in human HT-29 cells incubated for 1 hr by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acsmedchemlett.2c00461
CHEMBL4100677 159485 None 11 Human Binding pEC50 = 8.5 8.5 - 1
Agonist activity at GPR-35 in human HT-29 cells incubated for 1 hr by DMR assayAgonist activity at GPR-35 in human HT-29 cells incubated for 1 hr by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acsmedchemlett.2c00461
135468531 90858 None 19 Human Binding pEC50 = 8.5 8.5 - 1
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm4009373
CHEMBL2392141 90858 None 19 Human Binding pEC50 = 8.5 8.5 - 1
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm4009373
71733940 90899 None 0 Human Binding pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
CHEMBL2392183 90899 None 0 Human Binding pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
71733940 90899 None 0 Human Binding pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
CHEMBL2392183 90899 None 0 Human Binding pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
71733745 90884 None 0 Human Binding pEC50 = 6.5 6.5 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392168 90884 None 0 Human Binding pEC50 = 6.5 6.5 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
71733745 90884 None 0 Human Binding pEC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392168 90884 None 0 Human Binding pEC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
4488 205479 None 66 Human Binding pEC50 = 4.5 4.5 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
CHEMBL63323 205479 None 66 Human Binding pEC50 = 4.5 4.5 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
1493 98143 None 45 Human Binding pEC50 = 4.5 4.5 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1ccc(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL273386 98143 None 45 Human Binding pEC50 = 4.5 4.5 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1ccc(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
71733648 90875 None 0 Rat Binding pEC50 = 5.5 5.5 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
CHEMBL2392159 90875 None 0 Rat Binding pEC50 = 5.5 5.5 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
71733743 90882 None 0 Rat Binding pEC50 = 5.5 5.5 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm400587g
CHEMBL2392166 90882 None 0 Rat Binding pEC50 = 5.5 5.5 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm400587g
12138435 68079 None 26 Human Binding pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.6b01431
CHEMBL1914576 68079 None 26 Human Binding pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.6b01431
135399235 4134 None 41 Human Binding pEC50 = 5.5 5.5 - 1
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
2919 4134 None 41 Human Binding pEC50 = 5.5 5.5 - 1
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
5722 4134 None 41 Human Binding pEC50 = 5.5 5.5 - 1
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
CHEMBL28079 4134 None 41 Human Binding pEC50 = 5.5 5.5 - 1
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
71733749 90888 None 0 Rat Binding pEC50 = 5.5 5.5 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392172 90888 None 0 Rat Binding pEC50 = 5.5 5.5 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
137648473 158084 None 4 Human Binding pEC50 = 6.5 6.5 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4085211 158084 None 4 Human Binding pEC50 = 6.5 6.5 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137648473 158084 None 4 Human Binding pEC50 = 6.5 6.5 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4085211 158084 None 4 Human Binding pEC50 = 6.5 6.5 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
71733748 90887 None 0 Human Binding pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392171 90887 None 0 Human Binding pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
135399235 4134 None 41 Human Binding pEC50 = 6.5 6.5 - 1
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
2919 4134 None 41 Human Binding pEC50 = 6.5 6.5 - 1
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
5722 4134 None 41 Human Binding pEC50 = 6.5 6.5 - 1
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
CHEMBL28079 4134 None 41 Human Binding pEC50 = 6.5 6.5 - 1
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
40119 84839 None 14 Human Binding pEC50 = 5.5 5.5 - 0
Agonist activity at recombinant human N-terminal FLAG/eYFP-fused GPR35a expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment by path hunter assayAgonist activity at recombinant human N-terminal FLAG/eYFP-fused GPR35a expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment by path hunter assay
ChEMBL 312 1 1 6 1.2 O=C1c2ccccc2S(=O)(=O)c2cc(-c3nn[nH]n3)ccc21 10.1021/acsmedchemlett.7b00510
CHEMBL22336 84839 None 14 Human Binding pEC50 = 5.5 5.5 - 0
Agonist activity at recombinant human N-terminal FLAG/eYFP-fused GPR35a expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment by path hunter assayAgonist activity at recombinant human N-terminal FLAG/eYFP-fused GPR35a expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment by path hunter assay
ChEMBL 312 1 1 6 1.2 O=C1c2ccccc2S(=O)(=O)c2cc(-c3nn[nH]n3)ccc21 10.1021/acsmedchemlett.7b00510
71735036 90873 None 0 Human Binding pEC50 = 6.5 6.5 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392157 90873 None 0 Human Binding pEC50 = 6.5 6.5 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71735036 90873 None 0 Human Binding pEC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 90873 None 0 Human Binding pEC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71735036 90873 None 0 Human Binding pEC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 90873 None 0 Human Binding pEC50 = 6.5 6.5 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
2295463 92255 None 29 Human Binding pEC50 = 6.5 6.5 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
CHEMBL2425825 92255 None 29 Human Binding pEC50 = 6.5 6.5 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
135399235 4134 None 41 Human Binding pEC50 = 5.5 5.5 - 1
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
2919 4134 None 41 Human Binding pEC50 = 5.5 5.5 - 1
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
5722 4134 None 41 Human Binding pEC50 = 5.5 5.5 - 1
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
CHEMBL28079 4134 None 41 Human Binding pEC50 = 5.5 5.5 - 1
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
71735030 90868 None 0 Mouse Binding pEC50 = 5.5 5.5 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm400587g
CHEMBL2392152 90868 None 0 Mouse Binding pEC50 = 5.5 5.5 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm400587g
71733938 90897 None 0 Rat Binding pEC50 = 5.4 5.4 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 367 6 2 5 3.5 CCCOc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392181 90897 None 0 Rat Binding pEC50 = 5.4 5.4 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 367 6 2 5 3.5 CCCOc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
13950958 157720 None 4 Human Binding pEC50 = 5.4 5.4 - 1
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4081238 157720 None 4 Human Binding pEC50 = 5.4 5.4 - 1
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
11872 107519 None 41 Human Binding pEC50 = 4.4 4.4 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3183545 107519 None 41 Human Binding pEC50 = 4.4 4.4 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
73294509 92252 None 0 Human Binding pEC50 = 7.4 7.4 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 353 4 2 5 3.1 COc1ccc(C(=O)Nc2cc(C)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425822 92252 None 0 Human Binding pEC50 = 7.4 7.4 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 353 4 2 5 3.1 COc1ccc(C(=O)Nc2cc(C)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733648 90875 None 0 Human Binding pEC50 = 6.4 6.4 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
CHEMBL2392159 90875 None 0 Human Binding pEC50 = 6.4 6.4 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
71733842 90889 None 0 Human Binding pEC50 = 6.4 6.4 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392173 90889 None 0 Human Binding pEC50 = 6.4 6.4 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
73294321 92251 None 0 Human Binding pEC50 = 8.4 8.4 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1F 10.1021/jm4009373
CHEMBL2425820 92251 None 0 Human Binding pEC50 = 8.4 8.4 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1F 10.1021/jm4009373
73294320 92250 None 0 Human Binding pEC50 = 8.4 8.4 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
CHEMBL2425819 92250 None 0 Human Binding pEC50 = 8.4 8.4 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
71733747 90886 None 0 Human Binding pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm400587g
CHEMBL2392170 90886 None 0 Human Binding pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm400587g
3325 2338 None 44 Human Binding pEC50 = 5.4 5.4 - 0
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
44564 2338 None 44 Human Binding pEC50 = 5.4 5.4 - 0
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
9743 2338 None 44 Human Binding pEC50 = 5.4 5.4 - 0
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
CHEMBL1201266 2338 None 44 Human Binding pEC50 = 5.4 5.4 - 0
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
DB06794 2338 None 44 Human Binding pEC50 = 5.4 5.4 - 0
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
2161 8735 None 73 Human Binding pEC50 = 5.4 5.4 - 0
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 10.1021/acs.jmedchem.6b01431
CHEMBL1096 8735 None 73 Human Binding pEC50 = 5.4 5.4 - 0
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 10.1021/acs.jmedchem.6b01431
71733848 90895 None 0 Rat Binding pEC50 = 5.4 5.4 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
CHEMBL2392179 90895 None 0 Rat Binding pEC50 = 5.4 5.4 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
13681 115308 None 44 Human Binding pEC50 = 4.4 4.4 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 218 2 1 5 1.9 O=[N+]([O-])c1cc(Cl)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3347428 115308 None 44 Human Binding pEC50 = 4.4 4.4 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 218 2 1 5 1.9 O=[N+]([O-])c1cc(Cl)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
171348957 194383 None 0 Human Binding pEC50 = 7.4 7.4 - 1
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 804 14 3 12 6.6 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5285029 194383 None 0 Human Binding pEC50 = 7.4 7.4 - 1
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 804 14 3 12 6.6 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
71734944 90864 None 0 Human Binding pEC50 = 5.4 5.4 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm400587g
CHEMBL2392148 90864 None 0 Human Binding pEC50 = 5.4 5.4 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm400587g
135399235 4134 None 41 Human Binding pEC50 = 5.4 5.4 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
2919 4134 None 41 Human Binding pEC50 = 5.4 5.4 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
5722 4134 None 41 Human Binding pEC50 = 5.4 5.4 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
CHEMBL28079 4134 None 41 Human Binding pEC50 = 5.4 5.4 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
71733846 90893 None 0 Human Binding pEC50 = 6.4 6.4 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 90893 None 0 Human Binding pEC50 = 6.4 6.4 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
71733846 90893 None 0 Human Binding pEC50 = 6.4 6.4 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 90893 None 0 Human Binding pEC50 = 6.4 6.4 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
21236027 159079 None 5 Human Binding pEC50 = 5.4 5.4 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 313 2 1 5 2.2 O=C(O)c1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4096323 159079 None 5 Human Binding pEC50 = 5.4 5.4 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 313 2 1 5 2.2 O=C(O)c1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
71733652 90880 None 0 Human Binding pEC50 = 6.4 6.4 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392164 90880 None 0 Human Binding pEC50 = 6.4 6.4 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
13950957 157420 None 8 Human Binding pEC50 = 5.4 5.4 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4077503 157420 None 8 Human Binding pEC50 = 5.4 5.4 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
21982642 90859 None 0 Human Binding pEC50 = 4.3 4.3 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 235 2 1 5 1.4 O=C(O)c1cc(=O)c2cccc([N+](=O)[O-])c2o1 10.1021/jm400587g
CHEMBL2392142 90859 None 0 Human Binding pEC50 = 4.3 4.3 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 235 2 1 5 1.4 O=C(O)c1cc(=O)c2cccc([N+](=O)[O-])c2o1 10.1021/jm400587g
71734946 90867 None 0 Human Binding pEC50 = 5.3 5.3 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm4009373
CHEMBL2392151 90867 None 0 Human Binding pEC50 = 5.3 5.3 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm4009373
71734946 90867 None 0 Human Binding pEC50 = 5.3 5.3 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm400587g
CHEMBL2392151 90867 None 0 Human Binding pEC50 = 5.3 5.3 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm400587g
71735036 90873 None 0 Human Binding pEC50 = 6.3 6.3 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 90873 None 0 Human Binding pEC50 = 6.3 6.3 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137646246 157827 None 4 Human Binding pEC50 = 6.3 6.3 - 0
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4082281 157827 None 4 Human Binding pEC50 = 6.3 6.3 - 0
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
2882 1208 None 41 Mouse Binding pEC50 = 5.3 5.3 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
741 1208 None 41 Mouse Binding pEC50 = 5.3 5.3 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
7608 1208 None 41 Mouse Binding pEC50 = 5.3 5.3 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
CHEMBL428880 1208 None 41 Mouse Binding pEC50 = 5.3 5.3 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
DB01003 1208 None 41 Mouse Binding pEC50 = 5.3 5.3 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
171356399 194234 None 0 Human Binding pEC50 = 7.3 7.3 - 1
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 790 13 3 12 6.2 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5281778 194234 None 0 Human Binding pEC50 = 7.3 7.3 - 1
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 790 13 3 12 6.2 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
71735031 90865 None 0 Human Binding pEC50 = 5.3 5.3 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392149 90865 None 0 Human Binding pEC50 = 5.3 5.3 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
71735031 90865 None 0 Human Binding pEC50 = 5.3 5.3 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392149 90865 None 0 Human Binding pEC50 = 5.3 5.3 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
4659569 22338 None 65 Human Binding pEC50 = 4.3 4.3 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1039/C2MD20210G
CHEMBL1324 22338 None 65 Human Binding pEC50 = 4.3 4.3 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1039/C2MD20210G
71733845 90892 None 0 Mouse Binding pEC50 = 5.3 5.3 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392176 90892 None 0 Mouse Binding pEC50 = 5.3 5.3 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733940 90899 None 0 Mouse Binding pEC50 = 5.3 5.3 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
CHEMBL2392183 90899 None 0 Mouse Binding pEC50 = 5.3 5.3 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
73294508 1140 None 0 Human Binding pEC50 = 8.3 8.3 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
9742 1140 None 0 Human Binding pEC50 = 8.3 8.3 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
CHEMBL2425821 1140 None 0 Human Binding pEC50 = 8.3 8.3 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
137662152 159485 None 11 Human Binding pEC50 = 8.2 8.2 - 1
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4100677 159485 None 11 Human Binding pEC50 = 8.2 8.2 - 1
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137662152 159485 None 11 Human Binding pEC50 = 8.2 8.2 - 1
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4100677 159485 None 11 Human Binding pEC50 = 8.2 8.2 - 1
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
2920 2997 None 64 Human Binding pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm400587g
54742459 2997 None 64 Human Binding pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm400587g
8546 2997 None 64 Human Binding pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm400587g
CHEMBL177880 2997 None 64 Human Binding pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm400587g
2920 2997 None 64 Human Binding pEC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
54742459 2997 None 64 Human Binding pEC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
8546 2997 None 64 Human Binding pEC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
CHEMBL177880 2997 None 64 Human Binding pEC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
71735036 90873 None 0 Mouse Binding pEC50 = 5.3 5.3 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 90873 None 0 Mouse Binding pEC50 = 5.3 5.3 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137646246 157827 None 4 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4082281 157827 None 4 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
137646246 157827 None 4 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4082281 157827 None 4 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
2882 1208 None 41 Human Binding pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
741 1208 None 41 Human Binding pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
7608 1208 None 41 Human Binding pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
CHEMBL428880 1208 None 41 Human Binding pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
DB01003 1208 None 41 Human Binding pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
2882 1208 None 41 Human Binding pEC50 = 6.3 6.3 - 1
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
741 1208 None 41 Human Binding pEC50 = 6.3 6.3 - 1
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
7608 1208 None 41 Human Binding pEC50 = 6.3 6.3 - 1
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL428880 1208 None 41 Human Binding pEC50 = 6.3 6.3 - 1
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
DB01003 1208 None 41 Human Binding pEC50 = 6.3 6.3 - 1
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
2882 1208 None 41 Human Binding pEC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
741 1208 None 41 Human Binding pEC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
7608 1208 None 41 Human Binding pEC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
CHEMBL428880 1208 None 41 Human Binding pEC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
DB01003 1208 None 41 Human Binding pEC50 = 6.3 6.3 - 1
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
9492 5471 None 25 Human Binding pEC50 = 4.3 4.3 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1ccc([N+](=O)[O-])c(O)c1 10.1039/C2MD20210G
CHEMBL107513 5471 None 25 Human Binding pEC50 = 4.3 4.3 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1ccc([N+](=O)[O-])c(O)c1 10.1039/C2MD20210G
11872 107519 None 41 Human Binding pEC50 = 5.3 5.3 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3183545 107519 None 41 Human Binding pEC50 = 5.3 5.3 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
4921319 107517 None 34 Human Binding pEC50 = 5.3 5.3 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 199 2 2 6 0.8 Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3183248 107517 None 34 Human Binding pEC50 = 5.3 5.3 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 199 2 2 6 0.8 Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
71735032 90869 None 0 Human Binding pEC50 = 5.3 5.3 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392153 90869 None 0 Human Binding pEC50 = 5.3 5.3 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
3495594 17196 None 28 Human Binding pEC50 = 4.3 4.3 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 277 3 2 5 2.4 O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F 10.1039/C2MD20210G
CHEMBL1256291 17196 None 28 Human Binding pEC50 = 4.3 4.3 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 277 3 2 5 2.4 O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F 10.1039/C2MD20210G
13681 115308 None 44 Human Binding pEC50 = 5.3 5.3 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 218 2 1 5 1.9 O=[N+]([O-])c1cc(Cl)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3347428 115308 None 44 Human Binding pEC50 = 5.3 5.3 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 218 2 1 5 1.9 O=[N+]([O-])c1cc(Cl)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
1231538 27526 None 29 Human Binding pEC50 = 6.3 6.3 - 0
Antagonist activity at human N-terminal HA-tagged GPR35a expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of agonist induced redistribution of GFP-fused beta arrestin-2 preincubated for 15 mins followed by agonist addition by fluorescence assayAntagonist activity at human N-terminal HA-tagged GPR35a expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of agonist induced redistribution of GFP-fused beta arrestin-2 preincubated for 15 mins followed by agonist addition by fluorescence assay
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL1368962 27526 None 29 Human Binding pEC50 = 6.3 6.3 - 0
Antagonist activity at human N-terminal HA-tagged GPR35a expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of agonist induced redistribution of GFP-fused beta arrestin-2 preincubated for 15 mins followed by agonist addition by fluorescence assayAntagonist activity at human N-terminal HA-tagged GPR35a expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of agonist induced redistribution of GFP-fused beta arrestin-2 preincubated for 15 mins followed by agonist addition by fluorescence assay
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
5281081 210115 None 57 Human Binding pEC50 = 5.3 5.3 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL953 210115 None 57 Human Binding pEC50 = 5.3 5.3 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
137632988 156459 None 4 Human Binding pEC50 = 6.2 6.2 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4066109 156459 None 4 Human Binding pEC50 = 6.2 6.2 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
171345773 194513 None 0 Human Binding pEC50 = 7.2 7.2 - 1
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 806 14 3 13 5.4 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCOCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5288015 194513 None 0 Human Binding pEC50 = 7.2 7.2 - 1
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 806 14 3 13 5.4 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCOCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
6191 115306 None 21 Human Binding pEC50 = 4.2 4.2 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc(O)c1[N+](=O)[O-] 10.1039/C2MD20210G
CHEMBL3347393 115306 None 21 Human Binding pEC50 = 4.2 4.2 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc(O)c1[N+](=O)[O-] 10.1039/C2MD20210G
71733847 90894 None 0 Human Binding pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
CHEMBL2392178 90894 None 0 Human Binding pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
3254949 115310 None 3 Human Binding pEC50 = 8.2 8.2 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 460 6 2 10 3.9 O=[N+]([O-])c1cc(C(=C(Cl)Cl)c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3347474 115310 None 3 Human Binding pEC50 = 8.2 8.2 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 460 6 2 10 3.9 O=[N+]([O-])c1cc(C(=C(Cl)Cl)c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
73294319 92254 None 0 Human Binding pEC50 = 8.2 8.2 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 391 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
CHEMBL2425824 92254 None 0 Human Binding pEC50 = 8.2 8.2 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 391 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
135399235 4134 None 41 Rat Binding pEC50 = 7.2 7.2 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2919 4134 None 41 Rat Binding pEC50 = 7.2 7.2 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
5722 4134 None 41 Rat Binding pEC50 = 7.2 7.2 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
CHEMBL28079 4134 None 41 Rat Binding pEC50 = 7.2 7.2 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
118985385 1701 None 63 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
1258 1701 None 63 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
3440 1701 None 63 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
4839 1701 None 63 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
CHEMBL35 1701 None 63 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
DB00695 1701 None 63 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
71733846 90893 None 0 Human Binding pEC50 = 6.2 6.2 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 90893 None 0 Human Binding pEC50 = 6.2 6.2 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
71733844 90891 None 0 Human Binding pEC50 = 6.2 6.2 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392175 90891 None 0 Human Binding pEC50 = 6.2 6.2 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733846 90893 None 0 Mouse Binding pEC50 = 5.2 5.2 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 90893 None 0 Mouse Binding pEC50 = 5.2 5.2 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
5281081 210115 None 57 Human Binding pEC50 = 4.2 4.2 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL953 210115 None 57 Human Binding pEC50 = 4.2 4.2 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
137653726 158768 None 4 Human Binding pEC50 = 7.2 7.2 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4092954 158768 None 4 Human Binding pEC50 = 7.2 7.2 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
2918 2204 None 75 Rat Binding pEC50 = 4.2 4.2 - 0
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
3845 2204 None 75 Rat Binding pEC50 = 4.2 4.2 - 0
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
CHEMBL299155 2204 None 75 Rat Binding pEC50 = 4.2 4.2 - 0
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
DB11937 2204 None 75 Rat Binding pEC50 = 4.2 4.2 - 0
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
71734943 90863 None 0 Rat Binding pEC50 = 5.2 5.2 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392147 90863 None 0 Rat Binding pEC50 = 5.2 5.2 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
20486870 61117 None 4 Human Binding pEC50 = 5.2 5.2 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 214 1 1 5 1.0 O=c1oc2ccccc2cc1-c1nn[nH]n1 10.1021/acs.jmedchem.6b01431
CHEMBL1765162 61117 None 4 Human Binding pEC50 = 5.2 5.2 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 214 1 1 5 1.0 O=c1oc2ccccc2cc1-c1nn[nH]n1 10.1021/acs.jmedchem.6b01431
71733647 90874 None 0 Human Binding pEC50 = 6.2 6.2 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm400587g
CHEMBL2392158 90874 None 0 Human Binding pEC50 = 6.2 6.2 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm400587g
137653726 158768 None 4 Human Binding pEC50 = 7.2 7.2 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4092954 158768 None 4 Human Binding pEC50 = 7.2 7.2 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
10800 163504 None 34 Human Binding pEC50 = 5.2 5.2 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL419564 163504 None 34 Human Binding pEC50 = 5.2 5.2 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
71735033 90870 None 0 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 354 4 2 6 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1cccc([N+](=O)[O-])c1 10.1021/jm400587g
CHEMBL2392154 90870 None 0 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 354 4 2 6 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1cccc([N+](=O)[O-])c1 10.1021/jm400587g
71733746 90885 None 0 Human Binding pEC50 = 6.2 6.2 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392169 90885 None 0 Human Binding pEC50 = 6.2 6.2 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
137632988 156459 None 4 Human Binding pEC50 = 6.2 6.2 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4066109 156459 None 4 Human Binding pEC50 = 6.2 6.2 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
2882 1208 None 41 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
741 1208 None 41 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
7608 1208 None 41 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL428880 1208 None 41 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
DB01003 1208 None 41 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
2882 1208 None 41 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
741 1208 None 41 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
7608 1208 None 41 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
CHEMBL428880 1208 None 41 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
DB01003 1208 None 41 Human Binding pEC50 = 5.2 5.2 - 1
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
137632781 156378 None 4 Human Binding pEC50 = 5.2 5.2 - 0
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4065291 156378 None 4 Human Binding pEC50 = 5.2 5.2 - 0
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137641148 157139 None 4 Human Binding pEC50 = 6.2 6.2 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 308 1 2 6 1.4 O=c1oc2cc(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4073902 157139 None 4 Human Binding pEC50 = 6.2 6.2 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 308 1 2 6 1.4 O=c1oc2cc(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
4659569 22338 None 65 Human Binding pEC50 = 5.1 5.1 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1039/C2MD20210G
CHEMBL1324 22338 None 65 Human Binding pEC50 = 5.1 5.1 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1039/C2MD20210G
11312 111581 None 28 Human Binding pEC50 = 4.1 4.1 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3278560 111581 None 28 Human Binding pEC50 = 4.1 4.1 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc([N+](=O)[O-])c1O 10.1039/C2MD20210G
171351254 194562 None 0 Human Binding pEC50 = 7.1 7.1 - 1
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 776 12 3 12 5.8 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5289040 194562 None 0 Human Binding pEC50 = 7.1 7.1 - 1
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 776 12 3 12 5.8 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
135468531 90858 None 19 Rat Binding pEC50 = 5.1 5.1 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
CHEMBL2392141 90858 None 19 Rat Binding pEC50 = 5.1 5.1 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
71733647 90874 None 0 Human Binding pEC50 = 6.1 6.1 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm400587g
CHEMBL2392158 90874 None 0 Human Binding pEC50 = 6.1 6.1 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm400587g
10800 163504 None 34 Human Binding pEC50 = 4.1 4.1 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL419564 163504 None 34 Human Binding pEC50 = 4.1 4.1 - 0
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
5464105 57849 None 47 Human Binding pEC50 = 6.1 6.1 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 265 4 2 6 1.6 CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O 10.1039/C2MD20210G
CHEMBL167055 57849 None 47 Human Binding pEC50 = 6.1 6.1 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 265 4 2 6 1.6 CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O 10.1039/C2MD20210G
137654727 158837 None 4 Human Binding pEC50 = 5.1 5.1 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 357 1 0 4 3.2 COc1c(Br)cc2cc(C#N)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4093683 158837 None 4 Human Binding pEC50 = 5.1 5.1 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 357 1 0 4 3.2 COc1c(Br)cc2cc(C#N)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
71733746 90885 None 0 Human Binding pEC50 = 6.1 6.1 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392169 90885 None 0 Human Binding pEC50 = 6.1 6.1 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
5066064 157464 None 5 Human Binding pEC50 = 5.1 5.1 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 239 0 0 3 3.0 N#Cc1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4078055 157464 None 5 Human Binding pEC50 = 5.1 5.1 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 239 0 0 3 3.0 N#Cc1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
3495594 17196 None 28 Human Binding pEC50 = 5.1 5.1 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 277 3 2 5 2.4 O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F 10.1039/C2MD20210G
CHEMBL1256291 17196 None 28 Human Binding pEC50 = 5.1 5.1 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 277 3 2 5 2.4 O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F 10.1039/C2MD20210G
71733648 90875 None 0 Human Binding pEC50 = 6.1 6.1 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
CHEMBL2392159 90875 None 0 Human Binding pEC50 = 6.1 6.1 - 1
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
137658472 159894 None 4 Human Binding pEC50 = 6.1 6.1 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4105535 159894 None 4 Human Binding pEC50 = 6.1 6.1 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
137658472 159894 None 4 Human Binding pEC50 = 6.1 6.1 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4105535 159894 None 4 Human Binding pEC50 = 6.1 6.1 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
71734945 90866 None 0 Human Binding pEC50 = 5.1 5.1 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 4 2 4 2.7 O=C(Cc1ccccc1)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392150 90866 None 0 Human Binding pEC50 = 5.1 5.1 - 1
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 4 2 4 2.7 O=C(Cc1ccccc1)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
10752 208275 None 69 Human Binding pEC50 = 4.0 4.0 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 190 1 1 3 1.5 O=C(O)c1cc2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL83294 208275 None 69 Human Binding pEC50 = 4.0 4.0 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 190 1 1 3 1.5 O=C(O)c1cc2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
137643561 158144 None 4 Human Binding pEC50 = 5.0 5.0 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 265 0 1 4 2.1 N#Cc1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4085935 158144 None 4 Human Binding pEC50 = 5.0 5.0 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 265 0 1 4 2.1 N#Cc1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
137632781 156378 None 4 Human Binding pEC50 = 6.0 6.0 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4065291 156378 None 4 Human Binding pEC50 = 6.0 6.0 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137632781 156378 None 4 Human Binding pEC50 = 6.0 6.0 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4065291 156378 None 4 Human Binding pEC50 = 6.0 6.0 - 0
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
54676038 38734 None 51 Human Binding pEC50 = 5.0 5.0 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
CHEMBL1466 38734 None 51 Human Binding pEC50 = 5.0 5.0 - 1
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
135399235 4134 None 41 Mouse Binding pEC50 = 6.0 6.0 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2919 4134 None 41 Mouse Binding pEC50 = 6.0 6.0 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
5722 4134 None 41 Mouse Binding pEC50 = 6.0 6.0 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
CHEMBL28079 4134 None 41 Mouse Binding pEC50 = 6.0 6.0 - 1
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2882 1208 None 41 Rat Binding pEC50 = 6.0 6.0 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
741 1208 None 41 Rat Binding pEC50 = 6.0 6.0 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
7608 1208 None 41 Rat Binding pEC50 = 6.0 6.0 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
CHEMBL428880 1208 None 41 Rat Binding pEC50 = 6.0 6.0 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
DB01003 1208 None 41 Rat Binding pEC50 = 6.0 6.0 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
71733940 90899 None 0 Rat Binding pEC50 = 6 6.0 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
CHEMBL2392183 90899 None 0 Rat Binding pEC50 = 6 6.0 - 1
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
5281855 205301 None 65 Human Binding pIC50 = 7 7.0 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
CHEMBL6246 205301 None 65 Human Binding pIC50 = 7 7.0 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
10752 208275 None 69 Human Binding pIC50 = 4 4.0 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 190 1 1 3 1.5 O=C(O)c1cc2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL83294 208275 None 69 Human Binding pIC50 = 4 4.0 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 190 1 1 3 1.5 O=C(O)c1cc2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
171351254 194562 None 0 Human Binding pIC50 = 6.0 6.0 - 1
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145
ChEMBL 776 12 3 12 5.8 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5289040 194562 None 0 Human Binding pIC50 = 6.0 6.0 - 1
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145
ChEMBL 776 12 3 12 5.8 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
2745687 933 None 27 Human Binding pIC50 = 5.0 5.0 - 1
Antagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assayAntagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
9741 933 None 27 Human Binding pIC50 = 5.0 5.0 - 1
Antagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assayAntagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
CHEMBL1708510 933 None 27 Human Binding pIC50 = 5.0 5.0 - 1
Antagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assayAntagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
725495 65557 None 43 Human Binding pIC50 = 6.0 6.0 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1830823 65557 None 43 Human Binding pIC50 = 6.0 6.0 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
16103462 68091 None 17 Human Binding pIC50 = 7.0 7.0 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
CHEMBL1914588 68091 None 17 Human Binding pIC50 = 7.0 7.0 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
153273978 198382 None 6 Human Binding pIC50 = 7.0 7.0 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
5098885 198382 None 6 Human Binding pIC50 = 7.0 7.0 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
CHEMBL559337 198382 None 6 Human Binding pIC50 = 7.0 7.0 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
694463 87514 None 63 Human Binding pIC50 = 5.0 5.0 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 268 1 1 3 2.3 O=C(O)c1cc2cc(Br)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL2333943 87514 None 63 Human Binding pIC50 = 5.0 5.0 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 268 1 1 3 2.3 O=C(O)c1cc2cc(Br)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
135399235 4134 None 41 Human Binding pIC50 = 5.9 5.9 - 1
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
2919 4134 None 41 Human Binding pIC50 = 5.9 5.9 - 1
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
5722 4134 None 41 Human Binding pIC50 = 5.9 5.9 - 1
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
CHEMBL28079 4134 None 41 Human Binding pIC50 = 5.9 5.9 - 1
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
4488 205479 None 66 Human Binding pIC50 = 5.9 5.9 - 1
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
CHEMBL63323 205479 None 66 Human Binding pIC50 = 5.9 5.9 - 1
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
137652009 157606 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4079816 157606 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137635873 155962 None 0 Human Binding pIC50 = 4.9 4.9 - 0
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 539 6 1 6 5.0 O=C(Nc1ccc2nc([S+]([O-])Cc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL4060393 155962 None 0 Human Binding pIC50 = 4.9 4.9 - 0
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 539 6 1 6 5.0 O=C(Nc1ccc2nc([S+]([O-])Cc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
271643 32788 None 45 Human Binding pIC50 = 4.9 4.9 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 224 1 1 3 2.1 O=C(O)c1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1414071 32788 None 45 Human Binding pIC50 = 4.9 4.9 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 224 1 1 3 2.1 O=C(O)c1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
137636652 156140 None 4 Human Binding pIC50 = 4.9 4.9 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 322 2 1 6 1.7 COc1cc2oc(=O)c(-c3nnn[nH]3)cc2cc1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4062531 156140 None 4 Human Binding pIC50 = 4.9 4.9 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 322 2 1 6 1.7 COc1cc2oc(=O)c(-c3nnn[nH]3)cc2cc1Br 10.1021/acs.jmedchem.6b01431
137655259 159060 None 4 Human Binding pIC50 = 4.8 4.8 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 327 0 0 3 3.2 N#Cc1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4096105 159060 None 4 Human Binding pIC50 = 4.8 4.8 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 327 0 0 3 3.2 N#Cc1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
5280343 188382 None 69 Human Binding pIC50 = 4.8 4.8 - 32
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL1520590 188382 None 69 Human Binding pIC50 = 4.8 4.8 - 32
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL50 188382 None 69 Human Binding pIC50 = 4.8 4.8 - 32
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
411 2593 None 63 Human Binding pIC50 = 5.8 5.8 - 3
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
5281670 2593 None 63 Human Binding pIC50 = 5.8 5.8 - 3
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
CHEMBL28626 2593 None 63 Human Binding pIC50 = 5.8 5.8 - 3
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
137647862 157745 None 4 Human Binding pIC50 = 5.8 5.8 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 324 2 0 6 2.3 COc1c(Br)cc2cc(C#N)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
CHEMBL4081445 157745 None 4 Human Binding pIC50 = 5.8 5.8 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 324 2 0 6 2.3 COc1c(Br)cc2cc(C#N)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
137647638 157730 None 0 Human Binding pIC50 = 4.8 4.8 - 0
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 537 6 1 6 6.5 CC(Sc1nc2ccc(NC(=O)c3ccccc3C(=O)N3CCOCC3)cc2s1)c1ccc(Cl)cc1 10.1016/j.bmcl.2016.12.012
CHEMBL4081331 157730 None 0 Human Binding pIC50 = 4.8 4.8 - 0
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 537 6 1 6 6.5 CC(Sc1nc2ccc(NC(=O)c3ccccc3C(=O)N3CCOCC3)cc2s1)c1ccc(Cl)cc1 10.1016/j.bmcl.2016.12.012
5215 2386 None 74 Human Binding pIC50 = 4.7 4.7 - 1
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
5280445 2386 None 74 Human Binding pIC50 = 4.7 4.7 - 1
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
CHEMBL151 2386 None 74 Human Binding pIC50 = 4.7 4.7 - 1
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
2745687 933 None 27 Human Binding pIC50 = 6.7 6.7 - 1
Antagonist activity at GPR-35 (unknown origin) by beta-arrestin assayAntagonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
9741 933 None 27 Human Binding pIC50 = 6.7 6.7 - 1
Antagonist activity at GPR-35 (unknown origin) by beta-arrestin assayAntagonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
CHEMBL1708510 933 None 27 Human Binding pIC50 = 6.7 6.7 - 1
Antagonist activity at GPR-35 (unknown origin) by beta-arrestin assayAntagonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
2745687 933 None 27 Human Binding pIC50 = 6.7 6.7 - 1
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
9741 933 None 27 Human Binding pIC50 = 6.7 6.7 - 1
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
CHEMBL1708510 933 None 27 Human Binding pIC50 = 6.7 6.7 - 1
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
5281672 56570 None 72 Human Binding pIC50 = 5.7 5.7 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL164 56570 None 72 Human Binding pIC50 = 5.7 5.7 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
782693 158333 None 19 Human Binding pIC50 = 4.7 4.7 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 205 0 0 3 2.3 N#Cc1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4088382 158333 None 19 Human Binding pIC50 = 4.7 4.7 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 205 0 0 3 2.3 N#Cc1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
137653726 158768 None 4 Human Binding pIC50 = 7.6 7.6 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4092954 158768 None 4 Human Binding pIC50 = 7.6 7.6 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
657910 53468 None 35 Human Binding pIC50 = 5.6 5.6 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 258 1 1 3 2.8 O=C(O)c1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1600989 53468 None 35 Human Binding pIC50 = 5.6 5.6 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 258 1 1 3 2.8 O=C(O)c1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
2286812 29474 None 32 Human Binding pIC50 = 7.6 7.6 - 1
Antagonist activity at GPR-35 (unknown origin) by beta-arrestin assayAntagonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/acsmedchemlett.2c00461
CHEMBL1384502 29474 None 32 Human Binding pIC50 = 7.6 7.6 - 1
Antagonist activity at GPR-35 (unknown origin) by beta-arrestin assayAntagonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/acsmedchemlett.2c00461
2286812 29474 None 32 Human Binding pIC50 = 7.6 7.6 - 1
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
CHEMBL1384502 29474 None 32 Human Binding pIC50 = 7.6 7.6 - 1
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
137646097 157992 None 4 Human Binding pIC50 = 5.6 5.6 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 367 3 1 8 1.7 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
CHEMBL4084237 157992 None 4 Human Binding pIC50 = 5.6 5.6 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 367 3 1 8 1.7 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
5281605 208190 None 72 Human Binding pIC50 = 4.6 4.6 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
CHEMBL8260 208190 None 72 Human Binding pIC50 = 4.6 4.6 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
137658268 159756 None 4 Human Binding pIC50 = 5.5 5.5 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4103860 159756 None 4 Human Binding pIC50 = 5.5 5.5 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
135403802 26539 None 39 Human Binding pIC50 = 4.5 4.5 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
CHEMBL1360563 26539 None 39 Human Binding pIC50 = 4.5 4.5 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
5328791 207442 None 48 Human Binding pIC50 = 4.5 4.5 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
CHEMBL76602 207442 None 48 Human Binding pIC50 = 4.5 4.5 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
137646246 157827 None 4 Human Binding pIC50 = 7.5 7.5 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4082281 157827 None 4 Human Binding pIC50 = 7.5 7.5 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
137648473 158084 None 4 Human Binding pIC50 = 6.5 6.5 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4085211 158084 None 4 Human Binding pIC50 = 6.5 6.5 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
21236027 159079 None 5 Human Binding pIC50 = 5.4 5.4 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 313 2 1 5 2.2 O=C(O)c1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4096323 159079 None 5 Human Binding pIC50 = 5.4 5.4 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 313 2 1 5 2.2 O=C(O)c1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
13950957 157420 None 8 Human Binding pIC50 = 5.4 5.4 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4077503 157420 None 8 Human Binding pIC50 = 5.4 5.4 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
137632781 156378 None 4 Human Binding pIC50 = 6.4 6.4 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4065291 156378 None 4 Human Binding pIC50 = 6.4 6.4 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
5491415 75318 None 18 Human Binding pIC50 = 6.4 6.4 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
CHEMBL2037378 75318 None 18 Human Binding pIC50 = 6.4 6.4 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
2918 2204 None 75 Human Binding pIC50 = 4.4 4.4 - 0
Antagonist activity at GPR35 (unknown origin)Antagonist activity at GPR35 (unknown origin)
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2016.12.012
3845 2204 None 75 Human Binding pIC50 = 4.4 4.4 - 0
Antagonist activity at GPR35 (unknown origin)Antagonist activity at GPR35 (unknown origin)
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2016.12.012
CHEMBL299155 2204 None 75 Human Binding pIC50 = 4.4 4.4 - 0
Antagonist activity at GPR35 (unknown origin)Antagonist activity at GPR35 (unknown origin)
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2016.12.012
DB11937 2204 None 75 Human Binding pIC50 = 4.4 4.4 - 0
Antagonist activity at GPR35 (unknown origin)Antagonist activity at GPR35 (unknown origin)
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2016.12.012
171348957 194383 None 0 Human Binding pIC50 = 6.4 6.4 - 1
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145
ChEMBL 804 14 3 12 6.6 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5285029 194383 None 0 Human Binding pIC50 = 6.4 6.4 - 1
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145
ChEMBL 804 14 3 12 6.6 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
73157 197815 None 27 Human Binding pIC50 = 5.3 5.3 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
CHEMBL551842 197815 None 27 Human Binding pIC50 = 5.3 5.3 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
1231538 27526 None 29 Human Binding pIC50 = 5.3 5.3 - 0
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL1368962 27526 None 29 Human Binding pIC50 = 5.3 5.3 - 0
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
137657450 159689 None 4 Human Binding pIC50 = 6.3 6.3 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4103143 159689 None 4 Human Binding pIC50 = 6.3 6.3 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
3884 44512 None 53 Human Binding pIC50 = 5.3 5.3 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
CHEMBL15193 44512 None 53 Human Binding pIC50 = 5.3 5.3 - 0
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
137641148 157139 None 4 Human Binding pIC50 = 6.3 6.3 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 308 1 2 6 1.4 O=c1oc2cc(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4073902 157139 None 4 Human Binding pIC50 = 6.3 6.3 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 308 1 2 6 1.4 O=c1oc2cc(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
171348957 194383 None 0 Human Binding pIC50 = 8.3 8.3 - 1
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulationAgonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation
ChEMBL 804 14 3 12 6.6 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5285029 194383 None 0 Human Binding pIC50 = 8.3 8.3 - 1
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulationAgonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation
ChEMBL 804 14 3 12 6.6 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
20486870 61117 None 4 Human Binding pIC50 = 5.3 5.3 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 214 1 1 5 1.0 O=c1oc2ccccc2cc1-c1nn[nH]n1 10.1021/acs.jmedchem.6b01431
CHEMBL1765162 61117 None 4 Human Binding pIC50 = 5.3 5.3 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 214 1 1 5 1.0 O=c1oc2ccccc2cc1-c1nn[nH]n1 10.1021/acs.jmedchem.6b01431
2286812 29474 None 32 Human Binding pIC50 = 6.3 6.3 - 1
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
CHEMBL1384502 29474 None 32 Human Binding pIC50 = 6.3 6.3 - 1
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
137646699 157829 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 555 6 1 7 4.6 O=C(Nc1ccc2nc(S(=O)(=O)Cc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL4082295 157829 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 555 6 1 7 4.6 O=C(Nc1ccc2nc(S(=O)(=O)Cc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
171356399 194234 None 0 Human Binding pIC50 = 6.3 6.3 - 1
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145
ChEMBL 790 13 3 12 6.2 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5281778 194234 None 0 Human Binding pIC50 = 6.3 6.3 - 1
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145
ChEMBL 790 13 3 12 6.2 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
13950958 157720 None 4 Human Binding pIC50 = 7.3 7.3 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4081238 157720 None 4 Human Binding pIC50 = 7.3 7.3 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
2745687 933 None 27 Human Binding pIC50 = 6.2 6.2 - 1
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
9741 933 None 27 Human Binding pIC50 = 6.2 6.2 - 1
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
CHEMBL1708510 933 None 27 Human Binding pIC50 = 6.2 6.2 - 1
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
137654727 158837 None 4 Human Binding pIC50 = 6.2 6.2 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 357 1 0 4 3.2 COc1c(Br)cc2cc(C#N)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4093683 158837 None 4 Human Binding pIC50 = 6.2 6.2 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 357 1 0 4 3.2 COc1c(Br)cc2cc(C#N)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
137632988 156459 None 4 Human Binding pIC50 = 6.2 6.2 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4066109 156459 None 4 Human Binding pIC50 = 6.2 6.2 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
171345773 194513 None 0 Human Binding pIC50 = 8.1 8.1 - 1
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulationAgonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation
ChEMBL 806 14 3 13 5.4 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCOCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5288015 194513 None 0 Human Binding pIC50 = 8.1 8.1 - 1
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulationAgonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation
ChEMBL 806 14 3 13 5.4 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCOCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
5346366 41511 None 4 Human Binding pIC50 = 5.1 5.1 - 0
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 489 6 1 6 5.3 O=C(Nc1ccc2nc(SCc3ccccc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL1490915 41511 None 4 Human Binding pIC50 = 5.1 5.1 - 0
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 489 6 1 6 5.3 O=C(Nc1ccc2nc(SCc3ccccc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
137658472 159894 None 4 Human Binding pIC50 = 6.1 6.1 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4105535 159894 None 4 Human Binding pIC50 = 6.1 6.1 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
171345773 194513 None 0 Human Binding pIC50 = 6.1 6.1 - 1
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145
ChEMBL 806 14 3 13 5.4 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCOCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5288015 194513 None 0 Human Binding pIC50 = 6.1 6.1 - 1
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145
ChEMBL 806 14 3 13 5.4 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCOCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
137662152 159485 None 11 Human Binding pIC50 = 8.1 8.1 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4100677 159485 None 11 Human Binding pIC50 = 8.1 8.1 - 1
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
5066064 157464 None 5 Human Binding pIC50 = 5.1 5.1 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 239 0 0 3 3.0 N#Cc1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4078055 157464 None 5 Human Binding pIC50 = 5.1 5.1 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 239 0 0 3 3.0 N#Cc1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
171356399 194234 None 0 Human Binding pIC50 = 8.0 8.0 - 1
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulationAgonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation
ChEMBL 790 13 3 12 6.2 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5281778 194234 None 0 Human Binding pIC50 = 8.0 8.0 - 1
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulationAgonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation
ChEMBL 790 13 3 12 6.2 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
171351254 194562 None 0 Human Binding pIC50 = 8.0 8.0 - 1
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulationAgonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation
ChEMBL 776 12 3 12 5.8 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5289040 194562 None 0 Human Binding pIC50 = 8.0 8.0 - 1
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulationAgonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation
ChEMBL 776 12 3 12 5.8 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
137643561 158144 None 4 Human Binding pIC50 = 5.0 5.0 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 265 0 1 4 2.1 N#Cc1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4085935 158144 None 4 Human Binding pIC50 = 5.0 5.0 - 0
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 265 0 1 4 2.1 N#Cc1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
71733843 90890 None 7 Human Binding pKd = 6.9 6.9 - 1
Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 90890 None 7 Human Binding pKd = 6.9 6.9 - 1
Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 90890 None 7 Human Binding pKd = 6.9 6.9 - 1
Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
171345773 194513 None 0 Human Binding pKd = 7.8 7.8 - 1
Binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assayBinding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assay
ChEMBL 806 14 3 13 5.4 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCOCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5288015 194513 None 0 Human Binding pKd = 7.8 7.8 - 1
Binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assayBinding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assay
ChEMBL 806 14 3 13 5.4 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCOCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
171356399 194234 None 0 Human Binding pKd = 8.4 8.4 - 1
Binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assayBinding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assay
ChEMBL 790 13 3 12 6.2 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5281778 194234 None 0 Human Binding pKd = 8.4 8.4 - 1
Binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assayBinding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assay
ChEMBL 790 13 3 12 6.2 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
71733843 90890 None 7 Human Binding pKd = 8.3 8.3 - 1
Binding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysisBinding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 90890 None 7 Human Binding pKd = 8.3 8.3 - 1
Binding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysisBinding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 90890 None 7 Human Binding pKd = 8.3 8.3 - 1
Binding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysisBinding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733843 90890 None 7 Human Binding pKd = 8.3 8.3 - 1
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 90890 None 7 Human Binding pKd = 8.3 8.3 - 1
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 90890 None 7 Human Binding pKd = 8.3 8.3 - 1
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733843 90890 None 7 Human Binding pKd = 8.2 8.2 - 1
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 90890 None 7 Human Binding pKd = 8.2 8.2 - 1
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 90890 None 7 Human Binding pKd = 8.2 8.2 - 1
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
171351254 194562 None 0 Human Binding pKd = 8.1 8.1 - 1
Binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assayBinding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assay
ChEMBL 776 12 3 12 5.8 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5289040 194562 None 0 Human Binding pKd = 8.1 8.1 - 1
Binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assayBinding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assay
ChEMBL 776 12 3 12 5.8 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
171348957 194383 None 0 Human Binding pKd = 8.1 8.1 - 1
Binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assayBinding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assay
ChEMBL 804 14 3 12 6.6 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5285029 194383 None 0 Human Binding pKd = 8.1 8.1 - 1
Binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assayBinding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assay
ChEMBL 804 14 3 12 6.6 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
73294508 1140 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
9742 1140 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
CHEMBL2425821 1140 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
71733748 90887 None 0 Human Binding pKi = 9.0 9.0 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
CHEMBL2392171 90887 None 0 Human Binding pKi = 9.0 9.0 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
71733848 90895 None 0 Human Binding pKi = 9.0 9.0 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm4009373
CHEMBL2392179 90895 None 0 Human Binding pKi = 9.0 9.0 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm4009373
73294320 92250 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
CHEMBL2425819 92250 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
73294321 92251 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1F 10.1021/jm4009373
CHEMBL2425820 92251 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1F 10.1021/jm4009373
73294319 92254 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 391 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
CHEMBL2425824 92254 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 391 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
145971442 163122 None 0 Human Binding pKi = 8 8.0 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.2c00461
CHEMBL4175848 163122 None 0 Human Binding pKi = 8 8.0 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.2c00461
2920 2997 None 64 Human Binding pKi = 8.0 8.0 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 2997 None 64 Human Binding pKi = 8.0 8.0 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 2997 None 64 Human Binding pKi = 8.0 8.0 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 2997 None 64 Human Binding pKi = 8.0 8.0 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71735035 90872 None 0 Human Binding pKi = 5.0 5.0 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 377 3 2 4 3.8 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(C(F)(F)F)cc1 10.1021/jm4009373
CHEMBL2392156 90872 None 0 Human Binding pKi = 5.0 5.0 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 377 3 2 4 3.8 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(C(F)(F)F)cc1 10.1021/jm4009373
2920 2997 None 64 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
54742459 2997 None 64 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
8546 2997 None 64 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
CHEMBL177880 2997 None 64 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
71733650 90877 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
CHEMBL2392161 90877 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
71733648 90875 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm4009373
CHEMBL2392159 90875 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm4009373
71733746 90885 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
CHEMBL2392169 90885 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
21982642 90859 None 0 Human Binding pKi = 4.9 4.9 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 235 2 1 5 1.4 O=C(O)c1cc(=O)c2cccc([N+](=O)[O-])c2o1 10.1021/jm4009373
CHEMBL2392142 90859 None 0 Human Binding pKi = 4.9 4.9 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 235 2 1 5 1.4 O=C(O)c1cc(=O)c2cccc([N+](=O)[O-])c2o1 10.1021/jm4009373
71733652 90880 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392164 90880 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
2920 2997 None 64 Human Binding pKi = 7.8 7.8 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 2997 None 64 Human Binding pKi = 7.8 7.8 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 2997 None 64 Human Binding pKi = 7.8 7.8 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 2997 None 64 Human Binding pKi = 7.8 7.8 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71733842 90889 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392173 90889 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733847 90894 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm4009373
CHEMBL2392178 90894 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm4009373
71733743 90882 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm4009373
CHEMBL2392166 90882 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm4009373
71734941 90861 None 0 Human Binding pKi = 4.7 4.7 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 247 2 2 4 1.5 CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392145 90861 None 0 Human Binding pKi = 4.7 4.7 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 247 2 2 4 1.5 CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
71734943 90863 None 0 Human Binding pKi = 4.7 4.7 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392147 90863 None 0 Human Binding pKi = 4.7 4.7 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
71734940 90879 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 385 5 1 6 3.4 CCOC(=O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(OC)cc3)c2o1 10.1021/jm4009373
CHEMBL2392163 90879 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 385 5 1 6 3.4 CCOC(=O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(OC)cc3)c2o1 10.1021/jm4009373
71733749 90888 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
CHEMBL2392172 90888 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
73294510 92253 None 0 Human Binding pKi = 7.7 7.7 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 369 5 2 6 2.8 COc1ccc(C(=O)Nc2cc(OC)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425823 92253 None 0 Human Binding pKi = 7.7 7.7 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 369 5 2 6 2.8 COc1ccc(C(=O)Nc2cc(OC)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71735036 90873 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392157 90873 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733846 90893 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm4009373
CHEMBL2392177 90893 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm4009373
2920 2997 None 64 Human Binding pKi = 7.6 7.6 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 2997 None 64 Human Binding pKi = 7.6 7.6 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 2997 None 64 Human Binding pKi = 7.6 7.6 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 2997 None 64 Human Binding pKi = 7.6 7.6 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71733647 90874 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm4009373
CHEMBL2392158 90874 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm4009373
2882 1208 None 41 Human Binding pKi = 5.6 5.6 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
741 1208 None 41 Human Binding pKi = 5.6 5.6 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
7608 1208 None 41 Human Binding pKi = 5.6 5.6 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
CHEMBL428880 1208 None 41 Human Binding pKi = 5.6 5.6 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
DB01003 1208 None 41 Human Binding pKi = 5.6 5.6 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
2745687 933 None 27 Human Binding pKi = 6.6 6.6 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
9741 933 None 27 Human Binding pKi = 6.6 6.6 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
CHEMBL1708510 933 None 27 Human Binding pKi = 6.6 6.6 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
71733651 90878 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392162 90878 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733940 90899 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm4009373
CHEMBL2392183 90899 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm4009373
71733653 90881 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
CHEMBL2392165 90881 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
71734945 90866 None 0 Human Binding pKi = 5.6 5.6 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 4 2 4 2.7 O=C(Cc1ccccc1)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392150 90866 None 0 Human Binding pKi = 5.6 5.6 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 4 2 4 2.7 O=C(Cc1ccccc1)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
154634314 186715 None 0 Human Binding pKi = 7.6 7.6 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acsmedchemlett.2c00461
CHEMBL4878979 186715 None 0 Human Binding pKi = 7.6 7.6 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acsmedchemlett.2c00461
2882 1208 None 41 Human Binding pKi = 5.5 5.5 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
741 1208 None 41 Human Binding pKi = 5.5 5.5 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
7608 1208 None 41 Human Binding pKi = 5.5 5.5 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL428880 1208 None 41 Human Binding pKi = 5.5 5.5 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
DB01003 1208 None 41 Human Binding pKi = 5.5 5.5 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
71734939 90860 None 1 Human Binding pKi = 5.5 5.5 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 283 1 2 4 1.8 Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392144 90860 None 1 Human Binding pKi = 5.5 5.5 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 283 1 2 4 1.8 Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
118985385 1701 None 63 Human Binding pKi = 5.5 5.5 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
1258 1701 None 63 Human Binding pKi = 5.5 5.5 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
3440 1701 None 63 Human Binding pKi = 5.5 5.5 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
4839 1701 None 63 Human Binding pKi = 5.5 5.5 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
CHEMBL35 1701 None 63 Human Binding pKi = 5.5 5.5 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
DB00695 1701 None 63 Human Binding pKi = 5.5 5.5 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
71735031 90865 None 0 Human Binding pKi = 5.5 5.5 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392149 90865 None 0 Human Binding pKi = 5.5 5.5 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
71733845 90892 None 0 Human Binding pKi = 6.5 6.5 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392176 90892 None 0 Human Binding pKi = 6.5 6.5 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
1024 16495 None 63 Human Binding pKi = 6.5 6.5 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acsmedchemlett.2c00461
CHEMBL1235421 16495 None 63 Human Binding pKi = 6.5 6.5 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acsmedchemlett.2c00461
13950958 157720 None 4 Human Binding pKi = 6.5 6.5 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acsmedchemlett.2c00461
CHEMBL4081238 157720 None 4 Human Binding pKi = 6.5 6.5 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acsmedchemlett.2c00461
71734944 90864 None 0 Human Binding pKi = 5.5 5.5 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm4009373
CHEMBL2392148 90864 None 0 Human Binding pKi = 5.5 5.5 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm4009373
4488 205479 None 66 Human Binding pKi = 5.4 5.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
CHEMBL63323 205479 None 66 Human Binding pKi = 5.4 5.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
71733937 90896 None 0 Human Binding pKi = 5.4 5.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 379 6 2 5 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(OCC2CC2)cc1 10.1021/jm4009373
CHEMBL2392180 90896 None 0 Human Binding pKi = 5.4 5.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 379 6 2 5 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(OCC2CC2)cc1 10.1021/jm4009373
54676038 38734 None 51 Human Binding pKi = 7.4 7.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
CHEMBL1466 38734 None 51 Human Binding pKi = 7.4 7.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
2286812 29474 None 32 Human Binding pKi = 8.4 8.4 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/acsmedchemlett.2c00461
CHEMBL1384502 29474 None 32 Human Binding pKi = 8.4 8.4 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/acsmedchemlett.2c00461
71733649 90876 None 0 Human Binding pKi = 8.4 8.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
CHEMBL2392160 90876 None 0 Human Binding pKi = 8.4 8.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
71733747 90886 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm4009373
CHEMBL2392170 90886 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm4009373
135399235 4134 None 41 Human Binding pKi = 6.4 6.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
2919 4134 None 41 Human Binding pKi = 6.4 6.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
5722 4134 None 41 Human Binding pKi = 6.4 6.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
CHEMBL28079 4134 None 41 Human Binding pKi = 6.4 6.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
2745687 933 None 27 Human Binding pKi = 7.4 7.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
9741 933 None 27 Human Binding pKi = 7.4 7.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
CHEMBL1708510 933 None 27 Human Binding pKi = 7.4 7.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
73294509 92252 None 0 Human Binding pKi = 7.4 7.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 353 4 2 5 3.1 COc1ccc(C(=O)Nc2cc(C)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425822 92252 None 0 Human Binding pKi = 7.4 7.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 353 4 2 5 3.1 COc1ccc(C(=O)Nc2cc(C)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71735033 90870 None 0 Human Binding pKi = 5.4 5.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 354 4 2 6 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1cccc([N+](=O)[O-])c1 10.1021/jm4009373
CHEMBL2392154 90870 None 0 Human Binding pKi = 5.4 5.4 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 354 4 2 6 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1cccc([N+](=O)[O-])c1 10.1021/jm4009373
71735032 90869 None 0 Human Binding pKi = 5.3 5.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
CHEMBL2392153 90869 None 0 Human Binding pKi = 5.3 5.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
71733843 90890 None 7 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 90890 None 7 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 90890 None 7 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733744 90883 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392167 90883 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
2295463 92255 None 29 Human Binding pKi = 7.3 7.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
CHEMBL2425825 92255 None 29 Human Binding pKi = 7.3 7.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
137662152 159485 None 11 Human Binding pKi = 7.3 7.3 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acsmedchemlett.2c00461
CHEMBL4100677 159485 None 11 Human Binding pKi = 7.3 7.3 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acsmedchemlett.2c00461
71733939 90898 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm4009373
CHEMBL2392182 90898 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm4009373
326869 112874 None 2 Human Binding pKi = 8.2 8.2 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acsmedchemlett.2c00461
CHEMBL3306990 112874 None 2 Human Binding pKi = 8.2 8.2 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acsmedchemlett.2c00461
135399235 4134 None 41 Human Binding pKi = 6.2 6.2 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
2919 4134 None 41 Human Binding pKi = 6.2 6.2 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
5722 4134 None 41 Human Binding pKi = 6.2 6.2 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
CHEMBL28079 4134 None 41 Human Binding pKi = 6.2 6.2 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
12138435 68079 None 26 Human Binding pKi = 6.2 6.2 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
CHEMBL1914576 68079 None 26 Human Binding pKi = 6.2 6.2 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
71734942 90862 None 0 Human Binding pKi = 5.2 5.2 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 261 3 2 4 1.8 CCC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392146 90862 None 0 Human Binding pKi = 5.2 5.2 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 261 3 2 4 1.8 CCC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
71735030 90868 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm4009373
CHEMBL2392152 90868 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm4009373
71735034 90871 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 3 2 4 3.1 Cc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392155 90871 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 3 2 4 3.1 Cc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71734946 90867 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm4009373
CHEMBL2392151 90867 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm4009373
2286812 29474 None 32 Human Binding pKi = 8.1 8.1 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
CHEMBL1384502 29474 None 32 Human Binding pKi = 8.1 8.1 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
2920 2997 None 64 Human Binding pKi = 8.1 8.1 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 2997 None 64 Human Binding pKi = 8.1 8.1 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 2997 None 64 Human Binding pKi = 8.1 8.1 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 2997 None 64 Human Binding pKi = 8.1 8.1 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71733938 90897 None 0 Human Binding pKi = 5.1 5.1 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 367 6 2 5 3.5 CCCOc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392181 90897 None 0 Human Binding pKi = 5.1 5.1 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 367 6 2 5 3.5 CCCOc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733745 90884 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392168 90884 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
2920 2997 None 64 Human Binding pKi = 8.0 8.0 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 2997 None 64 Human Binding pKi = 8.0 8.0 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 2997 None 64 Human Binding pKi = 8.0 8.0 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 2997 None 64 Human Binding pKi = 8.0 8.0 - 1
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71733844 90891 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392175 90891 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
92934 169760 None 56 Human Binding pKi = 5.0 5.0 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 280 2 2 6 1.9 O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1 10.1021/jm4009373
CHEMBL443738 169760 None 56 Human Binding pKi = 5.0 5.0 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 280 2 2 6 1.9 O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1 10.1021/jm4009373
4488 205479 None 66 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 None
CHEMBL63323 205479 None 66 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 None
118985385 1701 None 63 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
1258 1701 None 63 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
3440 1701 None 63 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
4839 1701 None 63 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
CHEMBL35 1701 None 63 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
DB00695 1701 None 63 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
2882 1208 None 41 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
741 1208 None 41 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
7608 1208 None 41 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
CHEMBL428880 1208 None 41 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
DB01003 1208 None 41 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
54676038 38734 None 51 Human Binding pKi = 8.1 8.1 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O None
CHEMBL1466 38734 None 51 Human Binding pKi = 8.1 8.1 - 1
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O None
2745687 933 None 27 Human Binding pKi = 7.9 7.9 - 1
Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 20826425
9741 933 None 27 Human Binding pKi = 7.9 7.9 - 1
Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 20826425
CHEMBL1708510 933 None 27 Human Binding pKi = 7.9 7.9 - 1
Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 20826425
2745687 933 None 27 Human Binding pKi = 7.4 7.4 - 1
In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
9741 933 None 27 Human Binding pKi = 7.4 7.4 - 1
In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
CHEMBL1708510 933 None 27 Human Binding pKi = 7.4 7.4 - 1
In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
73294508 1140 None 0 Human Binding pKi = 9.2 9.2 - 1
In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 23888932
9742 1140 None 0 Human Binding pKi = 9.2 9.2 - 1
In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 23888932
CHEMBL2425821 1140 None 0 Human Binding pKi = 9.2 9.2 - 1
In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 23888932